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Abstract
The United Arab Emirates (UAE) has one of the highest rates of type 2 diabetes
mellitus in the world. Prior to the onset of type 2 diabetes mellitus, a period of
moderate hyperglycemia is often present, referred to as prediabetes. This is associated
with a significant loss of pancreatic beta cells, an increased risk of cardiovascular
disease and other serious health issues. There are gaps in the literature concerning the
prevalence of prediabetes and its associated correlates, as well as correlations between
the conversion rates from prediabetes to type 2 diabetes mellitus.
The primary objective of this study was to determine the prevalence of prediabetes and
its correlates in adults. The secondary objective was to identify the proportion of
conversions of prediabetes to type 2 diabetes mellitus and the major correlates.
This research was based on secondary data collected during prediabetes interventions
in Al Ain and Dubai, two cities in the UAE. In Al Ain, a random sample (n=605) of
parents participated in type 2 diabetes mellitus screening in a family-based study. In
Dubai, 700 Emirati adults diagnosed with prediabetes, at five primary health care
centers, were invited to take part in the intervention study. After ethical approval and
gaining informed consent, socio-demographic, anthropometric, lifestyle and clinical
data were then collected. Prediabetes and type 2 diabetes mellitus were defined in
accordance with the American Diabetes Association’s guidelines: based on fasting
plasma glucose (FPG ≥126 mg/dl (≥7 mmol/l) for type 2 diabetes, 110-125 mg/dl (6.17 mmol/l) for prediabetes, (HbA1c ≥6.5%) for type 2 diabetes and (HbA1c 5.7-6.4%)
for prediabetes.
We used a multivariable multinomial logistic regression analysis to identify the
independent correlates for prediabetes and type 2 diabetes mellitus in comparison to
people with normal glucose levels in Al Ain. In Dubai we used logistic regression
analysis to identify the correlates of the transition from prediabetes to DM in the data
from the various health centers.
The overall prevalence of prediabetes and type 2 diabetes mellitus was 37.7% and
18.7%, respectively, in Al Ain. Ageing, being overweight and obesity were positive
correlates for prediabetes. A secondary school, or higher, level of education correlated
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negatively for prediabetes. Ageing, obesity, central obesity, a lack of vigorous physical
activity and a family history of diabetes were positively correlated for diabetes, while
a secondary school, or higher, level of education, were negative correlates for diabetes.
In Dubai, a significant proportion (23%) of participants with prediabetes suffered from
DM within a two-year period. Low HDL-cholesterol was significantly (<0.05)
correlated with a deterioration from prediabetes to type 2 diabetes mellitus. Subjects
who reported vigorous physical activity at least once a week were less likely to acquire
type 2 diabetes mellitus.
Prediabetes is a significant public health problem in the UAE. Old age, being
overweight, obesity and educational levels were all found to be significant correlates
for prediabetes. A high proportion of people with prediabetes acquired type 2 diabetes
mellitus within a relatively brief period. This highlights the importance of both
screening and intervention in the case of prediabetes. Our findings were consistent
with previous studies carried out in other countries.

Keywords: Prediabetes, type 2 diabetes mellitus, obesity, prediabetes screening,
physical activity, prediabetes-to-type 2 diabetes, UAE.
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)Title and Abstract (in Arabic
دراسة مقطعية حول معدل االنتشار والخصائص والعوامل المؤدية إلى مرض ما قبل السكري
في مدينتي العين ودبي ،دولة اإلمارات العربية المتحدة
الملخص

المقدمة :تشير التقارير العالمية إلى أن دولة اإلمارات العربية المتحدة تعاني من ارتفاع كبير في
معدالت انتشار مرض السكري من النوع الثاني .غالبا ما يعاني األشخاص من ارتفاع في نسبة
السكر في الدم عن المعدل الطبيعي وذلك قبل تشخيص مرض السكري من النوع الثاني ،تسمى
هذه المرحلة بمرض ما قبل السكري .حيث ترتبط هذه المرحلة بفقدان عدد كبير من خاليا البيتا
المتواجدة في البنكرياس ،وبزيادة في نسبة اإلصابة بأمراض القلب واألوعية الدموية وغيرها من
التداعيات الصحية الخطيرة .بالرغم من ذلك فهناك نقص كبير في عدد الدراسات التي أجريت
حول أسباب انتشار مرض ما قبل السكري والعوامل المرتبطة به ومسببات تطوره إلى مرض
السكري من النوع الثاني.
هدف الدراسة :الهدف األساسي من هذه الدراسة هو تحديد مدى انتشار مرض ما قبل السكري
والعوامل المسببة له .أما الهدف الثاني فهو تحديد المسببات الرئيسية لتطور المرض من مرحلة
ما قبل السكري إلى مرض السكري من النوع الثاني ونسبة هذا التحول.
المنهج المتبع للدراسة :استند هذا البحث على بيانات ثانوية ،تم تجميعها خالل دراسة أخرى
أجريت في مدينتي العين ودبي في اإلمارات العربية المتحدة للحد من خطر مرحلة ما قبل السكري.
تمت دعوة عينة عشوائية (عدد= )605من أولياء أمور طالب المدارس الذين شاركوا في الدراسة
المعنية بفحص نسبة انتشار مرض ما قبل السكري في مدينة العين .أما في مدينة دبي فتمت دعوة
 700شخص إماراتي تم تشخيصهم سابقا بمرض ما قبل السكري ،في خمسة مراكز للرعاية
الصحية األولية التابعة لهيئة الصحة بدبي للمشاركة في الدراسة .تم جمع بيانات خاصة بهم
ومتعلقة بالحالة االجتماعية والبدانة والنشاط البدني وقياس مدى خطر إصابتهم بمرض انقطاع
التنفس أثناء النوم عن طريق استخدام استبيان برلين لقياس توقف التنفس أثناء النوم .علما بأنه تم
تحديد نسبة مرض ما قبل السكري والسكري من النوع الثاني وفقا لتعريف الجمعية األمريكية
للسكري ،وذلك استنادا على نسبة السكر في حالة الصيام ( 121-111ملغ/ديسيلتر لمرض ما قبل
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السكري و ≥ 121ملغ/ديسيلتر لمرض السكري من النوع الثاني) ومعدل السكر التراكمي (5.7-
 ٪6.4لمرحلة ما قبل السكري و ≥ ٪6.5لمرض السكري من النوع الثاني).
تم استخدام نموذج االنحدار اللوجستي المتعدد لتحديد العوامل المرتبطة بمرض ما قبل السكري
والسكري من النوع الثاني عبر المقارنة بأشخاص يتمتعون بمستوى سكر طبيعي في مدينة العين.
أما البيانات المأخوذة من مراكز هيئة الصحة في دبي فتم تحليلها باستخدام نموذج االنحدار
اللوجستي ثنائي االستجابة لتحديد مسببات التطور من مرحلة ما قبل السكري إلى مرض السكري
من النوع الثاني في مدينة دبي.
نتائج الدراسة :بلغت نسبة انتشار مرضي ما قبل السكري والسكري من النوع الثاني في مدينة
العين  ٪73.3و ٪1..3على التوالي .كما أظهرت نتائج الدراسة ارتباطا إيجابيا بين مرض ما قبل
السكري وكل من التقدم في العمر ،وزيادة الوزن والبدانة ( )P<0.05كما ارتبط مرض ما قبل
السكري سلبا بمستوى التعليم (الثانوي والتعليم العالي).
أما بيانات مدينة دبي فقد أظهرت أن نسبة كبيرة ) (%23من المشاركين الذين كانوا يعانون من
مرض ما قبل السكري أصيبوا بمرض السكري من النوع الثاني خالل السنتين من المتابعة .كما
أشارت نتائج الدراسة إلى ارتباط إيجابي بين انخفاض نسبة الكوليسترول عالي الكثافة ()P<0.05
بخطر التحول من مرض ما قبل السكري إلى مرض السكري من النوع الثاني .وإلى ارتباط
هامشي مع معدل السمنة ( .)P=0.054كما أظهرت الدراسة ارتباط النشاط البدني عالي الجهد
مع خطر التحول من مرحلة ما قبل السكري إلى السكري من النوع الثاني.
خالصة الدراسة :يعد مرض ما قبل السكري من أهم التحديات الصحية في دولة اإلمارات العربية
المتحدة .حيث تشكل زيادة الوزن والسمنة ،والتقدم في العمر ،عوامل مسببة لمرض ما قبل
السكري .وقد لوحظ تطور مرض ما قبل السكري إلى مرض السكري من النوع الثاني لدى نسبة
كبيرة من األشخاص خالل فترة زمنية قصيرة نسبيا .مما يسلط الضوء على أهمية الفحص الدوري
والتدخل المبكر لمعالجة مرض ما قبل السكري .وهذا ما أجمعت عليه العديد من الدراسات السابقة
في بلدان أخرى.
مفاهيم البحث الرئيسية :مرض ما قبل السكري ،السكري من النوع الثاني ،البدانة ،النشاط البدني،
التحول من مرض ما قبل السكري إلى مرض السكري من النوع الثاني ،دولة اإلمارات العربية
المتحدة ،معدل السكر التراكمي في الدم.
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Chapter 1: Review of Literature
1.1 Overview of Prediabetes
Prediabetes is a stage of intermediate hyperglycemia between normal glucose
tolerance and type 2 diabetes mellitus (DM), that is observed in the fasting and/ or
postprandial stage1. Prediabetes not only correlates for future incidences of DM, but
also prefigures other non-communicable diseases (NCD).
The concept of prediabetes has been around since the 1950s. From 2000 onwards,
the term prediabetes started to be commonly used2. Both the World Health Organization
(WHO) and the American Diabetes Association (ADA) have used the term ‘Intermediate
Hyperglycemia’ and ‘High Risk State of Developing DM’ respectively, rather than
prediabetes. The term prediabetes has been criticized for many reasons. One of these is
that many people with the condition may not eventually develop DM. Furthermore, the
term prediabetes could indicate that people with the condition are actually healthy (with
no disease currently present) and imply that no intervention is required, despite the fact
that prediabetes is a major public health concern and requires early intervention3.
1.1.1 Pathophysiology of Prediabetes
An important metabolic concern is the disturbance of glucose-insulin
homeostasis. Impaired fasting glucose (IFG) or glycaemia refers to elevated glucose
levels in a fasting state that are not yet at the level of diabetes. Impaired glucose
tolerance (IGT) can be defined by elevated postprandial glucose levels, indicating an
impairment in the capacity of the human body to handle consumed carbohydrates. It
is evaluated by administering an oral glucose tolerance test (OGTT).

2
Insulin resistance is where a normal amount of insulin is not enough to yield a
predictable glucose response in muscles, the liver, and adipose tissues. A study has
shown that genetics plays a role in insulin resistance and this can be worsened by
environmental factors, such as obesity (especially central obesity and related visceral
fat) and PA4. Therefore, interventions that improve insulin resistance and limit the
secretary load on beta cells has been proven to prevent prediabetes progressing as far
as DM.
The mechanisms for IGT and IFG are different depending on where exactly the
body is failing to respond to insulin5. For IFG, insulin resistance is mainly located in
the liver, while for IGT it is in the muscle6. The patterns of insulin resistance for both
disorders (IFG and IGT) also differ. Insulin is usually secreted in two stages following
a meal, the early and late phases. The early phase occurs 30 to 60 minutes after
consumption, while the late phase occurs from 60-120 minutes. Abnormalities in
insulin secretion in the early phase lead to IFG and in the later phase they lead to IGT.
In people with IGT, muscle tissues are resistant to insulin. Therefore, glucose blood
levels remains high for two hours after the meal, despite the fact that they remains
normal after fasting overnight and between meals. In people with IFG, blood glucose
levels are elevated in the morning and for half an hour after they have eaten food, as
the liver will secrete because it is resistant to the insulin. Therefore, in people with
IFG, an early insulin response is abnormal while a late insulin response is the norm7.
Impaired Beta Cells Function
The pancreas is a vital organ consisting of the pancreatic islet, or the islet of
Langerhans. These islets are scattered throughout the pancreas. They consist of
different cell types, including insulin secreting beta cells, glucagon producing alpha
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cells and pancreatic polypeptide producing delta cells8. An appropriate beta cell
function requires there to be a normal beta cell anatomy, which is essential for an
appropriate response to a changeable metabolic need for insulin. Beta cell dysfunction
results from there being inadequate glucose sensing that would stimulate insulin
secretion. Therefore, elevated glucose concentrations prevail. A constant elevation in
the level of glucose above the normal range results in prediabetes. At least a 60%
decrease in beta cells is required to develop DM4. Beta cell dysfunction is more serious
than insulin resistance, as is found in beta cell dysfunction. Insulin secretion is reduced,
but can still be secreted even when there is insulin resistance.
Beta cell dysfunction is correlated to the 2-hour plasma glucose level during
OGTT in normal glucose tolerant individuals. It is also a correlate for people with
normal glucose level becoming IGT and, thus, eventually transitioning to DM. In
people with IGT, there is a 70%-80% decline in beta cell function4. Therefore,
interventions that stop, or delay, the dysfunction of beta cells are valuable tools in
fighting DM.
1.1.2 Diagnosis and Screening of Prediabetes
The WHO proposed the term prediabetes as early as 1980, but later
discouraged people from using it because slightly increased glucose levels do not
always translate into DM. In 2005, the ADA proposed the term prediabetes for
impaired glucose tolerance (IGT) and impaired fasting glucose (IFG). However,
different cut-off values were used for IFG – 5.6 mmol/l by the ADA9 and 6.1 mmol/l
by the WHO10. Thus, different criteria were used in parallel to define prediabetes as
an intermediate phase of altered blood glucose concentration between normal glucose
levels and DM that was not yet serious enough to be diagnosed as DM comprising of
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IFG and IGT11. FBG and OGTT were used for the diagnosis of prediabetes by the
ADA and the WHO, and lately HbA1c has been added to these criteria12. HbA1c refers
to glycated hemoglobin, which mirrors overall blood glucose levels present two to
three months prior to laboratory testing. A consensus on the diagnostic criteria that
defines prediabetes has not yet been agreed13.
Although the ADA has recommended HbA1c as a diagnostic tool for
identifying prediabetic adults at risk of developing DM, several points need to be taken
into consideration. Firstly, the ADA considered HbA1c to be a poor diagnostic tool for
prediabetes, due to low sensitivity and specificity14. Secondly, the accuracy of the
HbA1c test to diagnose prediabetes in adults, and its correlation to mean serum glucose
concentrations, requires more work to identify how several covariates can influence
the HbA1c level in adults. These covariates are age, race/ ethnicity and mineral
deficiencies among others)15.
The ADA recommends that if a diagnostic test needs to be repeated, it is
preferable to repeat the same test as there is greater likelihood of an agreement with
the initial test result1. However, if two different tests have been performed and the
results are in conflict regarding a diagnosis of DM, it is the test that yielded the positive
result that should be repeated.
In contrast to previous recommendations specifying FBG as the preferred test,
new criteria leave the choice of diagnostic test to the physician. In total 19,182
participants, aged ≥12 years, were interviewed in the United States to identify the
prevalence of prediabetes. This study utilized HbA1c 5.7-6.4% or FBG 100 to 125
mg/dl: OGTT was not used. Overall, there was an increase in the prevalence of ageadjusted prediabetes from 27.4% in 1999-2002 to 34.1% in 2007-2010 according to
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the HbA1c criterion. However, the prevalence of prediabetes, when using IFG with
the same population, remained fundamentally unchanged (23.8-25.9%) over the same
period16.
a) Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT)
IFG and IGT are types of prediabetes where the patient’s blood sugar level is
constantly greater than normal levels, but not high enough for a diagnosis of DM to be
made. The ADA’s most recent (2010) definition of IFG is a fasting blood sugar level
of 5.6-6.9 mmol/l (100 mg/dl to 125 mg/dl - a measurement of 2-hour post load glucose
is not recommended). This cut-off point is lower than the one set by the WHO, where
the fasting blood sugar is ≥6.1 and <7.0 mmol/l and the 2-hour post load is <7.8
mmol/l (if measured)16. The reason the ADA set a lower fasting glucose level is to
make the prevalence of IGT and IFG consistent. However, this did not achieve its
target and instead led to an approximately three to four-fold increase in the overall
prevalence of IFG17. In most populations, IFT is more common than IGT. Data from
the United States indicates that the prevalence of IFG and IGT is around 26% and 15%
respectively18. It is predicted that both will rise in the future. Furthermore, the
prevalence varies considerably according to a person’s age and sex.
The prevalence of IFG, compared to IGT, is higher in older people and among
men than it is in women for some unknown reasons3. The IFG level tends to incline to
a plateau in middle age, while the prevalence of IGT increases in old age. The
European Diabetes Epidemiology, a collaborative analysis of diagnostic criteria in
Europe, showed a prevalence of IGT that was 2.9% in men aged 30-39 and 15.1% in
those aged 70-7919. Both IFG and IGT are related to a substantially increased risk of

6
developing DM, with the highest risk being in people who have combined IFG and
IGT20.
b) Glycated hemoglobin HbA1c
Glycated hemoglobin (also called hemoglobin A1c, HbA1c, A1C or Hb1c) is
the product of non-enzymatic glycosylation of hemoglobin β-chains and the measure
of glucose bound to the hemoglobin. It is equivalent to the overall level of glucose in
the blood over the previous two to three months (which is the lifespan of red blood
cells)21. Poor glycemic control leads to the elevation of HbA1c levels and vice versa.
It has been used to assess glycemic control since 197622.
The ADA recommended using the HbA1c 5.7-6.4% test as a method of to
diagnose prediabetes in 201523. However, it did not establish firm guidelines for the
use of the HbA1c test in adolescents, as their study did not validate thresholds for this
group. Research has shown that HbA1c results are affected by a variety of factors
influencing glycemic control. These factors are classified as non-modifiable.
Modifiable factors include BMI, vitamin D/ iron/ magnesium levels, PA, red cell
lifespan, renal and liver function and pregnancy. Non-modifiable factors are age,
ethnicity/ race, genetic factors, family history, infection, hormonal and autoimmune
conditions. Consequently, the HbA1c test has not been used consistently by clinicians
to identify individuals with prediabetes24.
Using HbA1c for the diagnosis of prediabetes has many advantages. These
include the convenience of the test with no need to fast beforehand. It exhibits good
stability after specimen collection and also reproducibility (including less day-to-day
variability in comparison with either the FBG or 2-hour postprandial glucose level)
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and can successfully detect adult individuals at a lower risk of developing DM24. The
International Expert Committee, appointed by the ADA and the European Association
for the Study of DM, has warned of the tests limitations. These are the fact that the
HbA1c test is expensive when compared to OGTT, and is not readily available in
developing countries.
The committee found that the HbA1c test did not accurately diagnose DM as
well as other tests, such as the FBG or OGTT. Therefore, use of HbA1c alone to
diagnose DM, or prediabetes, requires that it be translated into a meaningful clinical
practice1, or that a combination of the HbA1C and FBG tests is used in the diagnosis
of prediabetes. This can decrease the risk of any systematic bias inherent when testing
only with HbA1c25.
HbA1c has been shown to correlate with the likelihood of diabetic retinopathy
and microvascular complications. This continuous linear relationship is even stronger
than that of FBG. The ADA and WHO have set a cut-off point for HbA1c of 6.5% as
the diagnostic criteria for prediabetes, because retinopathy increases above this level.
This is in addition to previous criteria that uses IFG and IGT26.
1.1.3 Classification of Prediabetes and DM
Current ADA guidelines for the diagnosis of prediabetes and DM27 are as follows:
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Table 1.1: The ADA guidelines for diagnosis of prediabetes and DM (2017)
Categories for diagnosis of prediabetes
FBG

2-hour post prandial glucose

100-125 mg/dl (5.6-6.9 mmol/l) 140-199 mg/dl (7.8-11.0 mmol/l)
IFG and
IGT Or

HbA1c
5.7-6.4%
(39-46 mmol/mol)

Criteria for DM diagnosis
≥126 mg/dl (7.0 mmol/l) or

≥200 mg/dl (11.1 mmol/l) during
OGTT (75-g) or

≥6.5% (48 mmol/mol)
or

Random PG ≥200 mg/dl (11.1 mmol/l)

Current WHO guidelines for diagnosis of prediabetes and DM28 are as follow:
Table 1.2: WHO guidelines for diagnosis of prediabetes and DM (2017)
Categories for diagnosis of prediabetes
FBG

2-hour post prandial glucose

110-125 mg/dl (6.1-6.9
mmol/l)
IFG

140 mg/dl (<7.8 mmol/l)
IFG

126 mg/dl (<7.0 mmol/l)
IGT

140-200 mg/dl (7.8-11.0 mmol/l)
IGT

HbA1c

Categories for diagnosis of DM
≥126 mg/dl (7.0 mmol/l)

≥200 mg/dl (11.1 mmol/l)

≥6.5%
(48 mmol/mol)

1.1.4 Epidemiology of Prediabetes
The prevalence of prediabetes is increasing worldwide. It is estimated that
>470 million people will have prediabetes by 2030, and the highest increase is
expected to be in South-East Asia and the Western Pacific Region3. The prevalence of
prediabetes differs, depending on the criteria used for diagnosis16. Studies have shown
that only using the FBG level for the diagnosis of prediabetes results in an
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underestimate of the scale of the disorder29. Therefore, HbA1c remains a useful
complimentary tool alongside FBG for the diagnosis of prediabetes26.
In the United States (USA), the prevalence and emerging trends of prediabetes
and DM from 1988-2012 among adults aged 18 and above were described by the
National Health and Nutrition Examination Survey. The incidence of DM was
identified by using a self-reported diagnosis of DM, or HbA1c (≥6.5%) or FBG (126
mg/dl) or a 2-hour PG (200 mg/dl) if DM had not been previously diagnosed.
Furthermore, prediabetes was defined by HbA1c (5.7-6.4%) and FBG (100-125
mg/dl), or a 2-hour PG (140-199 mg/dl). In this study, it was reported that the crude
(unadjusted) tally for DM was 14.3% (95% CI 12.2-16.8%). The age-standardized or
age-adjusted prevalence of DM increased from 9.8% (95% CI 8.9%-10.6%) in 19881994 to 12.4% (95% CI 10.8%-14.2%) in 2011-2012 (p<0.001 for trend). Furthermore,
DM in the USA increased in all of the age groups, as well as in both sexes and every
racial and ethnic group surveyed. In the same study, the crude percentage for
prediabetes in adults was 36.4% (95% CI 30.5-42.7%). Moreover, the prevalence of
prediabetes was particularly high in Hispanics in the USA30.
In Canada, the incidence of prediabetes and DM among adults aged 20 and
above was estimated using the Canadian Health Measurement Survey (n=3,494)31, a
national population-based sample. Prediabetes and DM were defined by using the
Canadian guidelines, based on fasting FBG and HbA1c levels. Prediabetes was defined
as an FBG level of ≥6.1 and <7.0 mmol/l or an HbA1c level of ≥6.0% and <6.5% (≥42
and <48 mmol/mol). DM was defined as an FBG level of ≥7.0 mmol/l or an HbA1c
level of ≥6.5% (≥48 mmol/mol). The prevalence of prediabetes was 4.3% (95% CI
3.4-5.3) based on FBG criteria [(males 6.4%; (95% CI 4.6-8.8), females 2.2% (95%
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CI 1.7-3.0)]. The prevalence of prediabetes was 12.5% (95% CI 8.7-17.8) based on
HbA1c criteria (males 11.8%; 95% CI 8.1-16.8, females 13.3%; 95% CI 8.9-19.5).
Using both criteria (FBG or HbA1c), the prevalence of prediabetes was 15.2% (95%
CI 11.4-19.9) on average with 15.8% for males (95% CI 11.8-20.7) and 14.6% for
females (95% CI 10.4-20.1). The overall prevalence of DM was 5.6% when using the
FBG criteria, 7.7% with HbA1c criteria and 7.7% with FBG or HbA1c.
The trend in the incidence of prediabetes in England between 2003 and 2011,
for individuals aged 16 and above, was investigated by using data from the Health
Survey for England. Individuals were classified as having prediabetes if the HbA1c
level was between 5.7% and 6.4%32. According to the findings of this study, the
prevalence of prediabetes increased from 11.6% in 2003 to 35.3% in 2011. Socioeconomically deprived subjects were found to be at a substantial risk of developing
prediabetes after controls for age, gender, race/ ethnicity, BMI and BP were all taken
into account.
While in developed countries, this increase in prediabetes can be traced to an
increase in obesity, an ageing population and an increased life expectancy for people
with prediabetes33, in developing countries it is due to rapid urbanization, increasingly
sedentary lifestyles and unhealthy eating habits34. A high rate of DM and prediabetes
has been reported in many developing countries. The prevalence of prediabetes and
DM was examined in a population-based sample (n=57117) of adults aged 20 years or
above in 15 Indian states using WHO criteria35. The overall prevalence of prediabetes
was 10.3% (95% CI 10.0-10.6). This was higher in urban areas (14.7%; 95% CI 13.615.9) when compared to rural ones (6.0%; 95% CI 5.1-6.8). The overall prevalence of
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DM was 7.3% (95% CI 7.0-7.5). It was higher lowly socio-economic groups,
particularly in urban settings.
In China, the prevalence of prediabetes and DM was estimated via a crosssectional design in a random nationally representative sample of adults (n=170287).
DM and prediabetes were identified, based on FBG, HbA1c and a 2-hour OGTT that
followed the ADA’s classification system. The overall prevalence of prediabetes was
35.7%, while DM was 10.9% (95% CI 10.4-11.5), and already diagnosed DM stood at
4.0% (95% CI 3.6-4.3). The incidence of both DM and prediabetes varied by ethnicity.
There was a lower incidence in Tibetan (31.3%) and Muslim Chinese (31.9%)36.
The prevalence of prediabetes and DM was estimated in a demographic and
health survey of 7,541 adults aged 35 or over in Bangladesh in 2011. Prediabetes was
defined as a FBG level of 6.1 mmol/l to 6.9 mmol/l without DM medication. DM was
defined as a FPG level ≥7.0 mmol/l with the self-reported use of DM medication. The
prevalence of prediabetes and DM was estimated to be 22.5% and 10%, respectively.
The overall age-adjusted prevalence of DM and prediabetes was 9.7% and 22.4%,
respectively. Among urban inhabitants, the age-adjusted prevalence of DM was 15.2%
as compared to 8.3% in the rural population. The risk of prediabetes in Bangladesh
increased with age, and among wealthier and better-educated individuals, as well as in
those with hypertension37.
A community-based survey was conducted in Saudi Arabia in 2016 on 18 yearolds whether Saudi or not living in Jeddah (N=1420)38. DM and prediabetes were
identified, based on FBG and HbA1c, using the WHO’s classification system. Those
with FBG of 100-125 mg/dl, and/ or HbA1c 5.7-6.4% were identified as having
prediabetes. People with FBG of ≥126 mg/dl, and/or HbA1c ≥6.5% were categorized
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as DM. Also, self-reporting of any previous diagnosis of DM and those taking drug
treatments for DM were both classified as having DM. The prevalence of prediabetes
and DM was 11.9% and 18.3%, respectively. The age and sex-standardized incidences
of prediabetes was 9.0% (95% CI 7.5-10.5): 9.4% (95% CI 7.1-11.8) in men and 8.6%
(95% CI 6.6-10.6) in women. For DM, it was 12.1% (95% CI 10.7-13.5): 12.9% (95%
CI 10.7-13.5) in men and 11.4% (95% CI 9.5-13.3) in women. Also of note is that the
prevalence of prediabetes and DM increased with age.
The prevalence of prediabetes in Oman in 2011 was estimated by using a crosssectional design with an adult sample group aged 18 to 60 (n=1,600)39. Prediabetes
was identified, based on FBG (100 mg/dl and 126 mg/dl) and OGTT (140 mg/dl and
200 mg/dl) levels. The overall prevalence of prediabetes in Omani adults was 35% and
this increased with age. A higher prevalence of prediabetes was found among married,
divorced, and widowed people, as compared to those who never married. A higher
prevalence was also found among those with a lower level of education, the
unemployed, smokers, and people with hypercholesterolemia and dyslipidemia39.
In the UAE a multi-ethnic expatriate population accounts for 80% of the
population of the country. The prevalence of prediabetes has previously been
documented in native Emiratis in two studies. In 2007, a population-based sample was
obtained from 452 householdsin al Ain. There were 2,455 adult (>18) Emirati citizens
in this study. Their prediabetic status was based on a fasting venous blood glucose
concentration of 5.6-6.9 mmol/l or a 2 hour post-OGTT venous blood glucose level of
7.8-11.0 mmol/l. DM was defined according to WHO criteria. The prevalence of
prediabetes and DM was 20.2%, and 10.5% respectively. Age-standardized rates for
prediabetes and DM among 30-64 year olds were 24.2% and 29.0%, respectively40.
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The Weqaya study conducted in 2010 obtained data from 50,138 Emirati adults aged
18 or above in 25 primary care screening centers in Abu Dhabi. Participants with
HbA1c of 5.7%-6.4% were categorized as having prediabetes. Participants with a
history of adult-onset DM and those on DM medication, an HbA1c of 6.5% or higher,
or a random glucose level of 11.1 mmole/L were considered to have DM. The
prevalence of prediabetes and DM was 27% and 18%, respectively41. Correlates for
prediabetes were not evaluated in either of these studies.
Shah and his team reported on prediabetes and DM in a random sample
(n=599) of female expatriates (non-UAE nationals) which included South Asian, Arab
and Filipino subjects, aged 18 years and above living in Al-Ain (UAE) in 2012-13.
The ADA guidelines on HbA1c were used to diagnose prediabetes (an HbA1c level of
5.7-6.4%) and DM (an HbA1c level ≥6.5%). In this cross-sectional study, the
prevalence of prediabetes and DM was estimated at 18.6% (95% CI 13.9-24.4) and
10.7% (95% CI 7.2-15.6), respectively. The prevalence of prediabetes was 8.5% in
Filipinos, 16.7% in Arabs and 30.3% in South Asians. The prevalence of DM was
1.7% in Filipinos, 12.2% in Arabs and 16.7% in South Asians. The prevalence of DM
and prediabetes increased with the length of time spent in the UAE even after
controlling for age.
Prediabetes is a significant economic burden. Identifying people with
prediabetes is worthwhile from a clinical, financial and public health point of view1.
In the last 5 years, the cost of prediabetes has increased by 74% to $44 billion. The
increase is worrying as it means new cases of DM are not just an existing economic
burden, but will also pose a potentially greater future burden unless prevention efforts
are successfully implemented42. In the UAE, the annual medical cost of DM reached
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$60 million (AED 220 million). The DM prevention program has shown that making
lifestyle changes, including losing weight, increasing PA and changing one’s diet can
significantly decrease the risk of developing prediabetes and DM43.
1.1.5 Correlates of Prediabetes
As the onset of DM can be prevented or delayed, identifying reversible
correlates is essential in attempting to control the recent epidemic of DM44. It is
possible that correlates for prediabetes could mirror those for DM45.
According to guidelines from the European Society for Cardiology and the
European Association for the Study of DM, prediabetes is associated with numerous
conditions, including obesity, central obesity, ageing, physical inactivity, low
consumption of fruit and vegetable, hypertension and a family history of DM.
Furthermore, the American College of Endocrinology and the American Association
of Clinical Endocrinology, have identified correlates for DM and prediabetes. They
are as follows: a family history of the condition, being overweight or obese, an
unhealthy lifestyle and hypertension46. Other correlates can include race/ ethnicity47,
abuse of alcohol, poor sleep patterns and obstructive sleep apnea, smoking, poor eating
habits and a sedentary lifestyle48,49.
a) Age
Age is a correlate for many diseases. According to the European Society for
Cardiology and the European Association for the Study of Diabetes, age can be
correlated for both prediabetes and DM. Furthermore, this causal connection has been
confirmed by a study using secondary data from the Basic Health Research Survey
conducted by the Ministry of Health in the Republic of Indonesia. This was a cross-
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sectional study of 24,417 adults (aged 18 and above) from 33 provinces across
Indonesia46.
b) Family History
Having a family history of DM in a first degree relative, doubles the risk of
developing DM and prediabetes, respectively, in the offspring. This correlation is
evident even in the absence of obesity. Several studies have examined the association
between a family history of DM and prediabetes. In Germany, 5,400 people with
normal blood sugar levels and more than 2,600 with prediabetes were examined and it
was found, after adjusting for sex, age and BMI, that people with a family history of
DM were 26% more likely to develop prediabetes50. An earlier study in Sweden also
established a 50% increased risk of prediabetes in people with a family history of
DM51.
c) Obstructive Sleep Apnea
Apnea attacks can occur anywhere from a few times to hundreds of times in
one night44. Observational studies have identified sleep apnea as a correlate for
prediabetes and DM52,53. In the UK, a study confirmed that sleep apnea was a correlate
for DM, and effects the metabolism of glucose. This study involved 1,682 adults with
DM who answered a questionnaire and it also utilized overnight oximetry53. This
relationship can be explained by the sympathetic nervous system, the hypothalamicpituitary-adrenal stress axis, and pro-inflammatory pathways becoming activated by
chronic intermittent hypoxia and/ or sleep. Therefore, screening for sleep apnea should
be standard practice for every patient with DM54.
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d) Obesity
Obesity is a reversible correlate for prediabetes and DM55. Men and women with
abdominal obesity both displayed the strongest association to developing prediabetes.
This relationship was stronger in men when compared to women56. Adipose tissue
produces free fatty acids, adipocytokines, hormones, and other substances involved in
insulin resistance57. Waist circumference (WC) is another proven correlate for
prediabetes and DM58. These mechanisms are not clear but it might be because of the
release of fatty acids from excess adipose tissue, inducing resistance to insulin in the
muscle which, in turn, leads to a rise in plasma glucose levels59. Studies from around
the world have confirmed that obesity is one of the main correlates for prediabetes and
DM27,60. A cross-sectional study of 3,494 adults (≥20 years of age) obtained from a
Canadian Health Measures Survey, showed that a high BMI and WC were associated
with a higher prevalence of prediabetes and DM31. There was a similar finding in data
collected from the 2011-2012 in the National Health and Nutrition Examination
Survey in the USA30.
e) Physical Inactivity
PA (including aerobic, resistance, flexibility and balance exercises) is critical for
an individual’s overall well-being and plays a key role in controlling blood glucose
levels and BMI61. Adopting and maintaining regular PA (at least 150 minutes a week)
improves our sensitivity to insulin and protects against prediabetes and DM62.
According to the Pre-diabetes Consensus issued by the American College of
Endocrinology and the American Association of Clinical Endocrinology, an unhealthy
lifestyle and physical inactivity are correlates for prediabetes and DM63.
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1.1.6 Complications of Prediabetes
People with prediabetes have a higher risk of heart disease3, nephropathy,
retinopathy, neuropathies32, strokes26, DM and also higher mortality rates16. The
reasons prediabetic people develop these complications are not entirely clear.
However, it may be due to many causes such as the effect of higher blood glucose, the
presence of other abnormal metabolites, such as free fatty acids, or the occurrance of
correlates, that include dyslipidemia, hypertension and insulin resistance65.
Furthermore, studies have shown that glucose levels lower than those that currently
meet the definition of prediabetes might also be related to similar complications with
prediabetes, mostly in high-risk individuals64.
a) Neuropathies
Diabetic neuropathies are a heterogeneous group of disorders that have a
variety of clinical signs. Nerve damage, or diabetic neuropathy, results from
persistently high blood glucose levels. Although, it may take decades to develop, it is
considered as one of the most incapacitating complications of DM because of the pain
it causes and the lack of treatments available. The pain is due to the small fibers, which
cause an unpleasant sensation of burning and tingling. The large fibers can also
become involved, leading to numbness and the loss of protective sensations. This is
correlated to diabetic foot ulceration. Although pain or numbness in the legs or feet
might be the most common way of identifying neuropathy, it can also produce other
symptoms, such as increased male erectile dysfunction, a higher frequency of
idiopathic polyneuropathy, painful sensory neuropathy and the dysfunction of cardiac
autonomic activity. This is manifested in reduced heart rate variability and
parasympathetic modulation of the heart66.

18
There are four types of diabetic neuropathy: peripheral neuropathy, proximal
neuropathy, autonomic neuropathy and focal neuropathy. This study has demonstrated
that subclinical small unmyelinated nerve fiber neuropathy67 and autonomic
neuropathy are commonly present in prediabetic patients with IGT. It is usually milder
than the neuropathy suffered by people with DM68.
b) Nephropathy and Kidney Disease
Diabetic nephropathy accounts for a significant amount of morbidity and
mortality and is the principal cause of chronic kidney disease in Western countries
including the United States69. It can be characterized by structural and functional
changes in the kidney and is often diagnosed by persistent albuminuria (>300 mg/d or
>200 μg/min). This must be detected on at least two occasions that are three to six
months apart. Additionally, there is a progressive deterioration in rate of glomerular
filtration and higher arterial BP70.
Despite the fact that not everyone with DM develops diabetes neuropathy, it is
a well-known condition amongst such people71. The cause of this is unclear, but
cardiovascular disease (CVD) may explain much of the relationship between
prediabetes and the development of chronic kidney disease72. Individuals with
prediabetes need earlier detection and treatment to prevent the development,
progression and complications of chronic kidney disease. This includes intensive
glycemic control where the aim is to reach something close to normoglycemia and
keep BP (BP) below 140/90 mmHg66.
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c) Retinopathy
Diabetic retinopathy is the most common reason for loss of vision in adults
aged 20-74 years in the USA. The duration of DM and the level of glycemic control is
the strongest correlate for the progression of diabetic retinopathy. High blood sugar
damages micro blood vessels in the retina, leading to increased vascular permeability,
hemorrhage and distortion of vision. In its most advanced stage, this can result in the
formation of abnormal blood vessels on the surface of the retina and the posterior
surface of the vitreous (proliferative diabetic retinopathy), causing scarring and cell
loss in the retina. Macular edema can develop at every stage of retinopathy and is
characterized by retinal thickening caused by leaky blood vessels73.
The current study shows that retinopathy, a characteristic of DM, is present in
people with prediabetes. In the DM prevention study, 7.9% of prediabetes patients had
retinopathy74. Another study reported that IGT causes a fourfold increase in the
incidence of retinopathy, when compared to age-matched control subjects65. Screening
for diabetic retinopathy can prevent blindness by allowing for intervention and
treatment to take place. Strict blood glucose and blood pressure control and timely
laser photocoagulation therapy can prevent stop or, at least, delay the progression of
diabetic retinopathy and thus prevent a loss of vision.
d) Cardiovascular Disease
Atherosclerotic CVD is defined as having a history of one of the following: a
stroke, transient ischemic attack, peripheral arterial disease, stable/ unstable angina,
acute coronary syndrome, myocardial infarction or arterial revascularization. It is the
leading cause of mortality and morbidity worldwide. Large epidemiological studies
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have shown that there is an association between an individual with IFG and IGT and
an increased incidence of CVD and mortality75. Twigg et al. found that there was a
two to threefold increased risk of CVD in adults with prediabetes, independent of its
eventual progression to DM45. Therefore, early intervention at the prediabetes stage
can prevent diabetic macrovascular complications76.
Typical diabetic microvascular complications77 also occur in nearly one tenth
of prediabetic patients and are improved once restoration of the normoglycemia has
been achieved4. This relationship may be confounded by other common correlates that
are present between CVD and prediabetes66. This study indicates that IGT and HbA1c
are associated with metabolic syndrome and correlate strongly with CVD as compared
to IFG78. However, there is still an absence of longitudinal follow-up studies that
compare HbA1c to OGTT in terms of the prediction of CVD.
1.1.7 Screening and Control of Prediabetes
In the last decade, the prevalence of DM has increased enormously worldwide.
The IDF has put forward the idea of early diagnosis of prediabetes via screening and
intervention as a fundamental strategy required for the accurate identification of people
with prediabetes. Therefore, a robust and convenient screening test is essential to
reduce, prevent and control the overall societal costs of DM and to stop prediabetes
from progressing to DM. Screening for blood glucose has been used to identify
individuals at high risk of developing DM or asymptomatic DM. Once prediabetes has
been diagnosed, an aggressive treatment plan must be implemented in order to prevent,
or slow down, the progression to DM.
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Several recent randomized trials with adult subjects have confirmed that DM
can be prevented, or delayed, through lifestyle intervention programs that promote
improvements in diet, increased PA and weight loss. In the Finish Diabetes Prevention
Study79, 522 adults with IGT were randomized and received either a brief diet, a brief
diet or exercise counseling (control group), or intensive individualized instruction on
weight reduction through dietary control and PA (intervention group). After an average
follow-up time of 3.2 years, there was a 58% relative reduction in the incidence of DM
in the intervention group when compared to the control group. Similarly, in a Diabetes
Prevention Program in the US80, 3,234 subjects were randomized, according to their
lifestyle, medication (metformin) or received a placebo. Compared with the placebo
group, there was a 58% reduction in the progression to DM in the lifestyle intervention
group, and a 31% relative reduction in the progression of DM in the metformin group
over a period of 2.8 years on average.
Identifying patients with prediabetes, and then intervening before it has
progressed to DM, has significant benefits for both individuals and healthcare systems.
On an individual level, it leads to an improvement in health thanks to early referral to
specialists and by beginning treatment before the onset of complications. Such
complications include micro and macro-vascular diseases, as well as other comorbidities. Furthermore, studies have shown that prediabetic adults, who are aware
of their condition are more likely to get involved in DM risk-reducing activities
compared to people who are unaware81. In addition, the early detection of prediabetes
is cost-effective, as it leads to a reduction in the demands on the healthcare system and
gives DM patients a better chance of obtaining higher quality healthcare services82.
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This study has shown that prediabetic adults, who are aware of their condition
are more likely to get involved in activities to reduce their risk of developing DM than
those who are unaware of the issue81. Furthermore, there are no clear and especially
specific symptoms for prediabetes. Some people with prediabetes might have
symptoms such as fatigue and an increased appetite, or other complications of DM.
Therefore, a patient could have prediabetes without knowing it, making screening
vital80. As such, the ADA has recommended that screening for prediabetes should start
at age 45 and above for those who have no previous DM correlate1. However, it
recommends that overweight and obese people with one or more DM correlate should
be screened regardless of age, even if they are asymptomatic. Normally, testing these
groups requires repeated measures at a minimum of three-year intervals1. According
to the WHO, the downturn in the implementation of screening programs for
prediabetes and DM is down to cost involved and the increasing load on the healthcare
system. There is a need to not only screen for such cases, but also for treating the
increasing number of individuals diagnosed with prediabetes and DM28.
1.2 Overview of Obesity and its Role in Diabetes and Prediabetes
DM is fast becoming a major cause of illness and premature death worldwide
and its increase parallels a rise in obesity. With greater economic prosperity in the
UAE, the population has settled into a sedentary, well-fed lifestyle. Reports from the
UAE show that it has one of the highest rates of obesity in the world and this might
result in more DM and prediabetic cases.
Obesity is a major public health problem. It is principally a social and
environmental disease. The WHO considers “globesity” to be a growing epidemic, not
only in developed countries, but also in developing ones. This often neglected yet
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visible problem leads to a variety of health consequences, ranging from the increased
risk of premature death through a reduction in quality of life, to chronic diseases, like
cancer, CVD and DM83.
1.2.1 Definition and Classifications of Obesity
a) BMI Classification of Obesity
Obesity is defined as the accumulation of abnormal or excessive fat that puts
health at risk. There are several ways to the percentage of body fat. Some are used in
clinical settings and others in research environments. In research, methods include the
use of magnetic resonance imaging, multi-frequency bioelectrical impedance analysis
and underwater weighing (densitometry). In a clinical environment, the techniques
used are less accurate for the percentage of body fat, but are appropriate to identify
correlates for different diseases. These methods include the use of the body mass index
(BMI), WC and skin-fold thickness.
Adult obesity can be classified by using BMI. It uses two body dimensions to
describe people as being overweight and/ or obese: a person’s weight in kilograms (kg)
divided by the square of his or her height in meters (m2). The WHO has classified
people with a BMI (kg/m2) of 18.50-24.99 to be within the normal range, those with a
BMI (kg/m2) of 25.00−29.99 to be overweight and those with a BMI (kg/m2) that is
greater than, or equal to, 30 are considered as obese. Obesity can be sub-classified into
class I (BMI 30.00-34.99), class II (BMI 35.00-39.99) and class III (BMI ≥40)84.
BMI is the most common screening test for obesity. It is reliable, easy to
measure and its values are age-independent, and it is similar for both genders85. BMI
correlates well with the percentage of body fat and vital health outcomes, like coronary
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heart disease and DM. As it increases, mortality rates increase as well. This makes it a
good tool for screening, monitoring the effect of treatment and determining
institutional policies for individuals. BMI is limited, however, because it is unsuitable
for children due to their growing and changing body shape. It fails to distinguish
between fat and fat-free mass, like muscle and bone, which can lead to obesity being
exaggerated in large muscular individuals.
WHO classifications of being overweight and obese can be used
internationally. However, Mascie-Taylor and Goto have a different opinion86. They
have taken into consideration the differences between ethnicities, and concluded that
a universal BMI cut-off point does not seem appropriate for all ethnic groups.
Therefore, there is a growing discussion on whether there is a need to develop different
BMI cut-off points for different ethnic groups, as the current WHO cut-off point does
not provide an adequate basis for taking action when it is used with the Asian
population, for example. There are several reasons for this. Firstly, Asian people have
a higher percentage of body fat than Caucasian people of the same sex, age and BMI.
Secondly, the proportion of Asian people with correlates for DM and CVD is large,
even below the WHO cut-off point for being overweight (25 kg/m2). Also, BMI
grading in relation to the risk of disease may vary for different populations84. For
example, an obese lady (class one) will have a greater risk of disease if her WC is
higher than 88 cm, compared with a similar lady with a normal WC (<88 cm).
In 2002, WHO experts suggested that the international cut-point be used in the
Asian population for reporting purposes only. However, for public action the cut-off
points (23.0, 27.5, 32.5, and 37.5 kg/m2) must be lower level than for the European
population in general. Studies from Singapore and Hong Kong reported that a higher
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percentage of body fat at a lower BMI reflected an increase in the correlates for chronic
diseases and death in the Asian population. Likewise, Chinese studies have indicated
that a prevalence of hypertension, DM and dyslipidemia increases with the increase in
the BMI, even at indices that are below the current cut-off point for being overweight.
For many Asian populations, the cut-off point of 18.5-23 kg/m2 represents an
acceptable risk, 23.0-27.5 kg/m2 represents an increased risk and 27.5 kg/m2 and
higher represents high risk86.
Although BMI has usually been the indicator used to measure body size and
composition, WHO reports have confirmed that using other methods for measuring
abdominal adiposity, such as WC, waist-hip ratio and waist-height ratio (WHR), are
superior to BMI for predicting the risk of CVD. BMI and WC combined predict greater
variants in health risk than just using BMI alone83. The National Heart Lung and Blood
Institute confirmed that it was the same for WC87.
b) Central or Abdominal Obesity
As above, BMI has usually been used to measure body size and composition.
However, WHO reports suggest that other methods of measuring abdominal adiposity,
such as WC, WHR and waist-height ratio, are superior to BMI in predicting NCD,
especially DM. The National Heart Lung and Blood Institute has indicated that adding
BMI and WC predicts a greater range of health risks than using BMI alone83,87. A
twelve-year follow-up study of middle-aged men showed that abdominal obesity was
related to an increased risk of many diseases, including CVD and premature death. In
women, BMI was associated with an increased risk of these diseases as well: however,
central obesity was a stronger correlate than BMI83.
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WC is an accurate and simple measure of abdominal obesity, compared to
WHR and BMI. It is measured by using a stretch‐resistant tape that provides a constant
100g tension at the mid-point between the top of the iliac crest and the least palpable
rib. Hip circumference should be measured around the widest portion of the buttocks,
with the tape parallel to the floor. Both measurements must be taken while the subject
is in a relaxed standing position, with their feet close together and arms at the side of
the body, and at end of normal expiration. The normal range for WC is less than 80
cm for women and 94 cm for men. The higher the WC, the higher the risk of metabolic
complications (Table 1.3)83. The WHR is measured by dividing the WC by the hip
circumference.
Table 1.3: WHO cut-off points and the risk of metabolic complications
Indicator
WC
WC
WHR

Cut-off points
>94 cm (men);
>80 cm (women)
>102cm (men);
>88 cm (women)
≥0.90cm (men);
≥0.85 cm (women)

Risk of metabolic complications
Increased
Substantially increased
Substantially increased

This study has shown that BMI and WC have a strong positive correlation
(P<0.0001) with the percentage of body fat in males and females, and are good
indicators of metabolic syndrome, CVD and DM, compared to WHR88.
The cut-off points for WC and WHR, which are proposed for general use, are
based on Caucasian or European populations and so should not be applied uniformly
to every population and ethnic group. Many studies of populations have recommended
using cut‐off points that are specific to different ethnic groups. The reasons for this are
that Asian populations appear to have higher morbidity at lower cut-off points for WC
than Caucasians. In addition, the prevalence of abdominal obesity among Asian males
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was higher when using the WC cut-off points for Asian people, compared to the WC
cut-off points for Caucasians. Below is a table summarizing the WC cut-off points for
some ethnicities89 (Table 1.4).
Table 1.4: Cut-off values of WC based on ethnicity and gender
Country/ethnic group
Europid
South Asian
Chinese
Japanese
Ethnic South and Central
Americans
Sub-Saharan Africans
Eastern Mediterranean and
Middle East

Sex
WC
Men
>94 cm
Women
>80 cm
Men
>90 cm
Women
>80 cm
Men
>90 cm
Women
>80 cm
Men
>90 cm
Women
>80 cm
Use South Asian recommendations until more
specific data is available
Use European data until more specific data is
available
Use European data until more specific data is
available for (Arab) populations

Source: Alberti, 200690

1.2.2 Epidemiology of Obesity
Over the past 30 years, there has been a dramatic increase in the prevalence of
obesity. In fact, obesity rates almost doubled from 1980-2008. In 2008, 10% of men
and 14% of women worldwide were obese (BMI ≥30 kg/m2), compared with 5% for
men and 8% for women in 1980. An estimated 600 million adults were obese in 2014.
In the same year, an estimated 41 million children under the age of five years were
overweight or obese91. Obesity has reached epidemic levels worldwide92 and the WHO
considers it as being one of the most serious health challenges of the early 21st Century
and a major public health concern in developed and devolving countries93. Eating
unhealthy food, sedentary lifestyle and a lack of PA are major contributors to these
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alarming rates that, in turn, can lead to an increase in body fat that has been linked to
several diseases94.
The prevalence of obesity has increased at different rates in all of the WHO
regions. It is most prevalent in the WHO Regions of the Americas (26% obese) and
least prevalent in the WHO Region of South-East Asia (3% obese). Furthermore, the
prevalence increases with income level, up to upper middle-income levels. The
difference in both sexes more than triples from 7% obesity in lower middle-income
countries to 24% in upper middle-income countries. Women were more likely to be
obese than men in all of the WHO regions. Female obesity was significantly higher
than male in low and middle-income countries, but it was similar in high-income
nations94.
In the USA, obesity has increased across all age groups. During the past 20
years, there has been a dramatic rise in obesity rates in the United States92, according
to the Center for Disease Control and Prevention (CDC). From 2011-2014, the
prevalence of obesity was 36.5% among USA adults, and it is projected that this figure
will rise to 47% by 203092. Furthermore, there has been an increase in the number of
overweight men and women over the last few years. Between 2005 and 2015, the
proportion of overweight or obese adults rose from 60.5% to 62.9% and the proportion
of adults who are morbidly obese increased from 1.8% to 2.9%. In England, 27% of
adults are obese and an additional 36% are overweight, making a total of 63% who are
either overweight or obese95. The Organization for Economic Co-operation and
Development (OECD) reported in its Obesity Update for 2017 that more than one in
two adults is either overweight or obese in OECD countries96. Over the past decade,
the rate of overweight adults and obesity has increased in Canada, France, Mexico and
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Switzerland. In 2015, 19.5% of the adult population across the OECD countries were
obese, and there is no clear indication of a reduction in any country96. OECD
projections have also shown that obesity levels are expected to be high in Mexico and
England, where 39% and 35% of the population, respectively, are projected to be obese
by 203096. On the contrary, it is predicted the rise will be slower in Italy and Korea,
where obesity rates are expected to be 13% and 9% respectively in 203096.
Globally, there are more obese people than hungry people, even in developing
countries. Low and middle-income countries are now facing a double burden. They
are experiencing a rapid increase in people being overweight or obese, while
continuing to combat infection, disease and malnutrition. In Bangladesh, there has
been a dramatic increase in obesity. A secondary data analysis of the National
Bangladesh Demographic and Health Survey showed that the prevalence of obesity
stood at 4.6% among the adult population in 2011, compared to only 1.1% in 200897.
It also showed that the rate of obesity was higher among women, people with a higher
level of education, the wealthy and those who lived in urban areas98.
While the incidence of obesity has doubled in some countries in the past 25
years99, it has tripled in Arab nations100. It has even become a problem in poorer Arab
states and among low-income groups, creating both health and economic burdens on
government services. A 2008-2009 national survey in Lebanon showed that the
prevalence of obesity among adults aged 20 and over was 26.1%101. This figure
increased to 52.7% in 2016102.
The WHO has reported that the GCC countries have one of the highest rates of
obesity worldwide. Kuwait, Bahrain, Saudi Arabia and the UAE are in the top ten most
obese countries. In Saudi Arabia, obesity has increased on a national level. In 2008,
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the WHO reported that the prevalence of obesity was 42%, 33.2% and 33% in the adult
populations of Kuwait, Qatar and Saudi Arabia, respectively. In 2015, those figures
had risen to 39% in Saudi Arabia, remained stable Qatar and reached 42% in
Kuwait103. This places Kuwait in the top ten most obese countries globally. The
increase in obesity in the region is due to the high consumption of fast food and sugardense beverages, as well as technological advances that have reduced activity levels.
There has also been a reduction in the consumption of traditional, locally grown natural
food, such as dates, vegetables, and wheat103.
Over the past four decades, there has been a move from a traditional seminomadic, physically active lifestyle to a modern, urbanized, technology-driven
lifestyle in the UAE, characterized by low domestic, occupational, leisure time
physical activity (PA). This is combined with the over consumption of energy-dense
convenience foods of poor nutritional content. Therefore, there has been a dramatic
growth in the prevalence of obesity in both the native Emirati and expatriate adult
population living in the UAE104, which has resulted in an increased in obesity105. The
UAE’s Ministry of Health and Community Protection (MOH) considers obesity and
DM to be the biggest health issue facing its people. In 2012, the prevalence of obesity
among Emirati nationals from Abu Dhabi was 35% (38% women and 32% men)41,
compared to 32% (39.9% women and 30% men) in 2008106. In 2015, the prevalence
of obesity in the UAE was estimated to be 34% among adults107.
1.2.3 Correlates for Obesity
Obesity is a major problem worldwide and its causes are both complex and
multifactorial. It results from a long-term imbalance of energy intake and expenditure
that can lead to a positive energy status resulting in the accumulation of body fat91.
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The human brain regulates our feeding behavior while the hypothalamus controls longterm energy balance and body weight. Defects in hormone levels and the
hypothalamus are thought to cause the pathogenesis of energy imbalance that results
in obesity.
Genetic factors also play a role in developing obesity108. Some studies have
reported that BMI is 25-40% genetic. However, the prevalence of obesity has increased
in the last two decades, which indicates that the reason is not due to genetic factors. It
is reasonable to say that this recent increase in both developing and developed
countries is down to environmental factors. In addition, modern societies have adopted
a Western diet and time-allocation patterns have changed109, leading to a positive
energy situation caused by over-nutrition, physical inactivity and a sedentary
lifestyle110.
1.2.3.1 Environmental Factors
Public health experts agree that obesity is best fought by restructuring the
environment rather than concentrating on an individual’s behavior111. Harvard School
of Public Health has claimed that the "environment has become toxic to healthy living"
and it is difficult for an individual to make a healthy choice that is vital for a healthy
weight. The obesogenic environment has been defined as a sum of the effect that
surrounds us, and it encourages obesity in individuals and the population. It includes
schools/ universities, homes, workplaces, community spaces, and the media112.
Features of this environment include easy accessibility to, and the affordability of,
highly advertised foods and inactive lifestyles. Spence et al. reported that the proximity
of the obesogenic environment, where people struggle against unhealthy energy-dense
food consumption and a sedentary lifestyle, is a vital correlate for obesity. They added
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that shaping the environment in such a way that it encourages healthy decisions is the
key feature in the prevention of obesity113. Cities in the UAE are unfortunately not
designed for walking, making automobiles the first choice. The high temperature of
450C in the Summer and the dusty conditions restrict people in the UAE and
discourage and them from exercising, especially women114.
1.2.3.2 Physical Activity (PA)
PA is defined as any body movement made by the skeletal muscles that
involves energy expenditure. Lack of PA is the fourth leading cause of death
worldwide, and it is a major correlate for several common chronic diseases. Globally,
31.1% adults are physically inactive. A third of adults do not meet the public health
guidelines for suggested levels of PA115.
Between 1977 and 1995, active transportation has dropped for all age groups.
In the United States, it was estimated that only 21.1% adult and 35.9% children walked
regularly116. The level of PA among adults is also low in Canada117, the United
Kingdom and other developed countries118. Al-Hazzaa et al. reported that 71% of
young people in Saudi Arabia did not engage in PA for a sufficient duration or
frequency119.
A significant lack of PA among the UAE population has been documented in
several research studies120. A cross-sectional study, conducted in 628 randomlyselected households in all seven emirates, revealed that only 41% of adult Emirati
women have moderate or high levels of PA and 75% of Emirati girls and adolescents
spend more time (>5 hours per weekday) sitting, compared to their male counterparts
(50%)121. Age was a major determinant of the level of PA (negative association) in the
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UAE. Henry et al. confirmed that PA in childhood and adolescence may affect activity
patterns in adulthood in the UAE122.
It is advised that adults take at least 150 minutes of moderate intensity PA or
75 minutes of vigorous PA every week118. Berger and colleagues examined the barriers
to physical activity for 600 female students in a women’s college in Fujairah. This
study identified that important determinants for PA in the UAE were a lack of female
role models among peers and families, information about the benefits of exercise,
culture, climate, clothing, make-up, personal motivation, time and opportunity, as well
as school and government policies120. A qualitative study conducted by Habiba et al.,
demonstrated that environmental barriers, like not having culturally accepted exercise
facilities for women, hot weather and safety concerns – especially at night – played an
important role in discouraging Emirati females from exercising123.
1.2.3.3 Sedentary Lifestyle
A sedentary lifestyle is defined as the time that people spend sitting, resulting
in lower metabolic expenditure124. It is one of the key determinants of the growing
rates of being overweight and obese in Western populations125. Worldwide, the
proportion of adults who spend 4 or more hours per day being sedentary (watching
television, driving cars, sitting, sewing, playing board/ computer/ phone games) is
41.5%126. Owen et al. reported, in a cross-sectional study of 5,078 Australians, that
sedentary behavior increases with age, and is more common among less educated and
lower income people127. Similar findings were observed in the USA128. Most Canadian
adults’ working hours (68% men and 69% women) are sedentary129. They spend an
average of 10 waking hours per day being sedentary (not including sleep).
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The time spent in sedentary activity, including watching TV, has increased
dramatically in almost all the major Arab countries119. For instance, in the UAE, the
median number of hours that 58 adolescent females aged 11-16 years spent watching
television was 2.5 per day, and the number of hours increased at the weekend122.
Musaiger et al. found that watching television occupied significant amounts of
children’s and young adults’ leisure time in the UAE, and the practice of having meals
in front of the television was also very common for families in the UAE130.
1.2.3.4 Nutritional Factors
Dietary factors have been comprehensively studied for their likely
contributions to growing obesity rates. These factors are the size of food portions, daily
consumption of fruit and vegetables, the role of breakfast, consumption of fast food
and sugary beverages.
Studies suggest that two vital lifestyle choice factors contribute to the
increasing rate of being overweight and obese in the UAE. These are dietary (frequent
snacking, the replacement of traditional food with fast food, replacing water with a
soft drink, low fruit and vegetable consumption and wealth) and increased physical
inactivity121.
a) Food Portion Size
The size of food portions is the amount of a single food item served in a single
meal or snack time. For example, the amount of food put on a plate or the quantity
offered in readymade food packages. The WHO believe that large food portions play
an important role in the global obesity epidemic84. The propensity towards a rise in
portion sizes began in the late 1970s and has increased ever since. In the USA, portion
sizes have risen sharply over the last 30 years, especially those that have a high energy
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density. This has led to the overconsumption of food and has fueled the growing
obesity epidemic. The current portion sizes for hamburgers, French fries and soda are
2-5 times larger than they used to be131. A study shows that, except for sliced white
bread, all commonly available food portions exceed the USA Department of
Agriculture and Food and Drug Administration’s standard portions, sometimes to a
very large extent. In the UAE, there has been a change from traditional food to a more
Westernized diet leading to the consumption of high-dense energy foods and bigger
portions. Musaiger et al. have attributed the epidemic of childhood obesity in Dubai
mainly to these reasons130.
Ledikwe et al. have attributed the rise in the obesity rate in the last three
decades to the increase in portion sizes for many foods and the frequency of eating
outside the home. They emphasize the importance of eating a healthy balance of
different types of food in order to control obesity132. A study by Rolls et al. examined
how adults reacted to different portion sizes. They found that the bigger the portion,
the more the participants ate. Those offered a larger portion consumed 30% more
energy compared to others who were offered a smaller portion of food132.
b) Daily Consumption of Fruit and Vegetables
It has been well established that fruit and vegetables are important components
of a healthy diet and can help to prevent a wide range of diseases. Fruit intake in most
Western countries is well below the daily recommended amount (five servings a
day)133. The WHO recently recommended a minimum intake of 400g or five portions
of fruit and vegetables per day to prevent obesity and other chronic diseases134. Having
daily fruit and vegetables leads to good weight management through the replacement
of energy-dense food with healthier choices that ensure satiety due to eating fiber. This
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leads to the consumption of fewer calories and modulation of the dietary glycemic load
which affects postprandial hormonal shifts135.
Traditional UAE food, which is high in fiber and low in fat, has been largely
replaced by a Westernized diet with a higher content of fats, sugar, sodium and
cholesterol. It is also low in fiber-rich foods, such as vegetables, fruit and whole
grains136. The Bedouin Emirati, who live in rural areas and have maintained their
traditional food culture, have lower obesity rates than those in urbanized areas137. Daily
fruit and vegetable consumption is low in the UAE. This has been reported by
Musaiger and Abuirmeileh, who confirmed low fruit and vegetable consumption in a
cross-sectional study in all seven Emirates by random sampling of 1,122 men and
1,090 women138. Zaal et al. reported that fruit and vegetables are less accessible in the
UAE compared to high-dense energy food, and the consumption of canned fruit is
higher than fresh fruit and vegetables130.
c) Role of breakfast
There is a relatively strong public belief that having breakfast regularly plays
a role in human health. The frequency of people skipping breakfast has increased over
the past few years, during which time the obesity epidemic has increased worldwide.
Thus, there is a strong scientific belief that a causal relationship between obesity and
breakfast exists (inversely correlated).
Several clinical studies have demonstrated that regular food consumption
reduces the risk of obesity. A systemic review of 16 European studies has suggested
that skipping breakfast increases the correlate for people becoming overweight and
obese because they tend to overeat at lunch or dinner130. This positive association is
observed internationally, regardless of the culture in a diversity of countries139. The
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odds of becoming obese as a result of skipping breakfast is 4.5 times higher, compared
to people who regularly eat breakfast140.
Research studies have shown that skipping breakfast is highly prevalent in
many Arab countries. In the UAE, Musaiger reported that 28% of Emirati boys, aged
6-7 years, skip breakfast compared to 37% of girls of same age100. Furthermore,
Kerkadi conducted a study on 400 female students from UAE University. Students
who had breakfast regularly (72.2%) were less likely to be obese than those who did
not and were consequently either overweight or obese.141.
d) Consumption of Fast Food
Consumption of fast food has been closely associated with obesity in recent
years. Fast food consumption increased fivefold worldwide from 1977 to 1995 in 2-18
year olds and nearly one third of youths now eat fast food every day. Studies have
shown that weekly consumption of fast food by young adults is associated with an
increase in BMI142. Isganaitis et al. considered fast food to be the primary cause of the
current obesity epidemic143.
There is a close association between the proximity of fast restaurants to
residential areas, exposure to fast food advertisements and an increase in the risk of
obesity. Fuzhong et al. studied 1,221 residents from 120 neighborhoods. They
measured their BMI, level of PA, frequency of visits to local fast food restaurants and
fried food consumption. They reported that an increase in neighborhood fast food
outlets was associated with an unhealthy lifestyle and an increased risk of obesity
among adults144. Furthermore, a positive correlation between exposing children to fast
food advertising and BMI has been established in several studies. It has been shown
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that banning such advertisements reduces the number of overweight children and
adolescents by 10% and 12%, respectively.
The UAE’s economic boom and concomitant Westernization has resulted in a
greater dependence on fast food130. The easy accessibility of this food is another
concern. Studies have revealed that 76% of participants had consumed fast food at
least once a day during the seven days before the data was gathered145. This was much
higher than the figure reported by Kerkadi, who found that 34.9% of female students
at the same university consumed fast food at least once a day141.
e) Consumption of Sugar Sweetened Drinks
Many studies have been carried out into the relationship between consuming
sugary drinks and weight gain. These drinks have repeatedly been found to correlate
for obesity. Over the last three decades, the consumption of sugar sweetened drinks,
including soft drinks such as iced tea, fruit drinks and energy and vitamin water drinks,
has increased noticeably worldwide146. Between 1977 and 1996, there was an upsurge
in the percentage of people consuming these beverages (from 61.4% to 76%), the
frequency of consumption (from 1.96 to 2.39 servings per day), the portion size (from
13.6 to 21 oz/d) and calorie intake (from 70 kcal to 189 kcal per day)143. US studies
have shown that approximately 50% of Americans aged 4 and above regularly drink
soft drinks on a daily basis. They have replaced dairy drinks and become a leading
source of carbohydrates, especially in children and teenagers147. In the UAE, Zaal et
al. found that high consumption of energy-dense foods, such as carbonated canned
drinks, during the day and at night was a major reason for gaining weight130.
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1.2.4 Consequences of Obesity
Obesity is associated with a large number of health, social and emotional
problems. The social and emotional effects of obesity include suffering discrimination,
receiving lower wages, poor quality of life and depression. The health problems start
when an individual is slightly overweight and they increase as the weight increases,
causing serious mortality issues (CVD, DM, hypertension, kidney stones, infertility,
musculoskeletal illnesses), and some types of cancer (endometrial, breast and colon)
as well as morbidity91. The Nurse Health Study showed the risk of death rose in women
with a BMI of more than 29 kg/m2 and mortality was lowest among those women
whose weight had remained unchanged since early adulthood. The American Cancer
Society’s Cancer Prevention Study 1 and 2 came to the same conclusion.
1.2.5 Association of Obesity with Prediabetes and DM
Obesity is a major correlate for DM and prediabetes150. Furthermore, DM and
prediabetes are closely associated with a high BMI, and visceral fat is an independent
correlate for insulin resistance. Numerous other measurements of obesity, including
WC, WHR and waist-to-stature ratio, are associated with DM and prediabetes27,151.
The relationship between DM and obesity was explored in a National Health
and Nutrition Examination Survey, where 21,205 adults were examined for DM.
Among the people with DM (13.6%), 80.3% were overweight and 49.1% were obese,
and the prevalence of DM rose the more severely obese they were. ‘Diabesity’ is the
term used to describe the strong epidemiological and pathogenic relationship between
DM and obesity. Studies have also confirmed the significance of weight loss in
improving control of DM, which has, in some cases, led to people reverting back to
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normoglycemic status. “Look AHEAD” was a large multicenter trial where
overweight/ obese adults with DM randomly selected to participate in a rigorous
lifestyle intervention (with a reduction in calorie intake and increased PA levels) or
receive DM support and education only. After a follow-up one year later, it was noticed
that weight reduction in the intervention group (8.6% weight loss) was significantly
associated with an improvement in DM control in obese and overweight adults with
DM, when compared to patients in the control group (0.7% weight loss)149. In spite of
the close relationship between obesity and DM, the real mechanisms are not
straightforward, given that not all obese and overweight people develop prediabetes or
DM, and that there are people of normal weight who develop prediabetes and DM
regardless.
Studies have shown that obese people are five to six times more at risk of
developing prediabetes, compared to normal-weight people57. In addition, people who
lose 5-10% of their weight through a healthy diet and exercise regime can significantly
reduce their risk of developing prediabetes4,7. Furthermore, the USA Prevention
Program’s multicenter clinical research study involved training overweight patients
with prediabetes to lose weight through dieting and PA, medication or a placebo. After
both three and ten year follow-ups, it was evident that losing weight (through dietary
changes and increased PA) had an effect on reducing the incidence of DM when
compared to the placebo or the use of medication in prediabetic patients. Moreover,
the observed reduction in the incidence of DM in this study was 58% in people who
lost weight through dietary changes and 34% in people who lost weight through
increasing their level of PA80.
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1.3 Summary
The prevalence of prediabetes in every age group is rising exponentially around
the world causing massive health problems and a significant economic burden. This
increase is due to population growth, aging, urbanization, and a growing number of
people who are physically inactivate. Obesity is one of the main correlates for
developing prediabetes. The ADA and WHO use FBG, OGTT and HbA1c for the
diagnosis of prediabetes, which is a major correlating factor for many diseases.
However, people can revert to normoglycemic status through modification of their
lifestyle.
This dissertation is based on secondary data. Both sets of data were collected
during an intervention with prediabetic adults in Al Ain, Abu Dhabi and Dubai, in the
UAE as part of a National Research Foundation (NRF) funded grant for the
“prevention of diabetes through population-based strategies”. The data from Al Ain
was secondary data based on NCD correlates and was obtained from a random sample
of school children and their parents. In this dissertation we used parental data to
achieve the primary objective of the esearch i.e. to ascertain the prevalence of
prediabetes and its identify its correlates (Described in Chapter 2). The Dubai data was
collected as part of case study where 700 adults were identified with prediabetes in
five primary health care centers in Dubai in 2015 as part of the Dubai Health Authority
diabetes screening and prevention program. Participants were re-examined in 2017.
The data here was used for the secondary objective, that is to determine the correlates
when prediabetes develops into DM. The total number of participants was 605 in Al
Ain and 487 in Dubai (Described in Chapter 3).
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In the UAE, there is no recent data on the prevalence of prediabetes, and little
data on the correlates when prediabetes develops into DM. The results of this study
encourage two-way communication between researchers and decision makers to help
shape regulations and laws to fight obesity and prediabetes. It will also show evidence
that can inform policy makers on how to control diabetes in the UAE.
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Chapter 2: Prevalence of Prediabetes and its Correlates - Al Ain
2.1 Aims and Objectives
2.1.1 Aims
Prediabetes is a high-risk state for the development of DM. Furthermore, a
substantial number of people with DM remain undiagnosed and untreated. Our study
aims is to document the burden of prediabetes and its correlates in the UAE. Also, we
seek to improve the current understanding of the relationship between prediabetes and
its correlates in married adults in Al Ain, the UAE.
2.1.2 Specific Objectives
-

Objective 1:
o To estimate the prevalence of prediabetes in married adults in Al Ain,
the UAE

-

Objective 2:
o Evaluate the relationship between prediabetes and its correlates in
married UAE nationals/ Arab adults in Al Ain, the UAE

2.2 Methods
2.2.1 Study Design
We used a cross-sectional design to achieve our study objectives.
2.2.2 Study Site
This study was conducted at the Al Muwaiji Healthcare Center in Al Ain, Abu
Dhabi, in the UAE. Al Ain is the 4th largest city in the country. It is located 160
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kilometers east of the capital Abu Dhabi. The city covers an area of 13,100 Km2 and
has a population of 650,000 (according to the UAE census 2013). The United Arab
Emirates University is located in Ali Ain and Abu Dhabi Health Authority provides
health care through a number of primary healthcare centers. The participants were all
invited to attend the Al Muwaiji Healthcare Center to be measured and have blood
tests. This primary healthcare center is affiliated with Ambulatory Healthcare Services
in Al Ain, Abu Dhabi.
2.2.3 Study Population
The Al Ain based data used in this dissertation was secondary data about NCD
risk factors. Details of the primary study are summarized in Figure 1. For our study
purposes, every participant was either a married UAE national or an Arab national
with children in school who lived in Al Ain. Out of 866 participants contacted, 605
agreed to participate and signed the informed consent form.
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114 private and public schools in Al Ain with children aged 12-18 years old

1,630 students




401 students
refused to
participate
9 were not
fasting when
presented in
clinic

Parents of 60
students did not
attend to collect
the blood test
results of their
children despite
two reminders

1,220 students

34 students were
excluded – they did not
meet inclusion criteria.
Other students were
from multiple
ethnicities therefore
excluded despite
completing data
collection

1,186 students1

Parents of 1,120 student
Figure 1: Summary of primary data collection in Al Ain, Abu Dhabi, the UAE
1. As part of a previously completed global health study “Developed developing countries partnership for NCDs
prevention”, a random sample of 1,186 adolescent, aged 12 to 18 years from 114 public and private schools in Al
Ain completed a school-based NCDs risk factors study. Approval was obtained from Abu Dhabi Education
Council. Parents of 1,186 students were contacted though telephone by a staff nurse in Al Muwaiji Healthcare
Center in Al Ain to come and take a blood test (Fasting blood sugar& lipid) conducted by a pediatrician. Contact
numbers were obtained from the medical file of each student. Nurses from Al Muwaiji Healthcare Center in Al
completed the measurement of 1,186 students. The measurements were as followis: Self-administered
Questionnaire, I PAQ, Beck & Rosenberg self-esteem scale II. Weight, height, waist, blood pressure III. Blood
samples after fasting overnight.
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2.2.4 Selection of the Study Participants
2.2.4.1 Inclusion Criteria
1. The participants were either a father or mother of the adolescents studied.
2. UAE nationals and Arabs.
3. Resident in Al Ain.
4. They were willing to participate and signed the informed consent form.
2.2.4.2 Exclusion Criteria
1. Participants who did not fulfill any of the inclusion criteria.
2. Those who did not sign the informed consent form.
2.2.5 Sample Size Calculation
The sample size was determined by using a single population proportion
formula. It was reached by considering the 27% prediabetic prevalence discovered in
the Weqaya study41 of the prediabetic Emirati population. We had a 95% confidence
level with 0.05 margin for error. This came to 302, and by adding 50% for the nonresponse rate, the total sample size was 605 participants.
2.2.6 Study Measurement
2.2.6.1 The Primary Variable
The primary variable was the prevalence of prediabetes and DM.
2.2.6.2 The Study Variable
Being overweight, obesity and central obesity.
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2.2.6.3 Other Variables
Socio-demographic characteristics
-

Age, tobacco use, educational level, smoking, history of chronic diseases and
family history of chronic conditions.

Anthropometric measurements
-

Height, weight and BMI

Blood tests
-

FPG, HbA1c, total cholesterol, TG, HDL and LDL cholesterol

-

The level of PA

-

Diet

2.2.7 Data Collection Procedure
Data collection was conducted on secondary data from 1,120 participants in
2013. Funding was granted by the National Research Foundation (NRF). We selected
relevant and previously validated questions from the WHO STEP Surveillance
(STEPS) Questionnaire. The questions were culturally adapted and piloted on a sample
of the participants (n=12) after being translated into Arabic. We also relied upon a
shortened version of the International Physical Activity Questionnaire (IPAQ). A copy
of this questionnaire has been included in the appendix.
The pilot study was scheduled for two weeks in July 2013 on a randomly
selected sample of 12 participants form the original 866. Satisfactory results were
obtained from the pilot study in terms of ensuring that all the nurses understood the
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questions and in the same way. In addition, the time required to complete the survey
was determined and respondents were apparently comfortable with the questions.
Training workshops for the nurses were conducted in August, 2013 (4). These
sessions informed the nurses of the purpose of the study and trained them in
standardizing anthropometric methods prior to data collection. The workshop was run
by qualified trainers. After the workshop, the nurses identified those from the 1,120
participants who met the inclusion criteria. A total of 254 participants were excluded
as they did not meet these criteria.
The 866 participants who met the criteria were invited to take part in the study.
This number took into account the fact that there would be some who would not agree
to participate. The invitation was conducted along these lines: every week 50 subjects
received SMS messages inviting them to attend Al Muwaiji Healthcare Center in Al
Ain. They were asked to come to the center after fasting in order to do an investigation
of their blood samples. The SMS messages were followed up by phone calls in order
to ensure attendance. The invitations were sent out by a coordinator and four staff
nurses from the center. The invitations were sent out over a six month period and
resulted in 440 participants agreeing to become involved out of the possible 866. In
order to increase the number of participants, UAE national medical students (n=5)
from UAE university were informed of the study protocol and asked to call participants
who did not respond to the first invitation. As a result, 165 more participants agreed to
take part in the study, making the final number up to 605.
The 261 who did not participate in the study did so for a variety of reasons
including: refusal to participate (71) and no response (186), despite two reminders.
Four subjects were excluded as they were not fasting when they came to the center.

49
The 605 participants attended Al Muwaiji Healthcare Center for an evaluation
and a blood test. Thus, the response rate was 54%. The data collection was conducted
by a coordinator and trained nurses. They administered questionnaires, took
measurements and collected blood samples. See Figure 2.
We used a structured questionnaire and selected relevant and valid questions
from the WHO STEP Surveillance (STEPS) Questionnaire. The questions were
culturally adapted and piloed on a sample of parents (n=12) after being translated into
Arabic. We also included a shortened version of the International Physical Activity
Questionnaire (IPAQ). A copy of this questionnaire has been included in the appendix.
A SECA adult portable stadiometer was used to measure the participants’
height after they had removed shoes, socks, slippers and any headgear. It was measured
in centimeters to within 0.1 cm. The SECA digital scale was used to measure their
weight, and the scale was regularly calibrated against a standard weight. The
participants were asked to remove footwear and socks and their weight was recorded
in kilograms to within 0.1 kg. BMI (kg/m2) (BMI; calculated as weight in kilograms
divided by height in meters squared). Subjects were classified as being of a normal
BMI if less than 25 (BMI <25.0 kg/m2), the overweight category included those with
a BMI of 25 to 29.9 (BMI 25.0-29.9 kg/m2), and the obese group was those with a
BMI of 30 or greater (BMI ≥30.0 kg/m2).
WC was also measured by using a flexible, non-stretch nylon tape measure
(SECA Hamburg, Germany) while subjects were lightly clothed. It was done in
centimeters to the nearest 0.1 cm at the midpoint between the inferior margin of the
last rib and the iliac crest in the mid-axillary plane. Hip measurements were taken
around the widest portion of the gluteal muscles in centimeters to the nearest 0.1 cm

50
with the tape parallel to the floor. This was done while the individual was standing
with his or her feet close together, at the end of a normal expiration, with the arms
relaxed at the sides. Each measurement was repeated twice, and if the measurements
were within 1 cm of one another, the average was calculated. If the difference between
the two measurements exceeded 1 cm, then the two measurements were repeated. We
used a WC of >94 cm for men and >80 cm for women to define central obesity.
We also measured resting brachial BP. A trained research nurse carried this out
using a calibrated automated device (Omron HEM-705cp). The subject was in a sitting
position with an appropriate sized cuff applied to the upper right arm after a five minute
period of rest. BP was measured trice. The first value was discarded and the average
of the two subsequent measures was used for analytical purposes. Hypertension was
defined as a mean systolic ≥BP 140, a mean diastolic BP ≥90 or a if the subject was
currently undergoing hypertension treatment with prescription medication.
PA was assessed by using the International Physical Activity Questionnaire
(IPAQ). The activity level was measured using the intensity level, which is the rate at
which the activity is performed or the extent of the effort needed to achieve an activity
or exercise. The PA level can be classified into three levels: vigorous, moderate and
light. ‘Vigorous-intensity activities’ require hard physical effort and cause a large
increase in breathing or heart rate, ‘moderate-intensity activities’ require moderate
physical effort and cause a small increase in breathing or heart rate, and ‘light-intensity
activities’ do not achieve the aforementioned levels of activity. Participants were
classified as sufficiently active if they exceeded the minimum recommended duration
for PA per week according to WHO standards, i.e. 150 minutes of moderate intensity
PA, or 75 minutes of vigorous intensity PA, or an equivalent combination of moderate
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and vigorous intensity PA per week, with each activity performed for at least 10
minutes.
For biochemical measurements (HbA1c, lipid profile and FPG), venous blood
samples were taken from individuals, after 10-12 hours of overnight fasting, during
their visit to the Al Muwaiji Healthcare Center. 5 ml of venous blood was taken while
in a sitting position. It was then immediately centrifuged to separate the serum, and
transferred under cold chain conditions within less than three hours from collection, to
Tawam Hospital Laboratory in Al Ain for analysis.
Biochemical tests were then conducted to measure fasting blood glucose, total
cholesterol, TG, HDL and LDL cholesterol. The blood tests results generated an
electronic medical report at Tawam Hospital. Two different cut-off points were used
to define prediabetes: FPG ≥100 mg/dl and <126 mg/dl and FPG ≥110 mg/dl and <126
mg/dl or an HbA1c level of 5.7-6.4%. DM was defined by as a previous diagnosis of
DM or, if DM had not been diagnosed previously, the ADA guidelines for DM (HbA1c
= 6.5% or greater, or FPG of 126 mg/dl) were used. The National Cholesterol
Education Programme guidelines define dyslipidemia in the following way:
Hypercholesterolemia-serum

TG

levels

of

≥150

mg/dl

and/

or

a

Hypercholesterolemia-serum cholesterol level of <200 mg/dl. The optimal HDL
cholesterol level was <100 mg/dl and the LDL cholesterol level was <40 mg/dl.
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1120 participants1

254 excluded- did not
meet inclusion
criteria

261 excluded:




866 participants

71 refused to
participate
186 did not respond
despite two reminders
4 came to clinic
without fasting

605 agreed to participate in and completed the study
Figure 2: Summary of secondary data collected in Al Ain, Abu Dhabi, the UAE
(n=605) for this dissertation
1. The 1,120 participants were parents of students from the previously mentioned study. Their contact numbers
were noted when they attended Al Muwaiji Healthcare Center in Al Ain to collect blood results for their children.
When we got further funding (an NRF grant) we invited the parents, via SMS message and a telephone call, to
come to Al Muwaiji Healthcare Center in Al Ain for their own examination and test. Either the father or mother
was selected for the study based on whoever came to collect the blood test. If both parents came then both of them
were involved after obtaining consent.

2.2.8 Ethical Considerations
2.2.8.1 Ethical Approval of Study
Ethical approval was obtained from the Human Research Ethics Committee in
the College of Medicine and Health Sciences, UAE University (13/09, Appendix 1).
2.2.8.2 Informed Consent
Every participant who agreed to join the study, provided written informed
consent before taking part, see Appendix 6.
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2.2.8.3 Confidentiality
The data and questionnaires were stored in the Institute of Public Health at
UAE University with their data protection guaranteed. Thus the confidentiality of this
data was preserved. To maintain anonymity, unique personal identification numbers
were assigned to each participant in order to conceal the identities of the participants.
2.2.9 Data Analysis
The statistical analysis was carried out by using the STATA version 14.0 in
order to calculate the prevalence of DM and prediabetes. We used Microsoft Access
to enter the data before it was imported into STATA version 14.0 (StataCorp LP,
College Station, TX) for analysis. The categorical variables were summarized by
proportions, while the continuous variables were summarized by using mean and
standard error, whichever was most applicable, with 95% confidence intervals. A Chisquare test compared proportions across groups and an ANOVA test compared the
means across the groups. We used univariate and multinomial logistic regression
analysis to determine the correlates for prediabetes. Variables entered into the
multivariable multinomial logistic regression models were selected according to their
significance (p<0.2) in the univariate analysis.
Multivariate analysis was used as our dependent variable had three categories
(normoglycemia, DM and prediabetes). In addition, we controlled confounding
information by using a multivariate analysis. We checked the data for interactions but
could not find any between the variables in our study.
Design effect is important in cross sectional study. Therefore, probability
proportional to size, (when samples from different sized sub-groups are used and
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sampling is done with the same probability, the chances of selecting a member from a
large group are less than the chances of selecting a member from a smaller group),
takes varying sample sizes into account. This was not taken into consideration when
choosing our target population, therefore our data may be under-representative of the
general population in the UAE.
2.2.10 Timeline
The data was collected in a six-month period, from September 2013 to June 2014.
2.3 Results
The demographic and clinical characteristics of the study population are
presented as a percentage for the categorical variables and as a mean±standard
deviation for the continuous variables in Table 2.1.
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Table 2.1: Demographic and clinical characteristics of the study population (n=605)
in Al Ain, Abu Dhabi, the UAE
Variables
Emirati
Arab
Age (mean±std)
Married
Divorced or widowed
No formal education
Up to secondary level
>Secondary level
Employed
Unemployed
BMI (mean±std)
Height (mean±std)
Weight in kg (mean±std)
Waist in cm (mean±std)
Hip circumference in cm
(mean±std)
Total cholesterol (mg/dl)
LDL-cholesterol (mg/dl)
HDL-cholesterol (mg/dl)
TGs (mg/dl)
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
Under 25
25-29.99
≥30.0
Normoglycaemia
Prediabetes
DM

All
52.6
47.4
42.9±7.9
95.5
4.5
7.1
47.1
45.8
47.8
52.2
31.1±8.4
162.9±10.3
81.1±17.5
91.8±13.2

Male
39.3
51.9
45.9±8.2
98.9
1.1
4.4
46.1
49.5
82.5
17.5
30.4±9.8
169.9±9.8
86.7±16.7
98.8±10.8

Female
60.7
48.1
40.3±6.8
94.8
5.2
9.1
48.1
42.8
72.8
27.2
31.1±8.4
157.1±6.3
76.5±16.7
85.9±12.1

105.7±10.1

103.9±8.5

107.1±11.1

88.2±18.0
57.6±28.8
19.8±7.2
25.2±16.2
42.9
57.1
74.9
25.1
29.3
70.7
21.2
78.8
41.5
58.5
14.1
35.7
50.2
43.6
37.7
18.7

88.2±19.8
59.4±37.8
7.2±3.6
30.6±19.8
42.4
57.6
49.6
50.4
29.2
70.8
21.2
78.8
31.4
68.6
14.1
39.1
46.8
37.2
40.2
22.6

88.2±16.2q
55.8±14.4
23.4±7.2
21.6±14.4
43.5
56.5
95.8
4.2
29.3
70.7
21.1
78.9
49.8
50.2
14.1
33.1
52.8
48.9
35.7
15.4
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2.3.1 Baseline Demographic Characteristics of the Study Population
Participants were divided into two groups, based on their nationality – Emirati
or Arab (52.6% and 47.4%, respectively, P=0.002). The mean age of the study
population was 42.9±7.9 years, with a range from 35 to 50.8 years. The average age
of the male participants was significantly olderthan the female ones (45.9 vs. 40.3,
P<0.001). The percentage of married participants was 95.5%, while 4.5% of the study
population were divorced or widowed. The level of education varied from no formal
education, up to secondary level and higher than secondary level (7.1%, 47.1%, and
45.8%, respectively). The employment status was significantly different between the
employed and unemployed participants (47.8% and 52.2%, respectively, P<0.001).
2.3.2 Baseline Clinical Characteristics of the Study Population
Table 2.1 shows the characteristics of the study population. The mean values
for total cholesterol (mg/dl), LDL-cholesterol (mg/dl), HDL-cholesterol (mg/dl), and
TG (mg/dl) were significantly different between the male and female subjects
(P<0.003). The percentage of participants with no family history of DM was 42.9%,
whereas the percentage of participants who had never smoked cigarettes was 74.9%.
Based on the body mass index categories, 14.1% of the participants were found to have
a BMI of <25, 35.7% had a BMI between 25 and 29.9, whereas 50.2% had a BMI of
≥30.0 and were classed as obese (Figure 3). Furthermore, females were more often
obese than males, while more male subjects were classified as overweight than female
participants (Figure 4). The mean WC (WC >=94cm male >=80 cm female) was
91.8±13.2 cm. The average WC of the male participants was significantly different
from that of the females (98.8 vs. 85.9, P<0.001).
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60
50.2

Percentage

50
40

35.7

30
20

14.1

10
0
BMI <25

BMI 25-29.9

BMI >=30

Figure 3: The percentage of body mass index categories (n=605), in Al Ain, Abu
Dhabi, the UAE
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14.9

13.3
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0
BMI <16.5

BMI 16.5-24.9
Male

BMI 25-29.9

BMI >=30

Female

Figure 4: The percentage of body mass index categories by gender (n=605), in Al
Ain, Abu Dhabi, the UAE
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2.3.3 Baseline PA Level
About 71% of the study participants reported that they did vigorous PA, 78.8%
stated they practiced moderate PA, and 58.5% reported walking for at least 30 minutes
once a week.
2.3.4 Prevalence of DM and Prediabetes
Overall, the unadjusted prevalence of DM and prediabetes using the HA1c and
FPG definition was 18.7% (CI 15.7-21.9) and 37.7% (CI 33.9-41.6), respectively. The
unadjusted prevalence of DM and prediabetes was higher in males than in female
subjects (22.6% of males had DM and 40.2% had prediabetes). The percentage of
normoglycaemic participants was 43.6% (Figure 5).
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90

15.4

22.6

80

Percentage

70
60

35.7
40.2

50
40
30
20

48.9
37.2

10
0
Male
Normal

Female
Prediabetes

Diabetes

Figure 5: Proportion (%) with normoglycemia, prediabetes and DM by gender
(n=605), in Al Ain, Abu Dhabi, the UAE
We further calculated the age-standardized prevalence of DM and prediabetes
based on the HA1c and FPG definition. The percentage of participants diagnosed with
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DM and prediabetes increased significantly as the participants got older. Univariable
analyses (Table 2.3) showed that the older participants (≥55 years) were 26 times more
likely to have DM, and three times more likely to have prediabetes than he younger
participants (P<0.006).
We have further subdivided the prevalence of prediabetes and DM by BMI
(using WHO criteria for BMI), and central obesity (WC >=94cm male >=80 cm
female). The prediabetic participants were more often obese and overweight and had
a higher percentage of central obesity when compared participants with DM (Figures
6, 7).
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BMI 16.5-24.9
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BMI 25-29.9
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Figure 6: Prevalence of DM and prediabetes (%) by BMI categories (n=605), in Al
Ain, Abu Dhabi, the UAE
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Figure 7: Prevalence of prediabetes and DM by central obesity (Waist circumference
>=94 cm in male >=80 cm in female) (n=605), in Al Ain, Abu Dhabi, the UAE
2.3.5 Prevalence of Overweight/ Obesity
The distribution of the population by BMI categories as defined by WHO
criteria and showed that 14.1% (CI 11.5-17.1) had a BMI of <25 kg/m2; and 35.7%
(CI 31.9-39.6) were overweight (a BMI between 25.0 and 29.9 kg/m2), while 50% (CI
46.1-54.1) were obese (MBI ≥30).
Table 2.2 demonstrates that 50.1% of the study population could be classified
as obese (≥30.0 kg/m2) according to BMI. However, central obesity was also prevalent
in 70.4% of the population, based on WC classification (WC >=94cm male >=80 cm
female). In addition, 50.7% were found to have central obesity when WHR ≥0.90 cm
for men and ≥0.85.0 cm for women were used as cut-off points.
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Table 2.2: Distribution of the study population, according to different measures of
obesity
Variable

N (%)

Males

Females

84 (14.1)

14.1%

14.1%

Overweight (25.00-29.99 kg/m2)

213 (35.7)

39.1%

33.1%

Obese (≥30.0 kg/m2)

299 (50.1)

46.8%

52.8%

>94.0 cm (men); >80 cm (women)

426 (70.4)

70.1%

70.7%

<=94 cm (men); <=80 cm (women)

179(29.6)

29.9%

29.3%

≥0.90 cm (men); ≥0.85.0 cm (women)

307 (50.7)

81.8%

25.1%

<0.90 cm (men); <0.85 cm (women)

298 (49.3)

18.2%

74.9%

BMI
Under and Normal weight (<25
kg/m2)

WC

WHR

We used multinomial logistic regression analysis to determine the association
between independent variables, such as age, family history, anthropometric measures
and biochemical measures, and dependent variables to determine the presence of DM
and prediabetes. Table 2.3 and Table 2.4 show the univariable, and multivariable,
regression analyses results for the possibility of having DM and prediabetes according
to potential correlates, respectively.
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Table 2.3: Univariate analyses− unadjusted odds ratios for DM and prediabetes
Variable

Overall prevalence
(n, %)
Nationality
Emirati
Arab
Age (n, %)
35-54 years
≥55
Sex (n, %)
Male
Female
Marital status
Married
Divorced widowed
Family type
Nuclear family
Joint family
Education level (%)
No formal education
Up to secondary
level
>Secondary level
Employment status
Employed
Unemployed
BMI categories
<25
25.0-29.9
≥30.0
WHR
≥0.90 cm (men);
≥0.85.0 cm (women)
<0.90 cm (men);
<0.85 cm (women)
Central obesity
(WC)
>94.0 cm (men); >80
cm (women)
<=94 cm (men);
<=80 cm (women)
Family history of
DM
Yes
No

DM

All

Prediabetes

N

n (%)

OR (95% CI)

n (%)

OR (95% CI)

605

113(18.7)

318
287

56 (17.6)
57 (19.9)

1
1.16 (0.81, 1.65)

117(36.8)
111(38.7)

1
1.24 (0.79, 1.93)

447
53

83 (18.6)
23 (43.4)

6.54 (2.29, 18.61)
25.65 (7.57, 86.92)

180(40.3)
17 (32.1)

2.57 (1.51, 4.39)
3.44 (1.44 8.25)

274
331

62 (22.6)
51 (15.4)

1.93 (1.23, 3.01)
1.0

110(40.1)
118(35.6)

1.48 (1.03, 2.12)
1

578
20

106 (18.3)
4 (20.0)

1.0
1.15 (0.37, 3.52)

219(37.9)
9(35.0)

1
0.89 (0.33, 2.45)

471
126

92 (19.5)
18 (14.3)

1.0
0.64 (0.36, 1.15)

178(37.8)
47 (37.3)

0.87 (0.56, 1.34)
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14 (33.3)

1.0

20 (47.6)

1

282

55 (19.5)

0.25 (0.10, 0.64.9)

105(19.5)

0.34 (0.14, 0.81)

274

41 (14.9)

0.18 (0.07, 0.45)

101(14.9)

0.31 (0.13, 0.72)

316
289

56 (17.7)
57 (19.7)

0.88 (0.58, 1.37)
1.0

121(38.3)
107 37.0)

1.01(0.71, 1.45)
1

84
213
299

11 (13.1)
25 (11.7)
75 (25.1)

1
1.23 (0.56, 2.68)
3.92 (1.92, 7.99)

16 (19.0)
83 (38.9)
125(41.8)

1
2.81 (1.51, 5,26)
4.49 (2.43, 8.33)

258

80 (26.1)

3.50 (2.18, 5.62)

118(38.6)

1.54 (1.08, 2.21)

347

33 (11.0)

1

110(36.8)

324

63 (26.6)

2.89 (1.83, 4.56)

94 (39.7)

281

50 (13.7)

1

132(36.1)

325
245

77 (23.7)
31 (12.6)

2.44 (1.50, 3.97)
1

124 38.1)
92 (37.5)

228(37.7)

1.64 (1.13, 2.37)

1.33 (0.91, 1.91)
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Table 2.3: Univariate analyses− unadjusted odds ratios for DM and prediabetes
(Continued)
Variable

DM

All

Prediabetes

N

n (%)

OR (95% CI)

n (%)

OR (95% CI)

Ever smoked
cigarettes
Yes

152

32 (21.0)

1.61 (0.07, 2.68)

68 (44.7)

1.73 (1.14, 2.63)

No

453

81 (17.8)

1

160 (35.3)

1

Total cholesterol
(mg/dl)
<200

377

76 (20.2)

1

130 (34.5)

1

≥200

228

37 (16.2)

0.89 (0.56, 1.43)

98 (42.9)

1.38 (0.96, 1.99)

LDL-cholesterol
(mg/dl)
<130

377

84 (22.3)

1

118 (31.3)

1

≥130

226

29 (12.8)

0.68 (0.41, 1.11)

108 (47.8)

1.79 (1.25, 2.59)

HDL-cholesterol
(mg/dl)
Normal

151

18 (11.9)

1

47 (31.1)

1

454

95 (20.9)

2.55 (1.44, 4.49)

181 (39.8)

1.86 (1.23, 2.81)

Low (<40 in male
<50 in female)
TGs levels (mg/dl)
Normal

434

65 (14.9)

1

160 (36.9)

1

High (≥150)

171

48 (28.1)

2.80 (1.74, 4.52)

68 (39.8)

1.61 (1.07, 2.43)

Hypertension (BP
≥140/90)
No

493

77 (15.6)

1

184 (37.4)

1

Yes

112

36 (33.0)

3.60 (2.08, 6.23)

43 (39.4)

1,79 (1.08, 2.98)

PA (vigorous) at
least once a week
No

428

90 (21.0)

2.06 (1.22, 3.47)

165 (38.5)

1.38 (0.93, 2.03)

Yes

177

23 (12.9)

1

63 (35.6)

1

PA (moderate) at
least once a week
No

477

92 (19.3)

1,23 (0.71, 2.15)

179 (37.5)

1.03 (0.66, 1.58)

Yes

128

21 (16.4)

1

49 (38.3)

1

Walk for at least
30 minutes once a
week
No

139

26 (18.7)

0.84 (0.50, 1.42)

44 (31.6)

0.68 (0.44, 1.04)

Yes

466

87 (18.6)

1

184 (39.5)

1
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Table 2.4: Multivariable multinomial logistic regression analysis− adjusted odds
ratios (AOR) for DM and prediabetes
DM

Variable

Adjusted ORs (95%CI)

Age
18-34 years

1.0

35-54 years
≥55

5.74 (1.91, 17.29)
18.83 (4.97, 71.27)

Education level
No formal education
Up to secondary level
>Secondary level
WHR
≥0.90 cm (men); ≥0.85.0 cm
(women)
<0.90 cm (men); <0.85 cm
(women)
BMI
<25.0
25.0-29.9
≥30.0
Cigarette smoking
No

1.0
0.27 (0.09, 0.78)

0.015

1.0
0.37 (0.14, 0.90)

0.15 (0.05, 0.45)

<0.001

0.27 (0.10, 0.74)

2.24 (1.27, 3.91)

0.005

1.01 (0.65, 1.53)

1.0

1.0

1.0

1.0

1.05 (0.43, 2.55)
3.54 (1.55, 8.07)

0.922
0.003

1.0

TGs levels (mg/dl)
Normal
High (≥150)

No

1.0
2.44 (1.34, 4.47)
3.10 (1.10, 8.74)

1.04 (0.56, 1.92)

Family history of DM
Yes

Prediabetes
Adjusted ORs (95%
CI)

0.002
<0.001

Yes

Vigorous PA once a week
No
Yes

P
value

2.51 (1.24, 5.12)
4.52 (2.25, 9.08)
1.0

0.990

1.92 (1.18, 3.11)

2.09 (1.22, 3.61)

0.008

1.28 (0.81, 2.03)

1.96 (1.06, 3.62)

0.031

1.31 (0.85, 2.00)

<0.001

1.26 (0.84, 1.88)
1.0

1.0

1.0
2.95 (1.66, 5.23)
1.0
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2.3.6 Number of People Diagnosed with Prediabetes and DM
Figures 8 and 9 show the percentage of participants who were diagnosed with
prediabetes and DM by a doctor’s diagnosis or by HbA1c or FPG.

Figure 8: Percentage of participants diagnosed with prediabetes using HbA1c or FPG

Figure 9: Percentage of participants diagnosed with DM by a doctor’s diagnosis or
HbA1c or FBG
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2.3.7 Association between Prediabetes, DM and Age
In the univariable analyses, study participants were more likely to belong to
older age categories (≥55 versus 18-34 years) with DM (odds ratio [OR] =25.65; 95%
CI 7.57 to 86.92) as well as with prediabetes ([OR] =3.44; 95% CI 1.44 to 8.25) as
compared to their normoglycemic counterparts. Moreover, this correlation remained
significant in the multivariable analyses for both DM (adjusted odds ratio [a OR]
=18.8; 95% CI 4.9 to 71.2, P<0.001), and prediabetes ([a OR] =3.10; 95% CI 1.1 to
8.7, P=0.032), respectively.
2.3.8 Association between Prediabetes, DM and Education Level
Participants with DM were less likely to report having a formal education
(OR=0.18; 95% CI 0.00 to 0.4). The same was applicable for prediabetes (OR=0.3;
95% CI 0.1 to 0.7), when compared to participants with normoglycemia in the
univariable analyses. This remained significant in the adjusted analyses for DM
(aOR=0.1; 95% CI 0.0 to 0.4) and prediabetes (aOR=0.2; 95% CI 0.1 to 0.7).
2.3.9 Association between Prediabetes, DM and Waist Hip Ratio
Participants were more likely to have a WHR of more than 0.90 cm in men and
≥0.85.0 cm in women if they had DM (OR=3.5; 95% CI 2.1 to 5.6) or prediabetes
(OR=1.5; 95% CI 1.0 to 2.2) in univariable analyses, as compared to those with
normoglycemia. In the multivariable analysis (Table 2.4), the correlation of WHR with
prediabetes was not significant (p<0.0991). However, a high WHR remained a
significant correlate of DM.
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2.3.10 Association between Prediabetes, DM and Obesity
Participants with DM were more likely to be obese (OR=3.9; 95% CI 1.9 to
7.9) and, similarly, participants with prediabetes were more likely to have obesity
issues (OR=4.4; 95% CI 2.4 to 8.3), than those with a normal FBG level in the
univariable analysis. These findings remained significant even after adjusting for other
potential confounding data. This was true for both DM (aOR=3.5; 95% CI 1.5 to 8.0)
and prediabetes (aOR=4.5; 95% CI 2.2 to 9.0).
2.3.11 Association between Prediabetes, DM and Smoking
Participants with DM and prediabetes were 1.61 more likely to smoke
cigarettes. OR=1.61; 95% CI 0.07-2.6 for diabetes, and OR 1.73; 95% CI 1.14-2.63
for prediabetes when compared to participants with normoglycemia, in univariable
analyses, This was also significant in the adjusted analyses for prediabetes (aOR=1.9;
95% CI 1.1 to 3.1; P=0.008) but not for DM (aOR=1.0; 95% CI 0.5 to 1.9; P=0.990).
2.3.12 Association between Prediabetes, DM and TGs Levels
Elevated TGs levels (≥150mg/dl) showed a significant association with DM
(OR=2.8; 95% CI 1.7 to 4.5; P<0.001) and prediabetes (OR=1.6; 95% CI 1.0 to 2.4;
P=0.022) in univariable analyses. This remained significant for DM in the adjusted
analyses (aOR=2.09, 95% CI 1.2 to 3.6; P=0.008), but not for prediabetes (aOR=1.28,
95% CI 0.8 to 2.0; P=0.286).
2.3.13 Association between Prediabetes, DM and Physical Activity
Not practicing vigorous PA at least once a week had a significant correlation
to the presence of DM (OR=2.06; 95% CI 1.2 to 3.4; P=0.007), but not for prediabetes
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(OR=1.3; 95% CI 0.9 to 2.0; P=0.103) in the univariable analyses when compared to
those with normoglycemia.. This effect remained significant for DM in the adjusted
analyses (aOR=1.96, 95% CI 1.0 to 3.6; P=0.031).
2.3.14 Association between Prediabetes, DM and a Family History of DM
Participants with DM were 2.4 times more likely to report that they had a
family history of DM (OR=2.44; 95% CI 1.5 to 3.9, P<0.001) as compared to their
non-DM counterparts, in the univariable analyses. Again, this remained significant in
the adjusted analyses for DM (aOR=2.95; 95% CI 1.6 to 5.2; P<0.001). However, no
association was found between prediabetes and a family history of DM.
2.4 Discussion
2.4.1 Prevalence of Prediabetes
In this cross-sectional study in the UAE, we estimated the prevalence of DM
and prediabetes and quantified the effect of correlating conditions associated with
individual characteristics. Our findings suggest that DM and prediabetes have become
epidemic in the UAE’s adult population. We also found that the prevalence of DM and
prediabetes varied substantially with the individual’s age, educational level, WHR,
body weight, TGs levels and PA.
The study described here measured the prevalence of prediabetes in Al Ain
using the ADA 2016 recommended prediabetes diagnostic criterion of an HbA1c level
of 5.7% to 6.4%, and an FBS level of 100 mg/dl to 125 mg/dl1. It demonstrated that
the prevalence of prediabetes in Al Ain was significant and amongst the highest
reported globally. The reported prevalence of prediabetes was 37.7% in the study
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group, which was similar to the figure reported in 2012 for the US adult population
(38%)30. However, it was much higher than the prevalence reported in a populationwide cardiovascular screening program (Weqaya) in Abu Dhabi in 2012, where the
incidence of prediabetes was 27%41. This is probably because of differences in the
sample size and characteristics. For example, in our study, participants were married
and older than the population in the Weqaya study. In addition, participants in the
Weqaya study included different demographic characteristics such as single people
and people without children.
The high prevalence of prediabetes in our study should alert policy and
decision makers to the seriousness of the problem. Unless urgent prevention efforts
are successfully implemented the prevalence of prediabetes will increase even further,
and each new case of DM in the UAE will exacerbate future economic and health
burdens on the country.
Despite the fact that the incidence prediabetes differs depending on the
diagnostic criteria, our study’s findings are consistent with the increase in prediabetes
across the GCC38,39, Asian33,37,152, European32 and North American27,31 countries.
Roughly similar figures have recently been reported in the US (37%)153, in the UK
(35.3%)32, Oman (35%)39 and Canada (33.1%)31. However, a lower rate was found in
Saudi Arabia (11.9%)38 and Bangladesh (11.5%)37. It can be predicted from the
substantially higher prevalence of prediabetes in the UAE that there will be a further
increase in DM over the next few years. It also illustrates that prediabetes in the UAE
offers an urgent context for preventative intervention, especially as worldwide
evidence indicates that lifestyle modification can not only prevent the onset of
prediabetes, but also help patients to revert to a normoglycemia status43,154. In addition,
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effective intervention at the prediabetic stage can lead to a slowing down of the high
economic and health burden ($60 million per year in the UAE), or even help to prevent
it42.
The prevalence of prediabetes was higher among men (40.2%) as compared to
women (35.7%), even though there were more obese women (52.8%) than men
(46.8%). Similar findings were reported in the Weqaya study, where 27.8% of men,
compared to 26.5% of women had prediabetes despite the fact that 38% of women and
32% men were obese41. Our study also showed that obese people were 4.4 times more
likely to have prediabetes than those of a normal weight. This relationship indicates
that despite obesity being related to prediabetes in the UAE, the extent of the effect of
obesity on prediabetes is not the same for men and women. There is a difference in
gender-related factors that can affect prediabetes. In a longitudinal population-based
study in China, it was found that PA in males and WC in females were important
predictors and causes of prediabetes155. Identifying the most common reasons for
prediabetes in both men and women is vital in order to inform preventative measures
and any attempts to return patients back to normal glucose regulation.
2.4.2 Association between Prediabetes and Age
Our findings showed that age (non-modifiable), obesity, WHR, TGs levels, PA
and educational level (all modifiable) were significantly associated with prediabetes.
The current analysis showed a high proportion (40%) of people aged 34-54 years had
prediabetes as compared to participants from the younger age categories of 18-34
(26%). This age-specific finding supports the need for early detection and periodic
screening in people aged 34-54 years. This priority group also needs to be the target
of more lifestyle education programs that highlight the importance of increased regular
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PA, a healthy diet, self-monitoring of their BMI and periodic FBG checks. These can
be performed in the workplace, or in outpatient clinics in a primary health care setting.
The ADA suggests there should be prediabetic screening of asymptomatic
adults of any age who are overweight or obese (BMI ≥25 kg/m2) and have one or more
additional correlate for DM, like being from a high-risk race, physical inactivity,
having first degree relatives who have DM, high BP or hyperlipidemia154. The above
age-specific finding in this study also suggests that published information from the
WHO or ADA regarding prediabetes screening should can be taken as a general
guideline, but that each country needs to have its own, more population specific,
guidelines.
2.4.3 Association between Prediabetes and Obesity
As expected, obesity was one of the most important correlates that was
significantly associated with prediabetes. The distribution of the population per BMI
category showed that 35.7% were overweight (BMI between 25.0 and 29.9 kg/m 2),
and 50.1% were obese (MBI ≥30 kg/m2). In the univariable analysis, participants who
were obese were 4.5 times more likely to have prediabetes than those of a normal
weight. This relationship has also been demonstrated in other studies, including in
Saudi Arabia and Bangladesh37,38,156.
The results of this study indicate that there has been an extremely rapid rise in
the proportion of adults who meet the criteria for obesity. The most recent reports from
the UAE show a sharp rise (double) in the prevalence of obesity in adults (from 16%
to 35%), with grade III obesity (BMI ≥40) rising the most dramatically from 2% in
2000 to over 11% in 2010157. This is nearly four times higher than the increase
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observed in the proportion of people with morbid obesity in the UK (from 1.8% to
2.9% between 2005-2015)95. The figure obtained in our study for the prevalnce of
obesity (50.1% ) is alarming as it is higher than the one reported in the Weqaya study
(35%) and in other UAE cross-sectional surveys, which revealed an overall obesity
rate in the UAE of 34%41 in 2000. Our results are consistent with previous studies in
other GCC countries where there has been an increase in obesity in recent years. This
suggests that the lifestyle in the GCC countries is conducive to encouraging obesity.
However, this increase was lower than the rise observed in Saudi Arabia (39%) and
Kuwait (42%)103 in our study. It compares badly to the prevalence of obesity in
England (27%)95 and Bangladesh (4.6%)97.
The UAE has been ranked as the world’s fifth most obese nation158. A number
of factors at an individual and environmental level, mainly dietary and physical
inactivity, have contributed to rising numbers of overweight people and obesity in the
UAE121. Adults in the UAE consume over 3,000 calories per day on average, more
than 20% over the recommended daily allowance158. The daily fruit and vegetable
consumption in the UAE is not optimal either130. Between 1998 and 2003,
approximately 80% of males and over 75% of females in the Emirates reported eating
less than the recommended five daily servings of fruit and vegetables158. Skipping
breakfast is also highly prevalent in the UAE119 (28% of Emirati boys and 37% of
Emirati girls) and consumption of fast food has increased (76% consumed fast food at
least once per week)145. The number of fast food restaurants in the food courts of
shopping malls and petrol stations has increased in the UAE. Furthermore, the
consumption of sugar-sweetened drinks has also increased130 (making up 8%-14% of
the total calorie intake and 70% of the daily liquid intake158). This is still below the
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US, UK, and Mexico. In Saudi Arabia, two-thirds of males and adolescent females
consume sugar-sweetened drinks more than three days per week119. Snacking (1.5
snacks per day) represents a very large proportion of the calories (20%)158 consumed
by UAE nationals. In comparison the US population consumes 3 snacks a day on
average. However, Emiratis eat more calorie dense foods and have longer snack
periods when compared to Americans157.
There is a significant lack of PA in the UAE population, especially females and
those living in urban areas. Only 41%121 of adult Emirati women take moderate, or
high, levels of PA compared to 82%157 and 65%119 of American and Saudi women
respectively. A lack of female role models among their peers and families, not having
culturally acceptable exercise facilities for women, and the hot and dusty weather114
all create obstacles for women who want to get involved in sports in the UAE. Other
hindrances to exercise for Emirati women include a lack of information on the benefits
of exercise, personal motivation and not having the spare time for exercise123. As a
result, females spend more time indoors doing sedentary activities, including watching
TV and snacking on high calorie content food119. Furthermore, Emiratis forgo
domestic chores as these are often carried out by a domestic housekeeper, cook and
nanny, which results in an even more sedentary lifestyle159.
The environment in the UAE is obesogenic and cities are unfortunately not
designed for walking. Therefore, Emiratis rely heavily on automobiles145. Indeed, the
more urbanized areas may be even more obesogenic. In addition, the high temperatures
of up to 450C in the Summer and the concomitant dusty conditions discourage people
in the UAE from exercising114. Policy makers must reshape the environment in the
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UAE in a way that encourages healthy decision making as this is a key feature in the
prevention of obesity.
Furthermore, offering inventive social support programs to help people to
make better lifestyle choices, to eat healthier diets and do more PA is required. These
initiatives include improving access to a larger variety of healthier food options that
are more easily available, more accessible and cheaper in price. Food courts in malls
and petrol stations need to have healthy restaurants and takeaway outlets and
incentives must be available to help investors who are willing to open them. For
example, lower rents and utility costs. One way of limiting access to less healthy
options is by imposing a sugar tax. This would create an incentive for firms to supply
healthier alternatives and will also raise funds that can be used to both subsidize the
price of healthy food (fruit and vegetables) and fund public educational campaigns.
Health officials should work with city planners to create a more positive built
environment and design communities that promote active transport and improve access
to exercise and outdoor activities. This can be achieved through building community
parks, designing shopping malls with a walking track, and making roads safer for
exercise. Furthermore, they should ensure that communities, especially female
members, have easily accessible and reasonably priced exercise facilities that are
within their cultural context. Moreover, decision makers need to encourage healthy
behavior, particularly by women. This can be done by promoting a high level of PA
and encouraging healthy eating from a young age. This is important because children
are the most likely to adopt the lifestyle behaviors of family members, especially their
mothers.
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Health practitioners have a major part to play in combating obesity in the
community. Their role is to continue screening for obesity by measuring and
monitoring the weight of their patients (of all ages) during routine and follow-up visits
to clinics.
They have a role in preventing unnecessary weight gain and encouraging
healthy behaviors (PA and healthy eating), in addition to referring patients to dietitians,
nutritionists, or other specialists, as required.
The Nutrition Examination Survey (NHANES) showed that the prevalence of
prediabetes has increased even among adults of a healthy weight. This finding is
concerning as there are no clear reasons for it. Abdominal obesity and sedentary
lifestyle were two factors160, but it was concluded that abdominal obesity was not an
independent correlate. This was contrary to our finding where a WHR of ˃0.90 cm for
men and ≥0.85.0 cm in women was associated significantly with an increase of 1.5
times in the possibility of getting prediabetes. Similar findings have been reported in
Saudi Arabia38 and China161.
2.4.4 Association between Prediabetes and Educational Level
Educational level was among the correlates for prediabetes in our study. A high
educational level was found to be positively correlated with prediabetes. Participants
who reported an education level of more than secondary school were 0.3 times more
at risk of developing prediabetes, compared to participants without a formal education.
This finding might be explained by the fact that educated people are involved in more
sedentary office work and often have an urban lifestyle, in contrast to less educated
people who are more involved with manual labor and live in more rural areas. The
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associations between educational level and prediabetes vary internationally. Our
finding are in marked contrast to other population-based studies where prediabetes was
inversely associated with educational level in Indonesia46 and Australia162, while in
Saudi Arabia38 and Bangladesh37 the findings were consistent with ours. Other studies
conducted in Hong Kong with Chinese people and in Iran showed there was no
relationship between prediabetes and the education level of either sex, while one study
in Iran showed that a higher educational level was a prediabetic correlate only in
women162.
2.4.5 Prevalence of DM
The overall prevalence of DM in our study was 18.7%, which was similar to
the figure reported in a population-wide cardiovascular screening program (Weqaya)40
in Abu Dhabi, but lower than the one reported by the International Diabetes Federation
(IDF) in the UAE, (19.3%). Although earlier studies from GCC countries have
indicated very similar rates of DM compared to the UAE, our study showed a higher
rate than those reported in Saudi Arabia (17.6%) and Kuwait (14.3%)163. The
prevalence of DM in the UAE is rising (13.5% in 2000 compared to 18.7% in our
study) at a faster rate than in the MENA region and the rest of the world, and the
number of people with DM is expected to double to 2.2 million by 2040. Many
explanations exist for this high rate of DM in the UAE and other Gulf countries. The
most common reasons relate to high rates of obesity, which appear to have got worse
over the last few decades. Drastic measures need to be implemented at policy level in
the UAE in order to both combat the DM epidemic and protect the health of the next
generation.
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2.4.6 Association between DM and Age
Our findings confirmed that there are many correlations for DM, including age,
obesity, WHR, TGs levels, PA and education level. Older participants (≥55 years)
were 25.65 times more likely to have DM, which is similar to the relationships
observed around the world, including Bangladesh98. This finding is important as it will
help decision makers and clinicians to design a screening program for the UAE
population. People in this age group (≥55 years) have to be the focus before other age
groups.
2.4.7 Association between DM and Education Level
Our findings showed that participants who reported their educational level was
higher than secondary school had 82% less risk of DM, compared with participants
without a formal education. This association varies internationally. The positive
associations we found between these two factors and DM have also been previously
observed in Bangladesh154 and Brazil. In China, the prevalence of DM was generally
unaffected by educational level161 Studies from both developing and developed
countries have found there are inverse associations between DM and educational level,
maybe because better-educated people are more health-conscious154.
2.4.8 Association between DM and Waist Hip Ratio
In our study, we found that having a high WHR was significantly associated
with an increased risk of getting DM, compared to those with a normal weight. Other
studies in Saudi Arabia160, Kuwait103 and Bangladesh154 have supported this result.
The prevalence of obesity has recently increased in the UAE, which is due to rapid
urbanization that encourages a sedentary lifestyle and less traditional. And healthy,
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diets. This finding provides decision makers with a mandate to intensify their efforts
by concentrating on early intervention strategies to target obesity and central obesity
in adults by increasing their control of food choices, PA and enhancing public
awareness of obesity and its adverse consequences. These needs are particularly
significant to the UAE as health illiteracy is very common157.
Our findings could have important public health implications. The UAE's rapid
socio-economic growth over the past 46 years has reflected positively on many of the
UAE's health indicators like mortality rates and life expectancy. If this
accomplishment is to last, the government has to increase its efforts and focus on
proven, cost-effective primary prevention services that concentrate on behavior and
lifestyle modification because of the huge growth in chronic diseases, including
prediabetes, DM and obesity. In spite of the fact that preventive health services have
been prioritized in the last few years, policy makers have concentrated on the provision
of curative and tertiary healthcare services with little emphasis being placed on
prevention. Furthermore, the existing primary healthcare services that are available in
the UAE concentrate on providing immunizations and prenatal services instead of
combating the increased rate of NCD, including prediabetes, DM and obesity.
2.5 Strengths of Our Study
Training workshops for nurses were conducted by qualified trainers. The
training of the nurses in the use of standardized methods of anthropometric and BP
measurement prior to data collection, assured the quality of the data collection.
Furthermore, physical activity was assessed by using the IPAQ, which was used in
conjunction with the WHO STEPS Questionnaire. Both HbA1c and FPG levels were
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used to identify participants with prediabetes and DM. US National Cholesterol
Education Program guidelines were used for the definition of dyslipidemia.
2.6 Limitations of Our Study
The primary limitation of this study is that it does not allow for causal
conclusions regarding the relationship between the variables studied and prediabetes
and DM as it is a cross-sectional study. Also, the measurement of the variables i.e. diet
and physical activity was self-reported and depended on the participants’ memory and
accuracy. This might have led to inaccurate data, especially in relation to their family
history (father and mother), who might even be deceased.
In addition, the American Diabetes Association recommends a repeat
measurement after a single hemoglobin A1c, FPG, or 2-hour PG diabetes-positive test
result, which we could not do because most participants made only one visit.
Therefore, some participants without DM may have been misclassified as having DM
and we cannot be certain how frequently this may have happened.
A potential threat to internal validity was the lack of consistency in the
biometric testing procedures. For example, the weight and waist measurements were
taken with clothing on, which could have led to incorrect and inconsistent results.
Furthermore, design effect was not taken into consideration when choosing our target
population and our study population included only married adults with school children.
As such our results should be interpreted with caution as they may be underrepresentative of the general population of the UAE.
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Chapter 3: Characteristics of Prediabetes and Correlates of
Conversion from Prediabetes to DM in Dubai, the UAE
3.1 Introduction
Studies have established the use of simple clinical (weight, WC) and laboratory
measurements (e.g. glucose, uric acid, lipids) to derive DM prediction models that are
suitable for general practice3. Many studies have considered the risk factors for the
conversion of prediabetes to DM3,164,165,166. It is generally assumed that the risk factors
for prediabetes are similar to those for DM. Nevertheless, it is unclear if the strength
of association of these risk factors is the same for both prediabetes and DM. The
incidence of DM among those with prediabetes is higher in women when compared to
men due to a low level of PA and higher obesity3. Prediabetes is significantly
associated with being overweight or obese, hypertension, hypercholesterolemia and
arthritis66.
In the USA, the Strong Heart Study, a population-based longitudinal study of
CVD and its risk factors, showed that the risk factors for DM in individuals with
prediabetes was higher in women and in people with higher BMI, WC, and HbA1c
who took less PA165. Furthermore, a retrospective longitudinal study in Japan of 2,105
adults with prediabetes, with a mean observation period of 4.7 years ,showed that the
independent risk factors for prediabetes becoming DM were a family history of DM,
being male, a higher than normal BP and glycaemia levels. Additionally, this study
confirmed that a BMI reduction as small as 1 kg/m2 was related to a 16% decrease in
the incidence of DM in people with prediabetes26. Obesity was a common risk factor
for the transformation of prediabetes to DM in a population-based study in Denmark
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and in other studies (above). There were also other factors, like hypertension and
hypertriacylglycerolaemia167.
In the UAE, there have been several studies into the risk factors for DM in the
UAE population and fewer studies on prediabetes. However, to the best of our
knowledge, no study has been conducted on the predictors for the conversion of
prediabetes to DM in the UAE. The results of our study will have a major impact on
public health in the UAE and can be used as a guide for policy and decision makers. It
will also help to shape future healthcare in the UAE.
3.1.1 Secondary Aims and Objectives
3.1.1.1 Aims
Prediabetes is associated with a significant risk of developing DM and CVD.
Early screening and diagnosis of prediabetes, along with preventive measures, are
essential in preventing DM or delaying its progression. Our study aims to improve
current understanding of prediabetes in order to ensure early detection of DM. This
would allow us to plan for better control and prevention of DM in the UAE.
3.1.1.2 Specific Objectives
-

Objective 1: To identify the characteristics of Emirati adults with prediabetes.

-

Objective 2: To identify the correlates which lead to the progression of
prediabetes to DM in Emirati adults.

The Research Hypothesis:
People with prediabetes who reported positive symptoms related to sleep apnea
on the Berlin Questionnaire Scale are more likely to develop DM as compared to their
counterparts without the symptoms of obstructive sleep apnea.
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3.2 Methods
3.2.1 Study Design
We used a cross-sectional design to achieve our study objectives.
3.2.2 Study Site

This study was conducted in five healthcare centers in Dubai. Dubai is the most
populous city in the UAE. It is located on the southeast coast of the Arabian Gulf and
covers an area of 4,110 km2 with a population of 2.847million, according to the 2017
census.

3.2.3 Study Population
The previous data from Al Ain was sampled from other data. For this
dissertation a study planning workshop was conducted in order to recruit 700 UAE
nationals, aged over 18, with prediabetes from five primary healthcare centers in
Dubai. Out of 700 subjects contacted, 487 participants met the inclusion criteria of the
study protocols, agreed to take part and completed the questionnaires. Before reducing
the sample to 700, 300 subjects had already failed to meet the inclusion criteria.
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Figure 10: Study population in Dubai, the UAE (n=487)

3.2.4 Sample Size and Selection of Study Participants Correlate
Our main aim in this study was to evaluate the role of sleep apnea in the
conversion of prediabetes to DM. We could not perform sleep studies in order to
identify sleep apnea. However, we used the Berlin questionnaire to identify people at
risk of obstructive sleep apnea.
We wanted to demonstrate a difference of a third of the (within group) standard
deviation of blood sugar levels in the negative sleep apnea group, as compared to the
group of prediabetics with sleep apnea with a Type I error of 5% and a Type II error
of 10%. Using the standard formula for two groups with continuous outcomes, we
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required 146 participants per study strand. After adjusting for clustering effects in the
health care centers by using an average design effect of 1.76 (based on the largest
design effect that had been observed in previous studies), and accounting for the loss
to any follow-ups and retractions of informed consent, we recalculated the need for
400 study participants.
3.2.4.1 Inclusion Criteria
-

Emirati national.

-

Aged 18-64 years.

-

Living in the Emirate of Dubai.

-

Diagnosed with prediabetes (HbA1c 5.7-6.4) or (FBG 100-125
mg/dl).

-

Not using any medicine for DM.

-

Willing and agreed to participate.

3.2.4.2 Exclusion Criteria
-

Participants aged <18 and >65.

-

History of DM (self-report of a previous diagnosis by a physician or
other health professional or determined from a medical report).

-

Major psychiatric diseases (determined from medical report).

-

Current, planned, or previous pregnancy within the past 6 months.

-

Refusal to participate or withdrawal from the study.
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3.2.5 Study Measurement
3.2.5.1 The Primary Variable
The primary variable was the conversion from prediabetes to DM. DM was
diagnosed by self-reporting during telephone interviews, and/ or by having an FBG of
>=126 mg/dl and an HbA1c >=6.5.
3.2.5.2 The Other Variable
The other variable was sleep apnea. Symptoms for sleep apnea were detected
by using the Berlin questionnaire on sleep apnea.
3.2.5.3 Other Variables
Socio-demographic characteristics
-

Age, tobacco use, educational level, smoking, history of chronic diseases and
family history of chronic conditions.

Anthropometric measurements
-

Height, Weight and BMI.

Blood Tests
-

FPG, HbA1c, total cholesterol, TG, HDL and LDL cholesterol.

-

The level of PA.

3.2.6 Data Collection Procedure
Dubai Health Authority (DHA) launched the Dubai Standards of Health Care
on March 16th, 2015 to ensure early detection and unified management of DM and
prediabetes in the Emirate of Dubai. Prediabetes screening was conducted across 18
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primary health care centers. The subjects were originally 5,131 UAE nationals in
Dubai in 2015. They data came from 18 healthcare centers and the subjects were
identified via the electronic system SAM (electronic system available in primary
healthcare centers in DHA) as part of a screening program. The screening included
taking blood samples for a lipid profile, fasting blood sugar and HbA1C. The blood
results were obtained from the SAM system at the DHA.
In 2017, we used a sampling frame with the data above for our current study.
This time five primary healthcare centers in Dubai were chosen at random from the 18
(Simple Random Sampling). A list of the total number of patients in each of the five
healthcare centers was generated. Then a study sample proportionate to the size of each
of the five health centers was prepared.
Next, we conducted a workshop. The workshop included project staff, one
primary health care physician and a registered nurse from each of the five centers. The
study team explained the aims and objectives of the study to the workshop participants.
With the help of prediabetic screening staff and workshop participants, 1000 UAE
nationals with prediabetes were identified based on fasting plasma glucose and HbA1c
levels, according to the ADA guidelines. The identification of possible study
participations was undertaken by a nurse at each of the five centers under the
supervision of a doctor (one doctor per five nurses) using the SAM system. With a
grant in place from the NRF for Diabetes Prevention, 700 DHA screening program
subjects were contacted to participate in a more intensive diabetes prevention program.
A team of final year female medical students at UAE university (n=12) was
identified to serve as research assistants. A training workshop was also conducted for
the medical students by qualified trainers, to explain the study protocol and give
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training on standardizing methods for gathering data by phone call questionnaires.
Participants diagnosed with prediabetes (ADA guidelines of FBG 100-125 mg/dl and
A1C 5.7% to 6.4%) in our 2015 study were contacted to take part in the phone-based
study.
Each subject received three phone calls after which they were excluded if no
response was obtained. Verbal consent was granted by each participant at the
beginning of the call. Participants who did not give their consent were excluded from
the study. We used a structured questionnaire that identified socio-demographic,
lifestyle and clinical data and used the Berlin questionnaire to assess the extent, or not,
of symptoms of sleep apnea. The data was collected from 700 UAE nationals over the
phone. Out of the 700 Emiratis who completed screening test and were diagnosed with
prediabetes, 487 agreed (respond rate 69%) to complete our study questionnaire and
tanswer he Berlin questionnaire to scale obstructive sleep apnea. Socio-demographic
and behavioral information on tobacco use, daily consumption of fruit, PA level,
history of chronic diseases, and family history of chronic conditions was also obtained.
Data regarding anthropometric measurements, such as height and weight was selfreported.
Data regarding exercise behavior was determined by asking participants about
the frequency and duration of their daily exercise. The PA activity was classified into
three levels: vigorous, moderate and light. ‘Vigorous-intensity activities’ require hard
physical effort and cause a large increase in our breathing or heart rate, ‘moderateintensity activities’ require moderate physical effort and cause a small increase in our
breathing or heart rate, and ‘light-intensity activities’ require the least amount of effort.
Participants were classified as being sufficiently active if they exceeded the minimum
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recommended duration of PA per week, as suggested by the WHO, i.e. 150 minutes of
moderate intensity PA, or 75 minutes of vigorous intensity PA or an equivalent
combination of moderate and vigorous intensity PA per week, with each activity
performed for at least 10 minutes. Fruit and vegetable consumption was also measured
by finding out if they ate these foodstuffs “every day” or “not every day”.
Individuals were considered to have DM or high BP if a health care provider
had ever told them they had hypertension or DM, or were on medication for
hypertension or DM, excluding gestational diabetes. Hypertension was defined as a
mean systolic BP of ≥140, a mean diastolic BP of ≥90 or if individuals had been
diagnosed by a physician and were on anti-hypertensive medication (self-reported).
Participants with DM were asked about the type of treatment they were on (diet, tablets
or insulin injections) and if they had a device to check blood sugar levels at home.
Respondents were asked whether any of their living or deceased, first or second, blood
relatives (including grandparents, aunt, uncle, first cousin, parents, brothers, and
sisters) had ever been told by a physician that they had DM. We ascertained DM by
self-reporting or a physician’s diagnosis of DM and the use of diabetic medication or
a blood glycated hemoglobin level ≥6.5%. We excluded any individuals with a
previous history of DM from the analysis.
We also asked if they had a history of smoking cigarettes or shisha. Smoking
was classified into current, non-smoker or ex-smoker shisha or cigarettes. Shisha
smoking – a water pipe – is a way of smoking tobacco, which is sometimes mixed with
fruit, through a hose and bowl. The hose ends in a mouthpiece from which the smoker
inhales the smoke.
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The Berlin questionnaire evaluated whether participants were at risk of
obstructive sleep apnea. It is the preferred instrument rather than a STOP-BANG
questionnaire, STOP questionnaire or Epworth sleepiness scale. The questionnaire had
three categories ssociated with the risk of having sleep apnea. Participants can be
classified into high risk or low risk, depending on their responses to each question and
their overall scores in the symptom categories. The questionnaire consisted of nine
questions that related to snoring and the last question asked whether participants had
high BP, did not have it, or did not know if they did. The Berlin Questionnaire was
used to assess if sleep apnea was one of the correlates for developing prediabetes. A
copy is attached in Appendix 3 along with instructions on the scoring system used in
this study to identify participants with a high Berlin score.
Biometric screening exam data was extracted from the electronic medical
records at the Dubai Health Authority. This retrieved data was collected as part of the
prediabetic screening program at the Dubai Health Authority in 2005 and included
FBG, HbA1c, total cholesterol, TG, HDL and LDL cholesterol. Two different cut-offs
had been used to define prediabetes: fasting blood glucose of ≥100 mg/dl (≥5.6 and
<126 mg/dl) and fasting blood glucose of ≥110 mg/dl (≥6.1 and <126 mg/dl) or an
HbA1c level of 5.7-6.4%. Participants were classified as having DM, or being free of
DM, based on their HbA1c level of ≥6.5% and fasting blood glucose level of ≥126
mg/dl, and/ or those diagnosed by a physician and/ or on antidiabetic medication. The
National Cholesterol Education Programme guidelines that we used define
dyslipidemia as follows: HyperTGmia—serum TG levels ≥150 mg/dl and/ or
Hypercholesterolemia-serum cholesterol level of <200 mg/dl. The optimal HDL
cholesterol level was <100 mg/dl and LDL cholesterol level was <40 mg/dl40.
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3.2.7 Ethical Considerations
3.2.7.1 Ethical Approval of Study
The study protocol was approved by the Human Research Ethics Committee at
the Dubai Health Authority, Dubai, the UAE (MRC-05/2014_06, Appendix 2).
3.2.7.2 Informed Consent
Verbal consent was obtained over the phone from all of the subjects before
taking part.
3.2.7.3 Confidentiality
The data and questionnaires are stored in the Institute of Public Health at UAE
University, where their protection is guaranteed through a password protected file.
3.2.8 Timeline
The baseline data on prediabetes status, based on HbA1c, FBG and plasma
lipid levels, was collected within a six month timegrame, from April 2015 to August
2015. Follow-up data, by telephone, was collected within a six month timeframe, from
January 2017 to June 2017.
3.2.9 Data Analysis
We entered data into Microsoft Access before it was imported into STATA
version 14.0 (StataCorp LP, College Station, TX) for analysis. We summarized
categorical variables proportions, and continuous variables using the mean, or median,
depending on whichever was most applicable, with 95% confidence intervals. The
Chi-square test compared proportion across every group and the ANOVA test
compared means across the groups. A descriptive analysis describes the characteristics
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of the case data from Dubai. Some of the cases of prediabetes have become DM since
the date of the screening and we have completed univariate and multivariate analysis
to identify the correlates of prediabetes developing into DM.
Our outcome was to identify how many people with prediabetes have
developed DM without following up each patient to see when this transformation
actually took place (in term of how many weeks each prediabetic patient took to
develop DM) (dominator data was missing). Therefore, we used logistic regression
analysis. Furthermore, OR was used in our study to establish the strength of association
between the conversion from prediabetes to DM and its correlates.
As our objective was to identify all the variables associated with prediabetes
becoming DM, all the variables were included in the analysis. However to account for
unstudied variables (residual confounding) we used multivariable analysis.
Furthermore, we have checked our data for interactions but could not find any between
the variables in our study.
The issue of missing data was only present for the data collected in Dubai. We
treated our missing data by referring to a biostatistician who used statistical methods
to verify the data. Analysis on the Dubai data was done twice. One analysis was
without the missing data and second one was conducted with assumptions made for
the missing data. No difference was noted in the results.
3.3 Results
The demographic and clinical characteristics of the study population are
presented as a percentage for the categorical variables and as a mean±standard
deviation for the continuous variables, in Table 3.1.
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Table 3.1: Demographic and clinical characteristics of the study population
(n=487) in Dubai, the UAE
Variables
All
39.6±10.3
Age (years)
162.7±8.9
Height (cm)
80.4±19.9
Weight (kg)
2
30.5±10.1
BMI (kg/m )
196.8±38.3
Total cholesterol (mg/dl)
5.9±0.4
HbA1c (%)
122.6±33.7
LDL (mg/dl)
54.2±15.3
HDL (mg/dl)
116.5±63.1
TG (mg/dl)
102.4±13.2
FBG (mg/dl)
Marital Status
Single
82 (17.1)
Married
361 (75.4)
Widowed or Divorced
36 (7.5)
Occupation
Housewife
169 (35.7)
Healthcare
13 (2.7)
Army/ Police
24 (5.1)
Office job
109 (23)
Business
14 (3)
Other jobs
144 (30.4)
Education
No school
16 (3.4)
Primary or High school
200 (42.8)
College or University
251 (53.7)
PA for at least 30 minutes once a week
Yes
216 (45.4)
Consumption of fruits and vegetables
Everyday
285 (59.3)
Hypertension (BP ≥140/90)
Yes
106 (22.1)
Walk for at least 30 minutes once a week
Yes
312 (69.3)
PA (moderate) at least once a week
Yes
82 (19.7)
PA (vigorous) at least once a week
Yes
41 (10)
Current smoking state
Yes
46 (9.6)
Sleep apnea
Low risk
426 (87.5)
High risk
61 (12.5)

Male (n=135)

Female (n=352)

37.8±10.0

40.3±10.4

172.2±6.8

159.2±6.8

87.2±17.6

77.9±20.3

29.4±5.7

31±11.2

198.2±40.1

196.2±37.5

5.9±0.4

5.9±0.4

126.1±35.9

121±32.5

47.7±13.2

57.2±15.3

136.1±76.8

107.7±53.6

102.3±12.7

102.5±13.5

23 (17.6)
105 (80.2)
3 (2.3)

59 (17.0)
256 (73.6)
33 (9.5)

2 (1.6)
2 (1.6)
19 (14.7)
41 (31.8)
13 (10.1)
52 (40.3)

167 (48.5)
11 (3.2)
5 (1.5)
68 (19.8)
1 (0.3)
92 (26.7)

2 (1.6)
51 (40.2)
74 (58.3)

14 (4.1)
149 (43.8)
177 (52.1)

74 (56.5)

142 (41.2)

71 (53.4)

214 (61.5)

32 (24.1)

74 (21.4)

89 (71.2)

223 (68.6)

35 (31.3)

47 (15.5)

24 (21.8)

17 (5.7)

36 (27.3)

10 (2.9)

116 (85.9)
19 (14.1)

310 (88.1)
42 (11.9)
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3.3.1 Baseline Demographic and Clinical Characteristics of the Study
Population
The mean age of the study population was 39.6±10.3 years, ranging from 17 to
60 years. The average age of the male participants was significantly different from the
females (37.8 vs. 40.3, P=0.017). The percentage of single participants was 17.1%,
while 75.4% of the study population were married and 7.5% reported being divorced
or widowed. Marital status was found to be significantly different between the males
and females (P=0.025), as more women were widowed or divorced compared to men
(9.5% vs. 2.3%, respectively). Occupation was significantly different between males
and females too (P<0.001). Being a housewife, or househusband, was more common
among females than males (48.5% vs. 1.6%, respectively). Moreover, more males did
office jobs when compared to females (31.8% vs. 19.8%, respectively). The
participants’ level of education varied from no formal education, up to secondary level
and above secondary level (3.4%, 42.8%, and 53.7%, respectively). The mean values
of height (cm), weight (kg), HDL-cholesterol (mg/dl), and TG (mg/dl) were also
significantly different between males and females (P<0.001).
3.3.2 Follow-Up on PA Levels
Figure 11 shows the percentage of participants who reported walking for at
least 30 minutes once a week, or were physically active (moderate) at least once a
week, or were physically active (vigorous) at least once a week by gender.
The percentage of participants physically active for at least 30 minutes once a
week was 45.4%, whereas the percentage of participants who walked for at least 30
minutes once a week was 69.3%. When the participants were asked about practicing
moderate PA at least once a week, 19.7% of them answered “yes”, whereas only 10%
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reported practicing vigorous PA at least once a week. More men stated that they
practiced moderate and vigorous PA as compared to women (31.3% vs. 15.5% and
21.8% vs. 5.7%, respectively) (P<0.001).
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60
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31.3
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0
All

Male

Female

Walk for at least 30 minutes once a week
Physical activity (moderate) at least once a week
Physical activity (vigorous) at least once a week

Figure 11: Percentage of participants, by gender, who are PA (n=487) in Dubai, the
UAE

3.3.3 Follow-up on Fruit and Vegetable Consumption
Figure 12 shows the percentage of subjects who consume fruit and vegetables
on a daily basis compared to those who do not. We have compared by gender.
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The percentage who consumed fruit and vegetables on a daily basis was 59.3%.
Those who currently smoked cigarettes or shisha was 9.6%. Most of the smokers were
men (27.3%) rather than women (2.9%) (P<0.001).
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All
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Not everyday

Female

Everyday

Figure 12: Percentage of participants, by gender, who consume fruit and vegetables
on a daily basis (n=487) in Dubai, the UAE

3.3.4 Follow-Up on Sleep Apnea
Figure 13 shows the percentage of participants who appeared to be at high risk
of suffering from sleep apnea according to their Berlin Questionnaire answers. Once
again, it has been compared across genders. About 12% of females were at high risk
of developing sleep apnea as compared to 14.1% of the male subjects. Overall, about
12.5% of our study participants had a high risk of developing sleep apnea when we
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administered the Berlin Questionnaire, which identifies respondents as prone to sleep
apnea if they record a high Berlin score.
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Figure 13: Percentage of participants, by gender, who were found to be at high risk
of sleep apnea after using the Berlin Questionnaire (n=487) in Dubai, UAE

3.3.5 Rate of Conversion of Prediabetes to DM
The rate of prediabetic Emirati adult patients developing DM in Dubai was
23.4%, or 114 of our study subjects.
3.3.6 Association between Independent Variables and Conversion from
Prediabetes to DM
Regression analysis was used to determine the association between
independent variables, such as age, family history, anthropometric measures and
biochemical measures, and developing DM from prediabetes. Table 3.2 and Table 3.3
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show the univariable and multivariable regression analyses results for the potential for
prediabetes to become DM by possible correlates.
Table 3.2: Univariate analyses− unadjusted odds ratios for conversion to DM
Characteristic

All
n
487

Overall Prevalence
Age
17-30 years
100
31-44 years
165
45-60 years
184
Gender
Male
122
Female
327
Marital Status
Single
75
Married
337
Widowed or Divorced
35
Education
No School
15
Primary or High School
187
College or University
236
PA for at least 30 minutes once a week
No
245
Yes
199
Consumption of Fruit and Vegetables
Not Everyday
185
Everyday
264
Hypertension (BP ≥140/90)
No
349
Yes
99
Walk for at least 30 minutes once a week
No
134
Yes
287

Converted to DM
n (%)
OR (95% CI)
114 (23.4)
10 (8.8)
36 (31.6)
68 (59.6)

1
2.51 (1.19, 5.32)
5.28 (2.57, 10.82)

32 (28.1)
82 (71.9)

1.06 (0.66, 1.71)
1

10 (8.8)
91 (79.8)
13 (11.4)

1
2.40 (1.19,4.88)
3.84 (1.48, 9.99)

8 (7.1)
54 (47.8)
51 (45.1)

1
0.36 (0.12, 1.03)
0.24 (0.08, 0.70)

66 (58.9)
46 (41.1)

1
0.82 (0.53, 1.26)

44 (38.6)
70 (61.4)

1
1.16 (0.75, 1.79)

72 (63.7)
41 (36.3)

1
2.72 (1.69, 4.38)

36 (32.7)
74 (67.3)

1
0.95 (0.59, 1.51)
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Table 3.2: Univariate analyses− unadjusted odds ratios for conversion to DM
(Continued)
All
n
PA (moderate) at least once a week
No
310
Yes
79
PA (vigorous) at least once a week
No
342
Yes
39
Current Smoking State
No
406
Yes
41
Sleep Apnea
Low risk
393
High risk
56
BMI Categories
<25
72
25.0-29.9
109
≥30.0
147
Total Cholesterol Levels (mg/dl)
<200
184
≥200
165
LDL-Cholesterol Levels(mg/dl)
<130
203
≥130
146
HDL-Cholesterol Levels (mg/dl)
Normal
274
Low (<40 in male <50 in
75
female)
TGs Levels (mg/dl)
Normal
268
High (≥150)
81
Characteristic

n (%)

Converted to DM
OR (95% CI)

82 (84.5)
15 (15.5)

1
0.65 (0.35, 1.21)

92 (96.8)
3 (3.2)

1
0.23 (0.07, 0.75)

100 (87.7)
14 (12.3)

1
1.59 (0.80, 3.14)

96 (84.2)
18 (15.8)

1
1.47 (0.80, 2.69)

14 (16.9)
22 (26.5)
47 56.6)

1
1.05 (0.50, 2.21)
1.95 (0.99, 3.84)

55 (63.2)
32 (36.8)

1
0.56 (0.34, 0.93)

62 (71.3)
25 (28.7)

1
0.47 (0.28, 0.79)

59 (67.8)

1

28 (32.2)

2.17 (1.25, 3.76)

62 (71.3)
25 (28.7)

1
1.48 (0.86, 2.57)

By using multivariable analysis we were able to select variables that were
shown be significant in the univariable analysis. These were: age, marital status, level
of education, hypertension, practicing vigorous PA at least once a week, total
cholesterol levels, LDL-cholesterol levels, and HDL-cholesterol levels.
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Table 3.3: Multivariable logistic regression analysis− adjusted odds ratios (AORs)
for conversion to DM

Characteristic
Age
18-30 Years
31-44 Years
45-60 Years
Marital Status
Single
Married
Widowed or Divorced
Education
No School
Primary or High School
College or University
Hypertension (BP ≥140/90)
No
Yes
PA (vigorous) at least once a week
No
Yes
Total Cholesterol Levels (mg/dl)
<200
≥200
LDL-Cholesterol Levels(mg/dl)
<130
≥130
HDL-Cholesterol Levels (mg/dl)
Normal
Low (<40 in male <50 in female)

Converted to DM
Adjusted ORs
(95% CI)
1
0.95 (0.34, 2.62)
2.33 (0.84, 6.44)
1
1.28 (0.513, 3.19)
1.46 (0.37, 5.85)
1
0.44 (0.11, 1.80)
0.43 (0.11, 1.78)
1
1.70 (0.85, 3.39)
1
0.28 (0.08, 0.99)
1
1.18 (0.45, 3.06)
1
0.41 (0.15, 1.11)
1
3.45 (1.74, 6.85)

3.3.7 Association between DM and Age
Univariable Analyses
In the univariable analyses, older participants (45-60 years) were 5.2 times
more likely to develop DM ([OR] =5.2; 95% CI 2.57 to 10.82) as younger participants
(18-30 years).
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Multivariable Analyses
The relationship between DM and age was not significant in these
multivariable analyses.
3.3.8 Association between DM and Marital Status
Univariable Analyses
Widowed or divorced participants were 3.8 times more likely to develop DM
([OR] =3.8; 95% CI 1.4 to 9.9) as single participants (P=0.006), and married
participants were 2.4 times more at risk of becoming diabetic ([OR]=2.4; 95% CI 1.1
to 4.8) when compared to single participants (P=0.015).
Multivariable Analyses
The correlation between DM and marital status was not significant in these
multivariable analyses.
3.3.9 Association between DM and Educational Level
Univariable Analyses
Participants who reported an education at college or university level (n=236)
had a 0.24 times higher risk of becoming diabetic (OR=0.24; 95% CI 0.08 to 0.70)
when compared to participants without a formal education (n=15) in these univariable
analyses (P=0.009).
Multivariable Analyses
The association of DM and educational level was not significant in the adjusted
analyses.
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3.3.10 Association between DM and Physical Activity
Univariable Analyses
Practicing vigorous PA at least once a week was significantly associated with
a 0.23 risk of DM (P<0.015) in the univariable analyses, when compared to those who
did not do vigorous PA at least once a week (OR=0.23; 95% CI 0.07 to 0.75).
Multivariable Analyses
The association between DM and PA remained significant in the adjusted
analyses (aOR=0.28; 95% CI 0.08 to 0.99; P=0.047).
3.3.11 Association between DM and Hypertension
Univariable Analyses
Participants who reported having hypertension (n=99) had a 2.7 times higher
risk of DM (OR=2.72; 95% CI 1.69 to 4.38) as compared to participants with normal
BP(n=349) in these univariable analyses.
Multivariable Analyses
The relation between DM and hypertension was no longer found to be
significant after adjustment was made for confounding factors.
3.3.12 Association between DM and Cholesterol and HDL-Cholesterol Levels
Univariable Analyses
Elevated total cholesterol levels (≥200 mg/dl) showed a significant relationship
to the conversion of prediabetes to DM (OR=0.56; 95% CI 0.34 to 0.93; P<0.001) in
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univariable analyses. Participants who had low HDL-cholesterol levels (<40 mg/dl
male <50 mg/dl female) (n=75) had a 2.1 times higher risk of developing DM
(OR=2.17; 95% CI 1.25 to 3.76, P=0.006) when compared to participants with normal
HDL-cholesterol levels (n=274) in the univariable analyses.
Multivariable Analyses
There was no significant association between DM and cholesterol after
adjusting for confounding factors. However, the association between DM and HDLcholesterol levels remained significant in the adjusted analyses (aOR=3.45; 95% CI
1.74 to 6.85; P<0.001).
3.3.13 Association between DM and Other Associates
The univariable analyses did not show any significant association between
developing DM and any of the following variables: these were gender; being
physically active for at least 30 minutes once a week; walking for at least 30 minutes
once a week; practicing moderate PA at least once a week; daily consumption of fruit
and vegetables; smoking; being at high risk of sleep apnea; BMI categories and TGs
levels.
3.4 Discussion
In the retrospective follow-up study, we measured the correlates that lead to
prediabetes becoming DM and quantified the effect of these correlates on individual
characteristics. Although there is a widespread consensus that prediabetes is a risk
factor in developing DM20,32,45 and the correlates for DM in people with prediabetes
differ from those with normal glucose tolerance165 there are, to our knowledge, no
studies available that deal with this development (from prediabetes to DM) in the UAE.
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The majority of studies on the risk factors and correlates for NCD that have
been conducted in the UAE were done so in an educational setting (schools and
universities). Very few have been done outside of such settings and our study sought
to redress this imbalace. This study, which involved 487 prediabetic participants
showed that 37% of men and 21% of women practice moderate to vigorous PA. The
percentage of PA for women was much lower than the figures reported in previous
studies by Shu Wen (41%)121 but is consistent with the other studies120 showing that
men were more active than women in the UAE. In several previous studies, it was
reported that the consumption of fruit and vegetables is low in the UAE136. In our study
59% of the participants consumed fruit and vegetables on a daily basis.
Our findings show that age, marital status, education level, PA, hypertension,
elevated total cholesterol level and low HDL cholesterol level were associated with
the conversion of prediabetes into DM for our study population. There are several
studies extant in the UAE dealing with the risk factors for developing DM in the UAE
but fewer studies on prediabetes. However, to the best of our knowledge, there is no
other study, in a UAE context, that examines the correlates for prediabetes developing
into DM in the national population.
3.4.1 Rate of Conversion of Prediabetes to DM
Prediabetes is a high-risk disorder that can develop into DM11. Type one
diabetes is not associated with prediabetes as it has a different pathogenesis27. Between
5% and 10% of people with prediabetes develop DM each year164. In most of the
populations studied, 60% of people who develop DM have either IGT or IFG for five
years or so before the onset of the disease27. The rate of conversion from IFG and IGT
to DM is similar, with IGT having greater sensitivity but less specificity when
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compared to IFG in terms of predicting conversion to DM. The positive predictive
value for IGT and IFG to develop into DM is the same45.
The development of prediabetes into DM happens in stages3. The first phase is
the compensatory stage where insulin resistance is present, in addition to an increase
in insulin secretion and beta cell mass. Stable adaptation is the second stage where beta
cells no longer fully compensate for increased insulin resistance. At this stage, the
insulin level decreases but the fasting and postprandial glucose levels are still normal.
The first and second stages occur before the prediabetic stage has been reached. During
the third stage of developing DM, the period from prediabetes to DM, beta cells lose
their compensatory mechanism for insulin resistance. Thus, glucose levels increase
quickly3.
In our study, the rate of conversion of prediabetes patients to DM in Emirati
adults in Dubai was observed in 114 (23.4%) of our participants. The first FPG was
taken in 2015 as part of a DHA screening process in primary healthcare centers in
Dubai. Then in 2017, a 1,000 sample frame (prediabetic patients) was taken from the
date above and another FPG was measured with the same patients. The rate of
conversion from prediabetes to DM in a two-year period was 23.4%. This is equivalent
to a yearly conversion rate of around 12%. This rate was higher than was reported in
another study, where the rate was between 5% and 10% of people with prediabetes
developing DM each year164.
Adults in the USA with normal glucose levels have a 0.7% average yearly risk
of developing DM165. The ADA expert panel has predicted that up to 70% of
individuals with prediabetes will eventually develop DM165. This conversion varies,
according to the definition of prediabetes and population characteristics. In a Chinese
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diabetes prevention trial, the 20-year cumulative incidence of DM was >90% when
using IGT defined with repeated OGTTs66. In India, a 10-year follow-up to the
Chennai Urban Rural Epidemiology Study showed that 58.9% of people with
prediabetes developed DM. Those patients had a considerably greater level of FBG,
two-hour postprandial, and HBA1c, and were more likely to have a family history of
DM. They were also less likely to consume alcohol168. On the other hand, several trials
have proven that people with prediabetes can become normoglyceamic after lifestyle
and drug-based interventions81. In England, for example, 55%-80% of people with IFG
had a normal FBG after 10 years. However, other trials reported a lower conversion
rate11.
In summary, people with prediabetes face three different scenarios: around a
third of cases will develop DM, another third will remain prediabetic and the remaining
third can revert to normoglycemia status6. Studies show that the risk of developing
DM can be reduced by 58% if people exercise moderately for 30 minutes a day, five
days a week and lose 7% of their total body weight1.
3.4.2 Percentage of Smokers in our Study Population
The percentage of smokers (cigarettes or shisha) in our sample was 9.6%. Most
smokers were men (27.3%) as compared to women (2.9%). This figure is similar to
the one reported in a review of an approach to chronic diseases in Abu Dhabi by Hajat
et al. (9%), but is lower than the figure reported in the Weqaya screening program
(11%). It is significantly lower than the 2007 rates in the USA (20%) and the UK
(22%)41. The reasons for these findings are beyond the scope of this study.
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3.4.3 Percentage of People with Sleep Apnea in our Study
The current study used the Berlin questionnaire on sleep apnea a determinant
of sleep apnea syndrome in prediabetic patients. About 12.5% of sparticipants were
found to be at high risk of obstructive sleep apnea. This figure is much lower than the
one previously reported in the UAE (20.9%)169, Saudi Arabia (33.3%), Jordan
(16.8%)170 and Spain (26.7%)171.
3.4.4 Physical Activity as a Correlate of Conversion from Prediabetes to DM
Physical inactivity was one of the correlates in our study. Practicing vigorous
PA at least once a week was significantly associated with a 77% reduction in the
conversion of prediabetes to DM, when compared with those who do not do vigorous
PA at least once a week. This finding is consistent with findings in several other
studies168, including the Strong Heart Study165 where physical inactivity was reported
as being an independent correlate for the conversion of prediabetes to DM.
3.4.5 Lipid Profile as a Correlate of Conversion from Prediabetes to DM
Elevated total cholesterol levels and a low level of HDL were another correlate
for conversion of prediabetes to DM in our study. Participants who reported having
elevated total cholesterol levels (≥200 mg/dl) and low HDL-cholesterol levels (<40
mg/dl male <50 mg/dl female) had 44% more chance, and were 2.17 times more at
risk, of developing DM, when compared to participants with normal total cholesterol
and HDL-cholesterol levels in our univariable analyses. This finding has been
confirmed in other studies165,168,173. While an elevated total cholesterol level was found
to be no longer significant after adjusting for confounding factors such as age, low
HDL-cholesterol levels remained significant in the adjusted analyses (aOR=3.45). In
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spite of this, the HDL-level was not related significantly to the incidence of DM in the
Strong Heart Study165.
3.4.6 Age as a Correlate of Conversion from Prediabetes to DM
Our analysis showed that age is a significant correlate for DM in those with
prediabetes (univariable analyses). Older participants (45-60 years) were 5.28 times
more likely to develop DM than younger participants (18-30 years). This finding is
consistent with the results found in several other studies168,172, including the Strong
Heart Study165 and a retrospective cohort study, which studied 5,452 prediabetic
subjects in the United States. This study confirmed that the prevalence of DM increases
markedly with age in people with prediabetes. Furthermore, the younger the person is
at the time of the diagnosis of prediabetes, the more likely they are to develop DM.
This could be due to the fact that the development of hyperglycemia at a younger age
means there is a greater degree of insulin resistance and a decline in beta cell function,
leading to a fast rise in glucose levels. It is also possible this is due to an increase in
the rate of identifying DM at this younger age as clinicians do more frequent screening
for high glucose levels173. However, in our study, the effect of age on the conversion
to DM was not significant in the multivariable analyses, but it was in the Strong Heart
Study after adjusting for covariates165.
Our research has explored the correlates for DM developing in prediabetic
patients. These included age, marital status, education level, PA, hypertension,
elevated total cholesterol and low HDL cholesterol level. The significance of the
associations differed among the correlates. Some of the correlates showed a stronger
significance (age, marital status, the presence of hypertension, low HDL-cholesterol
levels) compared to others (PA level, educational status, elevated total cholesterol
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levels). Furthermore, some of the correlates that showed significant association in the
univariable analyses did not remain significant after adjusting for other potential
confounding factors such as hypertension, elevated total cholesterol levels, etc. in the
multivariable analyses. These were age, marital status, education level, HT. Low HDLcholesterol levels and physical activity levels were the only correlates that showed
significance in the univariable analysis and remained the same in the adjusted
multivariable analyses. Furthermore, many variables in our study, such as smoking,
gender, BMI and sleep apnea, were commonly reported as being independent risks for
the conversion of prediabetes into DM in previous studies164,165,172,173,177,178 but did not
show as significant in our study. We reflected that the biological difference between
the baseline and outcome cohort was not great enough for minor variables to be
recognized as independent and significant correlates. Of course, differences in the
entry and outcome standards of our study and previous studies might also account for
differences in the significance outlines.
3.5 Strengths of Our Study
To our knowledge, this is the first study in Dubai, the UAE, to explore the rate
of conversion of prediabetes to DM and its correlates and associations. Furthermore,
the recruitment of subjects followed strict inclusion criteria to ensure control of
selection bias. Measurement bias was overcome by collecting with well-trained staff
from five healthcare centers in Dubai. Furthermore, an adequate sample size was used
and our study adjusted for many correlates.
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3.6 Limitations of our Study
There are some potential limitations of our study that need to be considered.
For example, the primary limitation is the inability to find out the exact date of
conversion from prediabetes to DM as we did not follow-up individual participants
and could not calculate person-time to use as denominator. Furthermore, every
variable included in our analysis was self-reported, and thus dependent upon the
participants’ memory. This might have led to inaccurate data, especially in relation to
family history. However, the self-report format does have the advantages of
convenience, simplicity and low costs, and may be more uniform in its presentation
than face-to-face screening. In addition, the Berlin Questionnaire was used to assess
sleep apnea. This questionnaire has a very low specificity. Furthermore, we could not
independently approve or refute reports of snoring or daytime sleepiness by the
respondents.
Furthermore, the ADA recommends a repeat measurement after a single HA1c,
FPG, or 2-hour PG diabetes-positive test result, which we could not do because most
participants had only one blood test. Therefore, some participants without DM may
have been misclassified as having DM in our study and it is unclear how frequently
this has occurred.
Design effect is important in any cross-sectional study. With probability
proportional to size, where samples from different sized subgroups are used and
sampling is taken with the same probability, the chances of selecting a member from
a large group are less than selecting a member from a smaller group. This takes varying
sample sizes into account, but was not taken into account when choosing our target
population. Therefore our data may be under-representative of the general population
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of the UAE. We feel that not considering probability proportional to size in our design
is one of our study’s limitation. Moreover, the participants were not all UAE nationals,
so the findings cannot be generalized to groups with different ethnic backgrounds even
if living in the UAE.
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Chapter 4: Conclusion
4.1 Overall Summary
This descriptive study is intended to measure the prevalence, characteristics
and correlates of prediabetes in the adult population of the UAE. It is vital to identify
prediabetes in any population as it increases awareness levels in the community and
also helps in the design of appropriate educational programs to modify the correlates
for prediabetes and can lead to the prevention or delay in progression of prediabetes to
DM. Therefore, the information collected in this study will help both decision makers
and policy makers in many ways. Additionally, the analysis in this study provided
useful information about the prevalence of prediabetes, DM and obesity in the UAE.
It also explored the correlates of prediabetes and DM, and factors that can lead to the
conversion of prediabetes into DM.
The prevalence of prediabetes in this study (37.7%) was much higher than
reported in a population-wide cardiovascular screening program (Weqaya) in Abu
Dhabi in 2012, where prediabetes was only 27%40. This increase is consistent with the
increasing incidence of prediabetes in GCC38,39, Asian33,37,152, European32 and North
American23,31 countries. Furthermore, the prevalence of prediabetes increases with
age, with the highest incidence in people aged 34-54 years. Increased body mass index
was another correlate for developing prediabetes, particularly if in the obese BMI
range. Prediabetes was also significantly associated with educational level.
The overall prevalence of DM in our study was 18.7%, which was similar to
the one reported in a population-wide cardiovascular screening program (Weqaya)40
in Abu Dhabi. We found that older age (≥55 years), obesity, lack of PA, education
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level, high WHR, having a family history of DM and TGs level were statistically
significant correlates for DM in our study.
The prevalence of obesity in the UAE was shown to be rising and was
significantly associated with prediabetes and DM. Furthermore, being overweight
(BMI between 25.0 and 29.9 kg/m2) and obesity (MBI ≥30 kg/m2) were detected in
35.7% and 50.1% of the study population, respectively. This figure is alarming as it is
higher than the one reported in the Weqaya study in 2012 (35%) and a populationbased cross-sectional study in 2000, also in the UAE (34%)40.
Our findings show a lack of vigorous PA to be a significant correlate of DM
and prediabetes, and practicing vigorous PA at least once a week reduced the
conversion rate of prediabetes to DM by 77%. Furthermore, many variables in our
study, such as age, hypertension, smoking, gender, BMI and sleep apnea, have been
commonly reported in previous studies as independent risks for the conversion of
prediabetes to DM. However, they did not show any significance in our study. It is
likely this is due to the sample size of our study, which could somewhat clarify the
inconsistent results. Furthermore, having a healthy diet and good weight management
via PA and controlling lipid profiles will help to reduce the prevalence of prediabetes
and the conversion of prediabetes to DM.
The UAE’s health care system is facing difficult challenges as prediabetes, DM
and obesity are all becoming more prevalent and putting a strain on the UAE’s human
and financial resources. Unless policies, laws and the healthcare system are modified,
the advances in healthcare that have been accomplished over the past forty years will
be eroded.
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In addition, there needs to be future intervention studies in order to explore the
correlates for prediabetes and the conversion of prediabetes into DM in a larger, more
diverse non-local population in the UAE. The relationship between sleep apnea and
prediabetes also requires additional examination. Future studies must be conducted,
and repeated, in different Emirates to determine if the findings continue to be
consistent with the results of our study.
4.2 Recommendations
The UAE’s epidemic of obesity requires urgent and aggressive intervention.
This is necessary to prevent chronic diseases from damaging the accomplishments of
the UAE government over the last 40 years in improving the overall health of UAE
nationals. In order to achieve this, polices and laws must be formulated and efforts
united. Lifestyle management plays a major role in combating obesity, prediabetes and
DM at an individual level. Both policy makers and decision makers have an important
role in this battle.
As the prevalence of prediabetes is high in the Emirati population, educating
people about prediabetes, its correlates and the measures required to return to a normal
state, is vital. It is also crucial to recognize prediabetes as a disease that leads to several
complications, including DM. Moreover, early detection of prediabetes and
implementing preventative measures to stop its progression to DM is essential. Other
important recommendations include:


Collective efforts are needed to reduce the prevalence of prediabetes and DM
to empower the public to take care of their own health. This can be done
through education. This education should concentrate on the dangers of an
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unhealthy lifestyle and behaviors (PA and an unhealthy diet) and can be
delivered via the media and social media channels. Furthermore, educational
programs (which target the correlates for chronic diseases like DM and
hypertension) are required to target people in schools and the community.
Increasing levels of health education amongst the public will encourage people
to make healthier selections.


It is essential to strengthen the role of primary healthcare centers. This can be
achieved by applying preventative strategies in primary healthcare that can
detect who is at high risk of prediabetes and obesity. This will ensure the early
detection of prediabetes and interventions that can lead to a delay in the
progression of prediabetes to DM. An individualized wellness program could
be established, which must include diet counselling and exercise plans to
address the correlates for chronic diseases, like obesity, as well as a lack of PA
and unhealthy eating habits. These programs will increase people’s awareness
of the risks.



Public health policies at a national level need to be implemented in the UAE.
These polices have to focus on improving public health by creating a healthy
community that replaces the “obesogenic” environment and encourages
healthy lifestyle behaviors. This should concentrate on limiting the spread of
fast food outlets, making healthy food both easily affordable and accessible,
and imposing taxes on tobacco, foods high in fat and sweet drinks. It is also
important to create an encouraging environment for exercise and PA for both
genders and all ages.
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Researcher Name
Date of interview

Coordinator Name
Time of Interview

Student Name
Class
Name of School
Respondent’s Name:
1 Respondent’s Gender:
- 1. Male
2. Female
2 Nationality
3 Age in years …………………
-

Student No.

UAE
DOB …../…../………..

Others………………..
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Section A
General Information
5-

What is the highest class/level of education that
completed?

Illiterates

1

Primary

2

Middle
Secondary
Diploma, Graduate,
Masters/MBA,PHD

3
4
5

6-

What is your marital status?

Married
Divorced
Widowed
Do not know
Refused

1
2
3
77
99

7-

Are you blood related to your spouse?

Yes
No

1
2

8-

IF YES-What’s the relationship with your spouse?

First cousin1
1
2
Second cousin
2
Other: ________________

9-

How many children do you have?

Boys________ Girls _______

10-

In which type of family system do you live?
1. Husband, wife, parents, in-laws and other
2. Only husband, wife and children

Joint family system1
Nuclear2

11-

What is your Mother Language?

____________________

12-

Are you currently employed or engaged in any
business?
If Yes
What Nature of your work/employment?
………………………….
How Many Years in the current work?
……………………………….
Monthly salary/income? ………………………..Dh

Yes

131415-

No
____

16-

If Not
Reason for not being employed?
(Multiple responses possible)

17-

Do you own the house you live in?

Student
Housewife
Retired
Jobless
Other
Specify _____________
Yes

18-

How many people live in the house? ………………….

No

2

1
2

1
2
3
4
5
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SECTION B
In this section I would like to ask you about your health
B1

What would you say about your health in general?

Excellent
Very Good
Good
Fair
Poor

1
2
3
4
5

B2

How much you are satisfied with your life?

Very happy
Happy
Fair
Not happy
Very unhappy

1
2
3
4
5

B3

Before this interview, Had your BPever been
checked?

Yes

1

No

2

Yes
 No

1
2

B4

Has a health care provider ever told you that you
have high BPalso called hypertension?
If not-Move to Question B10

B5

What was your age when you were told that you
have high BP?

______ years

B6

Because of your high BPhave you were ever being
told by a health care provider to take prescribed
medicine?

Yes
No

1
2

B7

Are you currently (since last month) taking any
medicine for BP?

Yes

1

No

2

B8

No.
01
02
03
04
05

Please, mention the names and dosages of medicines you are using. If you do not know the
names of medicines then kindly show me these medicines.
Type
1. Tablets, 2. Capsules, 3.
Dosage per day
Name of Medicines
Syp/Susp, 4. Injection, 5. Inhalers,
6. Others
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B9

Have you taken your BPmedicine today or during
the last 2 days?

If not, what was the reason for not taking the
BPmedicine?

B10

Did any of your first degree relatives (mother,
father, brother, sister, son, daughter) were told by a
doctor or other health professional that they had
high BP?

Heart Disease
B11 Has a doctor or other health professional ever told
you that you have Heart Disease?

Yes today

1

Yes in last two days

2

No
3
__________________________
__
____________________________

Yes

1

No
Don’t know

2
3

Yes
 No

1
2

1
2
3

If Not-Move to Question B16
B12

What was that heart disease?

Angina
Heart Attack
Other (specify)_____________

B13

How old were you when you were told?

_________years

B14

Were you prescribed treatment for it?
If Not-Move to Question B16

Yes
 No

1
2

B15

If yes, the type of treatment was?

Medical treatment only
Medical & surgical treatment
Other (specify) _____________

1
2
3

B16

Did any of your first degree relatives (mother,
father, brother, sister, son, daughter) were told by a
doctor or other health professional that they had a
heart attack before the age of 55 years??

Yes
 No
 Don’t Know

1
2
3

Cholesterol and TG
B17 Have you ever had your blood lipids measured (Cholesterol or
TGs)?
B18

Have you ever been told by a doctor, or another health
professional that your blood cholesterol level was high?

Yes
No

1
2

Yes
 No

1
2

Yes

1

No

2

If Not-Move to Question B20
B19

Are you currently taking any treatment for your high
cholesterol?
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Kidney Disease
B20
Has a doctor or other health professional ever told you that
you have a kidney disease?
B21

If yes, what kind of kidney disease you had?

Diabetes
B22
Has a health care provider ever told you that you have
Diabetes?

Yes
 No

1
2

______________________
______________________

Yes
 No

1
2

Had symptoms
Screening test (high
blood sugar)
Sugar in Urine
Others
(specify)____________

1
2

Yes

1

No

2

Insulin injections

1

Tablets
Restricted Diet
Others
(specify)____________
Yes, today

2
3
4

Yes, in the last 2 days
No, I did not take any
medication
Why?______________
______
___________________
_____

2
3

If Not-Move to Question B20
B23
B24

B25

B26

B27

How was your diabetes diagnosed?
(More than one responses possible)

Were you prescribed any treatment or restricted diet for
your diabetes?

If yes, Type of current treatment you are taking for
diabetes?
(More than one responses possible)

Have you taken your diabetes medicine today or during the
last 2 days?

3
4

1

B28

Do you have a blood sugar checking device at your home?

Yes
No
Don’t Know

1
2
3

B29

Did any of your first degree relatives (mother, father,
brother, sister, son, daughter) were told by a doctor or
other health professional that they had diabetes?

Yes
 No
 Don’t Know

1
2
3
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Stroke
B30

Has a doctor or other health professional ever told
you that you had a stroke?

Yes
No

1
2

Don’t know

3
1
2

B31

Do you know the cause of stroke?

Yes
No

B32

If Yes, what is the major cause? Specify:

_______________________

B33

Did any of your first degree relatives (mother, father,
brother, sister, son, daughter) were told by a doctor
or other health professional that they had a stroke?

Yes
No

1
2

Did you get an injury in the past 12 month that
needed treatment?

Yes

1

Injury
B34
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SECTION C
International Physical Activity Questionnaire (IPAQ) Short-version
We are interested in finding out about the kinds of physical activities that people do as part of
their everyday lives. The questions will ask you about the time you spent being physically active in
the last 7 days. Please answer each question even if you do not consider yourself to be an active
person. Please think about the activities you do at work, as part of your house and yard work, to
get from place to place, and in your spare time for recreation, exercise or sport.
Vigorous
Think about all the vigorous activities that you did in the last 7 days. Vigorous physical activities
refer to activities that take hard physical effort and make you breathe much harder than normal.
Think only about those physical activities that you did for at least 10 minutes at a time.
C1

During the last 7 days, on how many days did you do vigorous
physical activities like heavy lifting, digging, aerobics or fast
bicycling?

None
1 Day
2 Day
3 Day
4 Day
5 Day
6 Day
7 Day
Don’t Know
Refuse

1
2
3
4
5
6
7
8
7
7
9
9

If None, Don’t Know, Refuse Skip to Q. C3
C2

How much time did you usually spend doing vigorous physical
activities on one of those days?

_____ hours/day
_____ minutes/day

Moderate
Think about all the moderate activities that you did in the last 7 days. Moderate activities refer to
activities that take moderate physical effort and make you breathe somewhat harder than
normal. Think only about those physical activities that you did for at least 10 minutes at a time.

C3

During the last 7 days, on how many days did you do
moderate physical activities like carrying light loads, bicycling
at a regular pace, or doubles tennis?
Do not include walking.

None
1 Day
2 Day
3 Day
4 Day
5 Day
6 Day
7 Day
Don’t Know
Refuse

If None, Don’t Know, Refuse Skip to Q. C5
C4

How much time did you usually spend doing moderate
physical activities on one of those days?

_____ hours/day
_____ minutes/day

1
2
3
4
5
6
7
8
7
7
9
9
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Walking
Think about the time you spent walking in the last 7 days. This includes at work and at home,
walking to travel from place to place, and any other walking that you might do solely for
recreation, sport, exercise, or leisure.
C5

During the last 7 days, on how many days did you walk for at
least 10 minutes at a time?

None
1 Day
2 Day
3 Day
4 Day
5 Day
6 Day
7 Day
Don’t Know
Refuse

1
2
3
4
5
6
7
8
77
99

If None, Don’t Know, Refuse Skip to Q. C7
C6

How much time did you usually spend walking on one of those
days?

_____ hours/day
_____ minutes/day

C7

During the last 7 days, how much time did you spent sitting on
week days during the last 7 days? Include time spent at work, at
home, while doing course work and during leisure time. This
may include time spent sitting at a desk, visiting friends, reading,
or sitting or lying down to watch television.

_____ hours/day
_____ minutes/day

Sitting

C8

During the last 7 days, on how many days did you spent
sitting or lying down to watch television, work/play
computer, play electronic games?

None
1 Day
2 Day
3 Day
4 Day
5 Day
6 Day
7 Day
Don’t Know
Refuse

If None, Don’t Know, Refuse Skip to Q. D1
C9

How much time did you usually spend sitting on one of
those days?

____________hrs/day
___________min/day

1
2
3
4
5
6
7
8
77
99
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SECTION D
Section of Lifestyle
D1
Have you ever smoked cigarettes/cigars/biddies?
2- At what age did you start smoking?
________ yrs
3- For how many years have you/did you
smoked? ________yrs
4- When did you quit smoking ?__________
years _________months
5- What was the average number of cigarettes
per day that you smoked in the
past?______ cigarettes
6- At what age did you start smoking?
________ yrs
7- How many years have you/did you smoked?
________yrs
8- How many cigarettes you smoke per day?
cigarettes/day ______
During the last week, 9-Ciggarettes
10-Cigar
How many smoke:
None
Once/week
2-3 times/week
4-5 times/week
Every day

Go to D13Never

1

Former Smoker

2

Current Smoker

3

11-Water pipe or shisha

12Naswar

D13

On how many of the past 7 days did someone smoke
in your indoor workplace while you were there?

None
Once/week
2-3 times/week
4-5 times/week
Every day
Don’t know

1
2
3
4
5
77

D14

On how many of the past 7 days did any one smoke
in your home while you were there?

None
Once/week
2-3 times/week
4-5 times/week
Every day
Don’t know

1
2
3
4
5
77

D15

How often are cigarettes smoked inside your home
in a typical week?

Never

1

Once in a week
2-3 times/week
4-5 times/week
Daily
Don’t know

2
3
4
5
77
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Section E
Questions related to diet at home
E1

Do you add extra salt on your food?
Skip to Q

Yes
 No

1
2

E2

How often do you add salt on your food?

Occasionally (<7/week)
Often (>7/week)
Always

1
2
3
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3-How often you eat the following food in a day, week, month or year.

S#
3-1

Food item
consumed

Use

Frequency

1. Yes
2. No

yearly

monthl
y

Serving
weekly

daily

Season
/fest
Plate

3-18

Mutton (curry,
roasts, etc.)
Beef (curry,
roasts, kabab,
qeema,
barbecued etc.)
Chicken (curry,
roasts, tikka,
barbecued, broast
etc.)
Fish (curry, fry,
etc.)
Milk
Lassi
Yogurt
(Dahi)/Raita
cheese
Other milk
products
Eggs
Lentils (Mung,
Masoor, etc),
Beans (Lobia,
Choley)
Raw
vegetables/Salad
(Tomato,
cucumber,
onions,
reddish/beetroot
etc)
Cooked
Vegetables (not
including
potatoes)
Fresh fruits (do
not include juices)
Pure fruit juices:
fresh/packaged
juices (not
including
packaged Drinks*
like Frost, Frooto
etc.)
Sweets
Dry fruits e.g.
nuts, peanuts,
pista, almonds,
chilgoza etc.
Bread

3-19

Rice

Plate

3-2

3-3

3-4
3-5
3-6
3-7
3-8
3-9
3-10
3-11

3-12

3-13

3-14
3-15

3-16
3-17

Plate

Plate

Plate
Glass
Glass
Cup

Numbers
Plate

Plate

Plate

Numbers
Glass

Piece/plate
Numbers

Numbers

Your
Portion
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SECTION F
Physical Examination
Have you smoked a cigarette or taken coffee or tea in the last 30
minutes?

Yes

1

No

2

BP

1st reading
2nd reading after 05 minutes
of 1st one
3rd reading after 05 minutes
of 2nd one

Height

Systolic
BP
_______

Diastolic BP

Pulse

_______

_______

_______

_______

_______

_______

_______

Anthropometric Measurements
1st reading
_______________c
m

_______

2nd reading
_______________cm

Weight

_______________Kg

_______________Kg

Waist circumference

______________cm

_______________cm

Hip circumference

______________cm

_______________cm

SECTION G
LABORATORY TESTS RESULTS
Test
Date

Report Number

G1

Glucose
Fasting

G2

Serum Cholesterol

G3

LDL

G4

HDL

G5

TGs

G6

Hb1C
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Appendix 5: Developed Developing Countries Partnership for NonCommunicable Disease Prevention
تعاون الدول المتطورة والدول النامية للوقاية من االمراض غير االنتاال

ة

جامعة اإلمارات العربية المتحدة
كلية الطب والعلوم الصحية
العين -دولة االمارات

دراسـة حول تعاون الدول المتطورة والدول النامية للوقاية من
االمراض الغير انتقالية

االستبيــــــان
بالتعاون مع
الخاص بأولياء األمور
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أ) أسئلة عامة
اسم المشرف وتوقيع:

اسم الباحث وتوقيع :

تاريخ الماابلة .............................................................. :الوقت........................... :

رقم الطالب:

اسم الطالب:
الصف والمرحلة الدراسية:
اسم المدرسة :

رقم بطاقة التأمين الصح

اسم المشارك (األب أو األم):

-1الجنس:

-1

-2الجنسية:

-1

ذكر
اإلمارات

-3تاريخ الميالد (اليوم | الشهر | السنة)__ __/__ __/__ __:

-2

أنثى

-2

أخرى/حدد:

أو العمر بالسنوات ................:

-5المستوى التعليم لول أمر الطالب
ابتدائي

-2

اعدادي

-7

-1

ال يقرأ وال يكتب

-1

معهد/جامعة /دراسات عليا (ماجستير/دكتوراه)

-4

الثانوي

-6الحالة االجتماعية الحالية لول األمر؟
-1

متزوج -2

مطلق

أرمل

-7

-4

ال يعلم

-1

رفض اإلجابة

-7هل هناك قرابة دم بينك وبين زوجك/زوجتك؟
-1

نعم

-2

ال

-8اذا كان الجواب نعم ،ما هو نوع الارابة بينك وبين زوجك/زوجتك؟
-1

من الدرجة االولى

-9كم عدد أوالدك وبناتك ؟

-2

من الدرجة الثانية

-7

أقارب من بعيد

أوالد ________ :بنات____________ :
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-11هل تعيش مع أوالدك ف
-1

عائلة ممتدة (الزوج-الزوجة-األوالد-الجد والجدة-اقارب آخرين)

-2

عائلة مفردة (الزوج-الزوجة-األوالد فقط)

-11ما ه لغتك األم (لغة األباء واالجداد)......................................:
-12هل انت تعمل حاليا؟
-1

-2

نعم

ال

* اذا كان الجواب نعم
-13ما نوع العمل/الوظيفة؟ ______________________
-11كم هو عدد السنوات الت قضيتها ف هذا العمل؟______________
-15ما هو معدل دخلك الشهري؟ ________________________
* اذا كان جوابك ال ،
-16ما هو سبب عدم انخراطك بالعمل؟
-1

ال ازال طالبا

-4

ال أجد عمل

-2
-1

ربة منزل

غير ذلك ,حدد___________

-17هل تمتلك البيت الذي تعيش فيه؟
-1

نعم

-2

-7

ال

-18كم شخص يعيش معك ف المنزل.......................... :

متقاعد
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ب)

الصحة العامة

نود االن ان نسألك عن صحتك
-1هل تستطيع أن تصف ل الوضع الصح العام لك على أنه
-1

ممتاز

-4

متوسط

جيد جدا

-2
-1

جيد

-7

ضعيف

-2كم أنت سعيد ف حياتك؟
-1

سعيد جدا

-4

غير سعيد

-2

متوسط

سعيد

-7

-1

أبدا ال أشعر بالسعادة

ضغط الدم
-3هل فحصت ضغط الدم من قبل؟
-1

-2

نعم

ال

-1هل تم اخبارك من قبل طبيب او اي اختصاص ان لديك ضغط دم مرتفع؟
-1

-2

نعم

إذا كان الجواب ب ال انتال الى السؤال رقم 11

ال

-5كم كان عمرك عندما أخبرت بأن ضغط الدم لديك مرتفع؟ العمر بالسنوات ............................
-6هل وصف لك دواء او عالج لضغط الدم المرتفع؟
-1

-2

نعم

ال

-7هل تتناول حاليا اي دواء لتخفيض ضغط الدم ( خالل الشهر األخير) ؟
-1

-2

نعم

ال

 -8أرجو كتابة اسماء االدوية التي تتناولها لعالج ضغط الدم (االسم والنوع والجرعة وعدد المرات):
عدد المرات
في اليوم

الجرعة

النوع

الرقم

اسم الدواء

(-1حبوب -2كبسوالت -7شراب -4حقن
-1بخاخ -1غير ذلك)
1
2
7
4
1
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-9هل تناولت دواء لتخفيض ضغط الدم ف اليومين االخيرين؟
-2

نعم-اليومين األخيرين

-1

نعم-اليوم

-7

ال-لم اتناول الدواء في اليومين األخيرين ( ما هو السبب ...................................................

)....................................................................................................................................
-11هل تم اخبار احد اقربائك (اب ,ام ,اخ ,اخت ,ابن ,ابنة) من قبل طبيب او اختصاص ان لديه ضغط دم مرتفع؟
-1

نعم

-2

ال

ال اعلم

-7

مرض الالب
-11هل تم اخبارك من قبل طبيب او اختصاص انك تعان من مرض الالب؟
-1

نعم

-2

ال

إذا كان الجواب ب ال انتال الى السؤال رقم 16

-12هل هذا المرض هو؟
-1

-2

ذبحة صدرية

-13كم كان عمرك عندما اخبرت بذلك:

نوبة قلبية

غير ذلك-حدد .......................

-7

العمر بالسنوات.................

-11هل وصف لك عالج لمرض الالب؟
-1

نعم

-2

ال

-15هل كان العالج الذي وصف لك
-1

دواء فقط -2

دواء مع جراحة قلب

غير ذلك-حدد ..........................

-7

 -16هل تم اخبار أحد اقربائك (اب ,ام ,اخ ,اخت ,ابن ,ابنة) من قبل طبيب او اختصاص انه تعرض لنوبة قلبية قبل
سن ال 55؟
-1

نعم

-2

ال

-7

ال اعلم

مم مستوى الدهنيات (الكوليسترول و التريغسيريد)؟
-17هل تم فحص مستوى الدهنيات لديك من قبل (الكوليسترول او التريغسيريد)؟
-1

نعم

-2

ال

-7

ال اعلم

-18هل تم اخبارك من قبل طبيب او اي اختصاص ان لديك نسبة عالية من الكوليسترول ف الدم؟
-1

نعم

-2

ال

-19هل تتناول حاليا اي دواء لتخفيض نسبة الكوليسترول ف الدم؟
-1

نعم

-2

ال

إذا كان الجواب ب ال انتال الى السؤال رقم 21
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مرض الكلى
-21هل تم اخبارك من قبل طبيب او اي اختصاص انك تعان من مرض الكلى؟
-1

نعم

-2

اذا كان الجواب ب نعم،

ال

-21ما هو هذا المرض؟ حدد ......................................................
مرض السكري
-22هل تم اخبارك من قبل طبيب او اي اختصاص انك تعان من مرض السكر؟
-1

نعم

-2

إذا كان الجواب ب ال انتال الى السؤال رقم 29

ال

-23كيف تم تشخيص أو اكتشاف مرض السكري لديك؟
أرتفاع سكر الدم

-2

أرتفاع سكر البول

-7

-1

وجود أعراض مرض السكري

-4

غير ذلك  ،حدد ......................................................................

-21كم عدد السنوات منذ تم تشخيص أو اكتشاف مرض السكري لديك؟
(ضع  1ف حال المدة أقل من سنة)

عدد السنوات .........

-25هل وصف لك عالج معين أو حمية غذائية لخفض مستوى السكر او لعالج السكري لديك؟
-1

نعم

ال

-2

-26اذا كان الجواب ب نعم ،هل تخضع حاليا الى أي من اآلت لخفض مستوى السكر او لعالج السكري لديك؟
-1

حقن االنسولين

-4

غير ذلك-حدد .......................

حبوب

-2

حمية غذائية

-7

-27هل تناولت دواء لتخفيض سكر الدم اليوم أو خالل اليومين االخيرين؟
-1
-7

نعم-اليوم

-2

نعم-اليومين األخيرين

ال-لم اتناول الدواء في اليومين األخيرين ( ما هو السبب ...................................................

-28هل تستخدم جهاز فحص السكر ف المنزل فحصت من قبل نسبة السكر (الغلوكوز) ف الدم او البول؟
-1

-2

نعم

-7

ال

ال اعلم

-29هل تم اخبار احد اقربائك (اب ,ام ,اخ ,اخت ,ابن ,ابنة) من قبل طبيب او اختصاص انه يعان من مرض
السكري؟
-1

نعم

-1

نعم

-2

ال
-2

-7
ال

ال اعلم
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السكتة دماغية Stroke
-31هل تم اخبارك من قبل طبيب او اختصاص انك تعرضت لسكتة دماغية؟
-1

نعم

-2

-7

ال

ال اعلم

-31هل تعلم سبب السكتة الدماغية؟
-1

نعم

-2

ال

إذا كان الجواب ب نعم ،

-32ما هو السبب الرئيس للسكتة الدماغية؟ .......................................
 -33هل تم اخبار احد اقربائك (اب ,ام ,اخ ,اخت ,ابن ,ابنة) من قبل طبيب او اختصاص انه تعرض لسكتة دماغية؟
-1

نعم

-2

ال

االصابات Injury
-31هل تعرضت ألي اصابة خالل ال  12شهرا الماضية مما استدعى تلا العالج لهذه االصابة؟
-1

نعم

-2

ال

-35كيف حدثت االصابة؟ .........................................................................................................
-36أين حدثت االصابة؟ ..........................................................................................................
-37ما هو سبب هذه االصابة؟ ...................................................................................................
-38اين تلايت العالج ل هذه االصابة؟
-1

مستشفى حكومي

-2

الرعاية الصحية (المراكز الصحية)

-7

المستشفيات الخاصة

-4

غير ذلك ،حدد ................................................

صحة االب واالم
-39كيف تايم صحة االب؟
-1

جيدة

-2

مريض ،حدد ما هو المرض ............................................................................................

-7

متوفي :حدد سبب الوفاة .................................................................................................

-11كيف تايم صحة االم؟
-1

جيدة

-2

مريضة ،حدد ما هو المرض ............................................................................................

-7

متوفية :حدد سبب الوفاة ..........................................................................................
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ج) األنشطة الجسدية (الرياضية)
سوف أسألك عن الوقت الذي قضيته ف نشاط بدن خالل ال  7أيام الماضية.
الرجاء إجابة كل سؤال حتى لو كنت ال تعتبر نفسك بأنك شخص نشيط .اعتبر األنشطة الت تاوم بها ف العمل  ،االنتاال
من مكان إلى آخر  ،وف وقت فراغك لإلستجمام  ،التمرينات الرياضية أو األلعاب الرياضية.
واآلن فكر ف جميع األنشطة الت تحتاج إلى جهد بدن شاق والت قمت بها خالل ال  7أيام الماضية
األنشطة الت تحتاج إلى جهد بدن شاق تجعلك تتنفس بصعوبة أكثر كثيرا من التنفس المعتاد وقد تشمل حمل األثاال،
الحفر ،األيروبك ،ركوب الدراجة بسرعة.
-1خالل الـــ  7أيام الماضية ,ما هو عدد األيام الت قام طفلك خاللها بأنشطة بدنية تحتاج الى جهد بدن شاق ,مثل العب
ف األن دية الرياضية أو الشارع ,ركوب المزلجة أو ركوب الدراجة بسرعة (لمدة  11دقائق على األقل)؟ (األنشطة الت
تحتاج الى جهد بدن شاق تجعل تنفسك بطرياة أصعب كثيرا من المعتاد)
-1

وال مرة

-2

يوم

-7

يومان

-4

 7أيام

-1

 4أيام

-1

 1أيام

-3

 1أيام

-.

 3أيام

-33

ال يعلم

-99

رفض االجابة

أذا أجاب بــ (وال مرة ,اليعلم ,رفض االجابة) انتال الى سؤال رقم 3
-2كم من الوقت تستغرق عادة في عمل االنشطة البدنية التي تحتاج الى جهد بدني شاق في يوم من تلك األيام؟
ساعة ف اليوم
دقياة ف اليوم
-3خالل الـــ  7أيام الماضية ,ما هو عدد األيام التي قمت خاللها بأنشطة بدنية معتدلة ,مثل قفز الحبل ,التزلج على الجليد
في مجمع تجاري أو مراكز التزلج ,أو ركوب الدراجة بسرعة عادية (لمدة  11دقائق على األقل)؟ ال تقم بتضمين المشي.
(األنشطة التي تحتاج الى جهد بدني معتدل تجعل تنفسك بصورة أصعب بعض الشي من المعتاد)
-1

وال مرة

-2

يوم

-7

يومان

-4

 7أيام

-1

 4أيام

-1

 1أيام

-3

 1أيام

-.

 3أيام

-33

ال يعلم

-99

رفض االجابة

أذا أجاب بــ (وال مرة ,اليعلم ,رفض االجابة) انتال الى سؤال رقم .5
-1كم من الوقت تستغرق عادة ف عمل االنشطة البدنية الت تحتاج الى جهد بدن معتدل ف يوم من تلك األيام؟
__________________ساعة ف اليوم
__________________دقياة ف اليوم
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-5خالل الـــ  7أيام الماضية ,ما هو عدد األيام الت قمت خاللها بالمشــ  ,لمدة  11دقائق على األقل؟ ويشمل ذلك المش
ف العمل ,ف المنزل ,المش للتنال من مكان الى آخر ,أو اي مش أخر قد تاوم به لمجرد الترفيه ,الرياضة ,التمرينات
البدنية أو ف وقت الفراغ؟
-1

وال مرة

-2

يوم

-7

يومان

-4

 7أيام

-1

 4أيام

-1

 1أيام

-3

 1أيام

-.

 3أيام

-33

ال يعلم

-99

رفض االجابة

أذا أجاب بــ (وال مرة ,اليعلم ,رفض االجابة) انتال الى سؤال رقم 7
 -6كم من الوقت تستغرق عادة ف المشـــ ف يوم من تلك األيام؟\
ساعة ف اليوم
دقياة ف اليوم
-7خالل الـــ  7أيام الماضية ,كم من الوقت قضيته جالسا ف يوم من أيام األسبوع ,قم بتضمين الوقت الذي قضيته
جالسا ف المدرسة ,ف البيت ,خالل أداء الواجبات المدرسية ,وأثناء وقت الفراغ ,ويشمل أيضا الجلوس ف المكتب,
عند زيارة األصدقاء ,عند الاراءة ,عند الحديث بالهاتف ,ال تضمن االستلااء أو الجلوس لمشاهدة التلفاز ,العمل/اللعب
بالحاسوب ,ولعب األلعاب االلكترونية ؟
ساعة ف اليوم
دقياة ف اليوم
-8خالل الـــ  7أيام الماضية ,ما هو عدد األيام الت قضيتها بالجلوس أواالستلااء لمشاهدة التلفاز ,العمل/اللعب بالحاسوب,
ولعب األلعاب االلكترونية ؟
-1

وال مرة

-2

يوم

-7

يومان

-4

 7أيام

-1

 4أيام

-1

 1أيام

-3

 1أيام

-.

 3أيام

-33

ال يعلم

-99

رفض االجابة

أذا أجاب بــ (وال مرة ,اليعلم ,رفض االجابة) انتال الى سؤال -1التدخين
 -9كم من الوقت تستغرق عادة ف بالجلوس أواالستلااء لمشاهدة التلفاز ,العمل/اللعب بالحاسوب ,ولعب األلعاب
االلكترونية
ساعة ف اليوم
دقياة ف اليوم
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د) نمط الحياة-التدخيــــــن
 -1هل دخـــنت في يوم من األيام (سيجارة  ،سيجار ،مدواخ ،شيشة ،نسوار)؟
-1

أبدا

-2

مدخن سابق

-7

إنتقل الى السؤال رقم 13

مدخن حالي

 -2كم كان عمرك عندما بدات بالتدخين؟ _____
 -7عدد سنوات التدخين؟ _____
_________
 -4منذ متى اوقفت التدخين؟ _______سنة
شهر
 -1ما هو معدل عدد السجائر التي كنت تدخنها في اليوم الواحد؟
العدد_____
 -1كم كان عمرك عندما بدات بالتدخين؟

العمر باالعوام _______

 -3كم هو عدد السنوات التي دخنت خاللها؟ _______ سنة
 -.ما هو معدل عدد السجائر التي تدخنها في اليوم الواحد؟ العدد
_____
خالل االسبوع الماضي ,كم مرة
دخنت:

-9السيجارة؟

-11السيجار؟

-11النارجيلة او
الشيشة؟

-12النسوار؟

وال مرة
مرة واحدة في االسبوع
 7-2مرات في االسبوع
 4 -5مرات في االسبوع
كل يوم

-13كم يوما خالل االيام السبعة الماضية دخن شخص ما ف مكان مغلق بينما انت كنت هناك؟
-1

وال مرة

-2

مرة واحدة في االسبوع

-7

 7-2مرات في االسبوع

-4

 1-4مرات في االسبوع

-1

يوميا

-33

ال يعلم

-11كم يوما خالل االيام السبعة الماضية دخن شخص ما ف بيتك بينما انت كنت هناك؟
-1

وال مرة

-2

مرة واحدة في االسبوع

-7

 7-2مرات في االسبوع

-4

 1-4مرات في االسبوع

-1

يوميا

-33

ال يعلم

-15كم مرة يتم تدخن السجائر داخل منزلك ف االسبوع بشكل عام (ليس فاط االسبوع الماض )؟
-1

وال مرة

-2

مرة واحدة في االسبوع

-7

 7-2مرات في االسبوع

-4

 1-4مرات في االسبوع

-1

يوميا

-33

ال يعلم
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هـ )األغذية المنزلية

-1هل تضع ملح بشكل اضاف على طعامك؟ هل تضع ملح بشكل اضاف على طعامك؟
-1

نعم

-2

ال

-2كم مرة تضيف الملح على الطعام؟
-1

احيانا (اقل من  7باالسبوع)

-2

كثيرا (اكثر من  7باالسبوع)

-7

دائما

 -3كم تتناول هذه االطعمة سواء سنويا-فصليا-شهريا-اسبوعيا أو يوميا
استخدام

رقم

الصنف

1-7

لحم ضأن (مطبوخ ،مشوي،
).....

صحن

2-7

لحم باري (مطبوخ ،مشوي،
كباب ،قيما)

صحن

7-7

دجاج (مطبوخ ،مشوي ،تكا،
)....

صحن

4-7

سمك (مطبوخ ،مال ).... ،

صحن

1-7

الحليب

1-7

لبنه

3-7

لبن (روب)

.-7

أجبان

عدد/قطعة

9-7

منتجات الحليب األخرى
.......................

تحدد الحقا

11-7

البيض

11-7

عدس بأنواعه ،الفاصوليا
واللوبيا..... ،

صحن

12-7

الخضراوات
الطازجة/السلطات (طماطم،
خيار ،بصل،

صحن

17-7

الخضراوات المطبوخة (ال
تشمل البطاطا)

صحن

نعم
ال

تكرار االستخدام

المقياس

سنويا شهريا اسبوعيا يوميا فصليا

كوب  211مل
ملعقة
كوب  211مل

عدد

الكمية
التي
تناولت
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14-7

الفواكه الطازجة (ال تشمل
العصائر)

عدد

11-7

عصائر الفواكه الطازجة:
طازجة/معلبة ،وال تشمل
شراب الفواكه

كوب  211مل

11-7

الحلويات (الحالوة)

13-7

الفواكه المجففة(التمر
والمشمش ،العنب ...
المكسرات الفول السودان
والفستق واللوز..

عدد

1.-7

خبز

عدد

19-7

رز

صحن

عدد/صحن
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و) الاياسات الحيوية
( يتم أخذ القياسات من قبل الممرض/الممرضة حسب المعايير المتفق عليها)

هل دخنت سيجارة او شربت شاي او قهوة خالل الثالثين دقياة الماضية؟
-1

-2

نعم

ال

ضغط الدم والنبض
( ثالث مرات مع مراعاة خمس دقائق بين كل قراءة واخرى)
(يرجى أخذ القياسات بعد تعبئة االستبيان واستخدام شريط القياس المناسب)

ضغط الدم االنبساطي ضغط الدم االنقباض

النبض ()Pulse

القراءة األولى:
القراءة الثانية:
القراءة الثالثة:

الطول والوزن ومحيط الخصر والحوض
(يرجى التأكد من أن الشخص يقف منتصبا وكذلك ال يلبس مالبس ثقيلة)

الاراءة األولى
الطول (سم)

الوزن (كجم)

قياس الخصر (سم)
قياس محيط الحوض (سم)

الاراءة الثانية
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ز) الفحوصات المخبرية
الفحوصات المخبرية

رقم المشارك--------------------

مالحظة :سوف يتم فحص االطفال من عمر  6الى  11سنة ف حضور احد الوالدين (ام/اب) من بعد
الحصول على موافاة الطفل واهله.
 .1نسبة الغلوكوز بعد الصوم____________
 .2نسبة الكولسترول _________________
_____________________LDL .3
__________________HDL .1
 .5التريغلسريد_________________
__________________:HbA1C .6
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Appendix 6: Consent form in Arabic

جامعه االمارات العربية المتحدة
كليه الطب والعلوم الطبية
التاريخ21 / / :

اقرار بالموافقة
دراسة حول تعاون الدول النامية والدول المتقدمة للوقاية من األمراض المزمنة
االهالي األعزاء،
نحن اعضاء في هيئة التدريس في جامعة االمارت العربية المتحدة نخطط الجراء دراسة هدفها اكتشاف العوامل الخطرة التي تؤدي الى
أمراض لقلب والسكري التي تظهر عادة مع تقدم العمر لكن جذورها تعود الى الطفولة.نمط الحياة غير السليم مثل االكل غبر الصجي
وقلة الحركة كلها عوامل من الممكن أن تؤدي لالصابة بالسكري وامراض القلب.لذا من المهم ان يكون االهل على وعي تام بوجود أي
من العوامل الجطرة الممكنة المؤدية المراض القلب.
في هذه الدراسه ،نحن ندعو أطفالكم مع أهاليهم ( االم واالب) الجراء فحص طبي من الدراسة (تعاون الدول النامية والدول المتقدمة
للوقا ية من االمراض المزمنة) .هذه الدراسه ستساعدنا النشاء برامج وقائية من امراض القلب والسكري في مجتمعنا.
سوف يتم جمع المعلومات عن العوامل الخطره التي تؤدي الى األمراض المزمنة باستخدام استبيان .القياس السريري يتضمن قياس
ضغط الدم والوزن والطول كما سيتم أخذ عينه من الدم لمعرفه .العوامل الخطره المؤذيه الى أمراض القلب .سوف يقوم ممرض متمرس
لسحب الدم.
الفحص الطبي سيكون مجانيا .والمعلومات التي سوف تعطونها سنبقى كيد الكتمان .أن مشاركه في هذه الدراسه اختياري .يمكنكم رفض
المشاركه او االنسحاب قِي اَي وقت.
نحن نقدر مشاركتكم معنا إلتمام هذه الدراسة.

موافقه الوالد/الوالده:

موافقه الطفل:

أوافق على الموافقة شخصيا

أوافق على مشاركة ابني/ابنتي في الدراسة

االسم—————— :

اسم االبن/االبنه———— :

اإلمضاء———— :

امضاء الوالد/الوالده———— :

موافقه على المشاركه مستقبال وتزويد بنتائج الفحوصات:
………………………Email:

التوقيع.......................…..:

اسم الممرض او منسق هذه الدراسه:
االسم ——————:

اإلمضاء————:
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Appendix 7: DM prevention questionnaire
Adults with Pre-diabetes (Fasting PG 100-125 mg/dl or HbAIC 5.7-5.4)
Q1. Patient Name:--------------------------------------------------------------االسم
Q2. Contact address. House number---------------- رقم المنزلStreet name and Number--------------------------رقم اسم الشارع
Q3. Cell Phone (from file and no need to ask the patient)------------------رقم الهاتف-النقال
Q4. Email Address ( of available if less than 50 years)-------------------------- البريد
االلكتروني
Q5.house phone number:----------------------رقم هاتف المنزل
Q6. Patient ID (from file and no need to ask the patient)--------------------رقم البطاقه
Q7.last visit Date: --------------\Dayيوم---------\Monthشهر---------\Yearسنه----------- اخر
زيارة للعيادة
Q8 .what was the fasting glucose level-------,  معدل سكر الدمQ8b A1C level------------معدل السكر التراكمي
-Q9. Date of birth or Age-------------------------------العمر اةو تاريخ الميالد
Q10. Gender(from file and no need to ask the patient) . (tick)
)الجنس

Male ( ) Female 2 (

Q11. Marital status 1 Single ) ( غير متزوج2 married ) ( متزوج3 widowed ) ( ارملة4
Divorced الحالة االجتماعية (مطلق
Q12. Occupation (Job)?  المهنهHouse wife 1 ) (ربه منزل2Health care ) ( مهني صحي3
Army\police ) ( شرطي\عسكري4. Office job ( ) 5. Business ( )
6. Others jobs (specify)مهن اخرى--------------------------------------------------------------Q13. Education (tick) ( formal schooling) مستوى التعليم
1 2 3 4 5 6 7 ( primary)  االبتدائية8 9 10 11 12 ( high school)  ( ) ( الثانويهcollege)
 ( ) ( جامعيuniversity) ( ) no schoolامي
Risk assessment تقييمالمخاطر
Q14 Are you physically active ( at least 30 minutes daily at work or during leisure
time)?
YES ( ) No ( ) دقيقع يوميا خالل العمل او للترفيه71 هل امارس الرياضة على االقل
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Q15 how often do you eat vegetable or fruits?كم مرة تتناول الخضروات والفواكه
Every day ( )  كل يومnot every day ( )ليس كل يوم
Q16 do have high BPor hypertension?هل تعاني من ارتفاع في ضغط الدم
YES ( ) No ( )
If Yes
Q17Are you taking medication for high BP?هل تتناول دواء الرتفاع ضغط الدم
YES ( ) No ( )
Q18 For married people only: have you ever been found to have high glucose during
pregnancy? ( do not ask the question is the patient is single or male) هل:للمتزوجات فقط
كنت تعاني من ارتفاع في نسبة السكر اثناء الحمل
YES ( ) No ( )
Q19 have your family members (parents, brothers, sisters) been diagnosed with
diabetes?
YES ( ) No ( )هل لديك اقرباء من الدجة االولى ( والدين اخ اخت) يعانون من ارتفاع في مرض السكري
Q20 have your other relative (second degree relative grandfather, aunt, uncle, first
cousin) been diagnosed with diabetes?
YES ( ) No ( ) هل لديك اقرباء من الدجة الثانية
( جد جدة عم خال عمه خالة) يعانون من ارتفاع في مرض السكري
Q21 have your doctor ever told you that you have diabetes?
طبيبك باخبارك بانك تعاني من مرض السكري

YES ( ) No ( ) هل قام

If yes
Q22 if yes, how long you have been told that you have diabetes? ما هي الندة التي تعاني
منها من مرض السكري
Month-------years------Q23 were you prescribed any treatment foe diabetes?
لمرش السكري

YES ( ) No ( ) هل تتناول الدواء

Q24 if yes what type of treatment? ما نوع العالج الذي تاخذه لعالج السكري.اذا نعم
Diet ( ) الحمية الغذائيةTablet ( ) حبوبinsulin injection ( )ابر االنسولين
Q25 Do you have a blood sugar device checking device at you home? YES ( ) No (
)هل لديك جهاز لفحص السكر بالمنزل؟
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Q26 Do you smoke cigarettes? Never ( ) Yes currently ( ) yes in the past ( ) هل تدخن
السيجارة؟
Q27 Do you smoke shisha? Never ( ) Yes currently ( ) yes in the past ( ) هل تدخن
الشيشه
Q28 Do you smoke Medyat? Never ( ) Yes currently ( ) yes in the past ( ) هل تدخن
المدواخ
International physical acitivty questionnaire:
Q29 during the last 7 days, on how many days did you walk for at least 10 minutes at
a time?
Number of days in a week------ 11 في سبع ايام الماضية هل قمت بممارسة رياضة المشي لمدة
-دقائق؟
Q30 how long do you usually spend walking on one of these days? الوقت المستغرق في
المشي لليوم الواحد
Hours-------minutes----Q31 During the last 7 days how many days did you spend doing moderate activates
such as cycling or playing a game which will make you breathe somewhat harder
than normal?
Number of days------ في سبع ايام الماضية هل قمت بممارسة رياضة كالدراجة او اي رياضه او لعبة
-ذات مجهود متوسط بحيث تزيد من سرعه التنفس لديك ؟
Q32 how long do you usually spend doing moderate activity on of these days?
Hours-----minutes---الوقت المستغرق لممارسة تلك الرياضه لليوم-الواحد
Q33 During the last 7 days how many days did you spend doing vigorous activates
for at least 10 minutes at a time such as running or playing football or other game
which will make you breathe somewhat harder than normal? في سبع ايام الماضية هل قمت
بممارسة رياضة قاسية كلعب الكرة او الجري السريع بحيث تزيد من سرعه التنفس لديك
Number of days-----Q34 how long do you usually spend doing vigorous activity on of these days?
Hours-----minutes----الوقت المستغرق لمم-الواحد

Digitally signed by
Shrieen
DN: cn=Shrieen,
o=United Arab Emirates
University, ou=UAEU
Library Digitizatio,
email=shrieen@uaeu.ac.
ae, c=AE
Date: 2020.02.10
11:25:47 +04'00'

